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ABSTRACT 
- This thesis describes the chemical arld,biological investigation of the'extracts 
of six different marine invertebrate organisms collected along the South African 
coastline. The work on these extracts has resulted in the isolation and structural 
elucidation of twenty-one previously undescribed secondary metabolnes; 
The history of marine natural product chemistry in South Africa has not 
previously been reviewed and so a comprehensive review covering the literature from 
the 1940's up until the end of 1995 is presented here. 
The marine ascidian Pseudodistoma species collected in the Tsitsikamma 
Marine Reserve was shown to contain four new unsaturated amino alcohols [47], [48], 
[49] and [50] which were isolated as their acetyl derivatives. These compounds 
exhibited strong antimicrobial activity. 
Four new pyrroloiminoquinone alkaloids, the tsitsikammamines A [90] to 0 [93], 
were isolated from a new genus of Latrunculid sponge collected in the Tsitsikamma 
Marine Reserve. These highly pigmented compounds also possessed strong 
antimicrobial activity. 
An investigation of two phenotypic colour variants of the soft coral Capnel/a 
thyrsoidea resulted in the isolation of the known steroid 5a-pregna-1,20-dien-3-one 
. "- - . 
[97] and an additional six new metabolites, 16~-hydroxy-5a-pregna-1 ,20-dien-3-one 
16-acetate [98], 3a,16~-dihydroxy-5d-pregna-1,20-diene 3,16-diacetate [99] and four 
xenicane diterpenes, the tsitsixenicins A [100] to 0 [103]. This is the first reported 
isolation of xenicane diterpenes from the soft coral family Nephtheiidae. Tsitsixenicin 
A and B showed good anti-inflammatory activity by inhibiting superoxide production in 
both rabbit and human cell neutrophils. 
A further four new metabolites were isolated from two soft corals which could 
only be identified to the genus level and were designated Alcyonium species A and 
species B. Alcyonium species A was collected in the Tsitsikamma Marine Reserve and 
yielded two new polyhydroxysterols, cholest-5-ene-3~, 7~, 19-triol 19-acetate [121] and 
cholest-5,24-diene-3~,7~, 19-triol 19-acetate [122]. The soft coral Alcyonium species 
xiii 
B was collected off Aliwal Shoal and was found to contain two known xenicane 
diterpenes, 9-deacetoxy-14,15-deepoxyxeniculin [110] and zahavin A [16], and two 
new xenicane diterpenes, 7 -epoxyzahavin A [123] and xeniolide C [124]. Compounds 
[110], [16] and [123] exhibited strong anti-inflammatory activity and compounds [110] 
and [16] showed good antithrombotic activity. 
The endemic soft coral A/cyanium fauri collected at Riet Point near Port Alfred 
yielded the new sesquiterpene hydroquinone rietone [141] in high yierd, fogether with 
the minor compounds 8'-acetoxyrietone [142] and 8'-desoxyrietone [143]. Rietone 
exhibited moderate activity in the NCl's in-vitro anti-HIV bioassays. 
xiv 
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CHAPTER ONE 
INTRODUCTION 
1 
1.1 INTRODUCTION 
Natural products from terrestrial sources have long provided a valuable source 
of useful pharmaceuticals, for example,- penJc~lIin from bread mould, aspirin .from the 
bark of willow trees, cardiac glycosides from the digitalis plant, morphine from opium 
poppies and insulin from cattle and sheep. It has been estimated that marine species 
comprise approximately half of the total global biodiversity1 and benee it seems 
reasonable to assume that the marine environment offers an enormous potential 
resource for novel compounds with possible pharmaceutical value. Added to this is the 
fact that marine invertebrate organisms have evolved over millions of years in a fairly 
stable environment and so have had the lUxury of time to divert their energy resources 
into the development of toxic secondary metabolites as an integral part of a chemical 
survival strategy2. 
It is only in the last three decades that marine natural products as a research 
field has evolved and grown considerably. There are many reasons which contribute 
to this late development. Firstly, man is primarily land based and so has -concentrated 
on utilizing his immediate terrestrial resources. Secondly, the use of SCUBA and 
submersibles which have given access to the marine environment is relatively new 
technology, and thirdly, there is a distinct lack of marine taxonomic literature and 
taxonomic studies in many parts of the world. The first comprehensive review of marine 
natural products did not appear unm 19733 and since then a host of papers have been 
published detailing the identification of novel marine natural products often with 
interesting biological activity. The field has been reviewed with regularity, in particular 
through the efforts of Faulkner4-14 and Scheuer·15-23. Faulkner has recently estimated 
that approximately 6500 marine natural products have been isolated24 and these have 
the following phylogenetic distribution (FIGURE 1.1). 
From these data it is clear that the international research effort has concentrated 
on soft bodied, sessile invertebrate phyla. The rationale behind this trend is the fact 
that these phyla produce an abundance of secondary metabolites for use in predator 
2 
defence, antifouling, inhibition of overgrowth, protection from ultraviolet radiation and 
as mediators in the competition for settling space25•26• It is these metabolites which may 
be of pharmaceutical value. 
[iJ ALGAE 
~ SPONGES 
II COELENTERATES 
~ OTHER (ascidians;opisthobranch molluscs; echinoderms; bryozoans) 
FIGURE 1.1 Phylogenetic distribution of marine natural products- isolated by 
researchers worldwide until 1994. 
With the exponential growth in marine natural product research several 
questions have arisen and problems have been encountered which require urgent 
attention. It has been suggested that many marine natural products are in fact not 
produced independently by the invertebrate but are a consequence of a symbiotic 
relationship between the host and micro-organisms27. This has opened up a whole new 
research area fraught with new problems. Symbionts often have unknown nutritional 
needs so that although the culture of marine microbes has the potential to provide large 
quantities of natural products 1 only around 10 per cent of marine bacteria observed by 
microscopic examination can be cultured in media employing methods designed for 
terrestrial bacteria28. Faulkner has suggested that the problem of defining the role of 
symbionts in producing marine natural products will indeed challenge researchers for 
years to come24. 
3 
A major hindrance in the search for new drugs is that the yields of pure 
compounds from marine invertebrates are so small that the natural resource cannot 
provide sufficient material for commercial development. Although extensive in vitro 
testing of a drug can be accomplished with mjll!gram quantities, usually several grams 
are required for full in vivo evaluation and hence an adequate supply of the drug can 
become a major limiting factor in the completion of clinical trials29. Previously the 
approach has been to collect larger quantities of the material. For exanwle-"J it is claimed 
that 1600 kg of the sea hare Do/abel/a auricularia was collected to obtain 10 mg of 
dolastatin 13 which shows activity against melanoma3o , in excess of 2400 kg of the 
Indo-Pacific sponge Spirastrel/a spinispirulifera was required to yield a few milligrams 
of the spongistatin anticancer compounds31 and 10 000 gallons of a bryozoan was 
needed to provide sufficient bryostatin 1 for clinical trials32• 
Recently this approach has incited criticism with protests that the ocean is being 
plundered in the name of science30 and rightly so taking into account the above 
examples. There is a definite need to consider environmental implications as little is 
known of just how fragile reef ecosystems are and how rare the collected- invertebrates 
may be. It is also often the developing countries which are sacrificing their precious 
natural resources33. The need to address these problems has fortunately been 
recognised with the United Nations Biodiversity Convention providing a basis to try and 
resolve these issues34. Strict control measures need to be introduced into legis~ation 
and a greater effort made to investigate the possible aquaculture of marine organisms 
to ensure a better relationship between environmentalists, scientists and multinational 
pharmaceutical companies. 
1.2 HISTORY OF MARINE NATURAL PRODUCT RESEARCH IN SOUTH AFRICA 
Arguably, the start of marine natural product chemistry, per se, in South Africa 
began during the 1940's and gained momentum during the 1950's. At this time the 
National Chemical Research Laboratory in Pretoria was internationally recognised as 
4 
a leading laboratory for the isolation and synthesis of long chain fatty acids. Initial work 
focused on the characterisation of highly unsaturated fatty acids and alcohols derived 
from South African fish oils35-39. The quality of this research was acknowledged in the 
Annual Report of the-Chemical Society for 1 ~q440, which called the paper bySilk and 
Hahn39, on the the isolation of hexadeca-6,9, 12,15-tetraenoic acid from pilchard oil, an 
"outstanding achievement". 
In Grahamstown, in the late 1950's, Nunn and co-workers pioneered research 
into the polysaccharides of seaweeds. Particular attention was paid to red seaweeds, 
resulting in the isolation of several polysaccharides from Graci/aria confervoides41 , 
Porphyra capensis42 and Hypnea specifera43• This work continued in the 1960's and 
into the early 1970's. During this time Parolis completed an investigation of the 
sulphated polysaccharides produced by the red seaweeds Aeodes orbitosa and 
Phyllymena cornea44 , and then joined Nunn in supervising further research into 
sulphated polysaccharides from the red seaweeds Pachymenia carnosa45 , Anatheca 
dentata, Chaetangium erinaceum46 , and Aeodes u/voida47 . 
In 1972 a report was compiled by the South African Prime Minister's Planning 
Advisory Council's Committee on Ocean Affairs entitled "Drugs from the Sea"48 which 
provided a fairly detailed review of the medicinal potential of marine plants and animals 
and concluded with the following statement: 
"Very little attention has as yet been paid in South Africa to 
the recovery of drugs from the sea. This field offers exciting 
and rewarding challenges to South African scientists. Once 
research brings down the unit cost, the sea may offer a vast 
potential for the production of drugs for South Africa." 
Unfortunately, little heed was taken of this report and, with the exception of the 
research of Nunn and co-workers, the field of South African marine natural product 
chemistry remained largely unexplored. It was only in 1977 that consideration was 
5 
once again given to the abundant potential of the South African coast line for natural 
product research and it was around this time that a Natural Product Research Group 
was established at the University of Cape Tow~ (UCT) under the direction of Elsworth 
and Cragg49. The aim of this group was to investigate primarily the terrestrial, and to 
a lesser extent, the marine natural product chemistry of indigenous South African 
species. 
Initial marine research involved analysing the sterol composition of two oceanic 
and three intertidal species of annelid by combined GC-MS techniques in collaboration 
with Ballantine in Swanseaso. It was reported that the oceanic annelids had more 
complex sterol profiles containing small quantities of Sa-stano Is while the intertidal 
species had simpler profiles with the absence of 5a-stanols. It was also found that 
lugworm species from South Africa and south Wales exhibited almost identical sterol 
compositions. This research was further extended to the steroidal analysis of two sea 
anemones, the ribbed mussel Aulacomya ater, starfish Marthasterias glacialis and 
Henricia ornata, and the sea cucumber Cucumeria frauenfeldiP1.52. More challenging 
projects involved attempts to characterise toxins from the sea hare Notarchus leachi 
and the puffer fish Amblyrhynchotes honckenip2. Difficulty was experienced in isolating 
and determining the pure compounds responsible for activity. 
In 1979 Pettit visited UCT, providing fresh input and enthusiasm, and by the end 
of the year a nearly-pure neurotoxin had been isolated from Notarchus leachp3. It was 
obtained as a yellow oil with the molecular formula C14H29NOs. Unfortunately the 
complete structure remained undetermined. Elsworth, while on sabbatical leave in 
Pettit's laboratory, investigated marmorastatin 1, a toxic glycoside from the sea 
cucumber Bohadschia marmorata54• FABMS was used to confirm the molecular formula 
of this compound as CS7H110032' Acid hydrolysis of the isolate suggested a mixture of 
genins with marmorastatin 1 as the predominant glycoside. After various hydrogenation 
and acetolysis studies the partial structures [1], [2] and [3] were proposed for 
marmorastatin 1. 
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At the end of 1983 Elsworth put forward a proposal for establishing a separate 
Marine Natural Product Chemistry Unit at UCT. He argued that, with considerable 
funding available to other marine sciences such as oceanography, oceanology and the 
Benguela Project, it was high time that marine natural products received much-needed 
attention54• Unfortunately his plea went unheeded. 
[4] [5] 
In 1986 results from the toxicity studies on the South African puffer fish 
Amb/yrhynchotes honckenii were published55. It was assummed that tedrodotoxin [4], 
previously isolated from a Japanese puffer fish, was the toxic principle. A new 
chamigrane [5] was isolated in 1989 from the red seaweed Laurencia g/omerata by 
Elsworth in collaboration with Thomson in Aberdeen56. This brought an end to the 
contributions of UCT to South African marine chemistry. 
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Perhaps the most pharmacologically successful South African marine natural 
products to be isolated so far, as well as among the most environmentally controversial, 
are several spongistatins reported by Pettie1.~7. An investigation of the antineoplastic 
constituents of a brightly coloured sponge Spirastrella spinispirulifera collecled off the 
south coast of Africa was begun in 1973. However, increasingly large (up to 360 kg) 
recollections of the sponge up until 1980 proved inadequate for the chemical/biological 
research. A further 2409 kg of the sponge was recollected and this -affOrded 10.7 mg 
of colourless spongistatin 4 [6] and 12.9 mg of spongistatin 5 [7]31. Evaluation of these 
two compounds against the US National Cancer Institute's (NCI) panel of 60 human 
cancer cell lines gave dramatic results and [6] and [7] were reported as being amongst 
the most potent of all substances tested in the NCI screen. Further work-up yielded 1.8 
mg of spongistatin 8 [8] and 5.4 mg of spongistatin 9 [9]57 which revealed an overall 
potel}cy comparable to or exceeding that of the previously isolated spongistatins. 
Importantly, spongistatin 9 along with spongistatin 1 (isolated from a Republic of 
Maldives' Spongia species58) appear to be the most potent cancer cell growth inhibitory 
antimitotic substances discovered to date. 
The decline of marine chemistry at UCT again left the South African coast wide 
open for marine natural product research. In the early 1990's two different groups of 
researchers emerged to fill the void. At Rhodes University in Grahamstown, Davies-
Coleman founded a Marine Pharmaceutical Discovery Programme in collaboration with 
Faulkner in Califomia and later with -SmithKline Beecham Pharmaceuticals (SKB) in the 
US34. Initial marine invertebrate collections were undertaken around the south east 
coast of South Africa but later extended to include the entire coast (FIGURE 1.2). At 
about the same time Kashman in Israel began to analyse marine invertebrate 
specimens supplied by Schleyer of the Oceanographic Research Institute in Durban 
and collected in the Sodwana Bay Marine Reserve situated on the north east coast of 
South Africa. 
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NAMIBIA MOZAMBIQUE 
Johannesburg _ 
SOUTH AFRICA 
RESEARCH GROUP 
Rhodes 1 SKB* 
Kashman 
Rhodes 1 SKB 1 Faulkner 
Faulkner 
Rhodes 
Rhodes 
Rhodes 
Rhodes 
Rhodes 1 SKB 
Durban 
Port St Johns 
YEAR 
1994/5 
1993 -
1994 
1992 
1992 -
1992 -
1992 -
1995 
1996 
LOCATION 
Ponto do Duro, Mozambique 
Sodwana Bay Marine Reserve 
Aliwal Shoal, Umkomaas 
Wild Coast, Transkei 
Riet Point, Port Alfred 
Algoa Bay, Port Elizabeth 
Tsitsikamma Marine Reserve 
Mossel Bay 
Hout Bay, Cape Town 
SKB*- SmithKline Beecham Pharmaceutical's marine drug discovery under the 
direction of Dr Brad Carte. 
FIGURE 1.2 Marine invertebrate collection sites around the coast of southern Africa 
for the purpose of marine natural product research. 
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The following reviews the chemical compounds isolated and characterised by 
the two research groups until the end of 1995 but excludes compounds isolated by the 
author which are covered in later chapters. T~e research efforts of both groups have 
largely focused on the chemistry of soft corats, sponges, ascidians and molluscs and 
hence the work is presented here in this phylogenetic order. 
In 1992, a survey of the marine invertebrates off the Wild Coas[ or the Transkei, 
whJch lies on the east coast of South Africa, resulted in the collection of ninety different 
sponges, ascidians and soft corals. Screening of the extracts of these invertebrates by 
Faulkner and co-workers revealed a rather disappointing incidence of bioactivity. A 
secondary screening of the crude extracts by 1H NMR spectroscopy led to the 
investigation of a yellow soft coral, A/cyonium va/diviae. This apparently endemic soft 
coral59 yielded the valdivone diterpene esters [10] - [14r. Although the valdivones 
proved inactive against a standard panel of bacteria and fungi, it was shown that 
valdivone A and B exhibited fairly strong inhibition of chemically-induced inflammation 
in the mouse ear assay. A curious observation in the report was the close relatLonship 
between the valdivones and the sarcodictyins61 .62 , despite the fact that the producing 
organisms, A/cyonium va/diviae (Order Alcyonacea) and Sarcodictyon roseum (Order 
Stolonifera), belong to different orders of the class Alcyonaria. Williams reports that the 
only previous record of the occurrence of the genus Sarcodictyon in southern Afri~ is 
also from a location on the Transkei coast59. It would be interesting to ascertain 
whether this stoloniferous octocoral also contains diterpene esters analogous to the 
valdivones. 
[10] R1 = H 
[11] R1 = H 
[12] R1 = Me 
[13] R1 = Me 
[14] R1=H 
R2 = a 
R2 = b 
R2 = a 
R2 = b 
R2 = C 
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[15] [16] R = H 
[17] R = OH ~ ~ ~ 
Kashman and co-workers have had an ongoing interest in the comparison of 
Red Sea soft corals with their Indo-Pacific counterparts and have recently investigated 
two Indo-Pacific soft corals from two different reef-inhabiting genera, Anthelia g/auca 
and A/cyanium aureum, collected from Sodwana Bay63. This species of A. g/auca, in 
contrast to the Red Sea species64, contained a single diterpenoid, antheliatin [15]. The 
second soft coral, reported as the newly described A. aureum, yielded two new 
xenicane diterpenes, zahavins A [16] and B [17]. Immediately prior to the publication 
of these results, the author had completed the isolation of several metabolites from an 
undescribed A/cyanium species (designated A/cyanium species B - see chapter five) 
collected from Aliwal Shoal and found that this A/cyonium species also contained 
zahavin A. All three compounds [15] - [17] were cytotoxic towards mouse leukaemia, 
human lung carcinoma, human melanoma and human colon carcinoma cell lines. 
N()<0 . H, 0-0 OMe RO ' .... _ ... ;."'~ 
[18] R = H 
[20] R = Me 
IT H" . .jo-°VoMe H 0-0 H 
RO/"-./"=I_·· """"~ 
[19] R = H 
[21] R=Me 
Although widespread in all tropical and subtropical seas, a collection of the 
sponge P/akoriis simp/ex from Sodwana Bay was the first report of this sponge's 
occurrence along the South African coast. The sponge afforded four new C16 1,2-
12 
dioxene polyketides [18] - [21ts. A number of similar oxygenated polyketides have 
previously been reported from sponges of the genus Plakortis66•67• The facile acid 
catalysed decomposition of [18] and [19] was suggested as a reason for the instability 
of these compounds even when stored at low temperature under nitrogen. Although this 
instability precluded an examination of the bioactivity of [18] and [19], their more stable 
methyl esters [20] and [21] exhibited cytotoxicity towards cultured murine leukaemia 
cells. 
o 
o 
[22] [23] 
[24] 
Six triterpenoids, sodwanones A-F, were isolated from the Indo-Pacific purple-
brown fan sponge, Axinella weltneri, collected in Sodwana Bay6s.69. The structure of 
. "- - . 
sodwanone A [22] was unambiguously determined by X-ray diffraction studies and it 
was found that [22] appears in higher concentration (0.1 %) relative to the other 
sodwanones which exist in the sponge in minute amounts (0.01-0.005%). The 
sodwanones are closely related to the previously reported sipholenols70, siphonellinol71 
and neviotine A72 , isolated from the Red Sea sponge Siphonochalina siphonella, and 
the raspacionins73, isolated from the Mediterranean red sponge Raspaciona aculeata, 
providing further evidence of a close affinity between metabolites isolated from 
Sodwana Bay marine invertebrates and those from other subtropical marine 
environments. A recent recollection of A. weltneri has yielded a further three 
triterpenoids, sodwanones G [23], H [24] and f4, which exhibited cytotoxic activity 
against several cancer cell lines. 
13 
H a a~»OH 
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[25] 
Fractionation of the EtOAc extract of the Indo-Pacific sponge Phorbas aff. 
e/athrata led to the isolation of four novel oxazole derivatives, the phor-bazoles A_D75. 
The_structure of phorbazole A [25] was determined by X-ray diffraction studies on its 
dimethyl derivative. Although there are numerous reports of oxazoles, pyrroles and 
bromopyrroles being isolated from marine sponges, these compounds appear to be the 
first examples where chlorination of the oxazole and pyrrole ring systems has occurred. 
HO Br Br OH 
Br 
OH 
OH 
[26] 
HO Br Br 
OH 
[27] R = H 
[28] R = Me 
OR 
Br 
A newly discovered translucent white colonial ascidian, Po/yeitor species, 
yielded three novel compounds, polycitone A [26] and polycitrins A [27] and 8 [2Sfs. 
The structures were established by NMR spectroscopy and, in the case of [26], also 
by single-crystal X-ray diffraction analysis. These compounds represent novel marine 
alkaloids with unprecedented skeletons and Kashman and co-workers proposed a 
plausible biogenetic relationship between these compounds and the lamellarins, which 
were first isolated from the prosobranch mollusc Lamel/aria species77 and then from the 
ascidian Didemnum ehartaeeum78• 
14 
Gastropod molluscs of the subclass Nudibranchia lack the usual protective 
molluscan shell and so have developed an alternative defense mechanism which 
involves the sequestering of dietary chemic~ls79.80. These chemicals are generally 
obtained from sponges, soft corals and bryo20ans. 
~ ~ ~ 0 .~H6 
[29] [30] [31] [32] 
A chemical investigation of the endemic nudibranch, Leminda millecra81 , 
colle~ted off the Transkei coast, resulted in the isoli3tion offour new sesquiterpenes, 
millecrone A [29] and B [30] and millecrol A [31] and B [32]. These metabolites are 
typical of those found in soft corals and an investigation of the digestive gland of L. 
millecra revealed spicules belonging to the soft corals A/cyonium fo/iatum, A. vakJiviae 
and Capnella thyrsoidea. A/cyonium and Capnella genera are known to produce 
sesquiterpenes82.83. It is interesting to note, however, that an investigation of the 
chemistry of A. va/diviae by Faulkner60 and the chemistry of C. thyrsoidea by the 
authorB4 (see chapter four), both collected off the South African coast, yielded 
diterpenes but no sesquiterpenes. 
, 1 /'" Ir "-/ "'" 
a·"'···· 
o 
o 
OH 
[33] [34] 
Specimens of the brilliantly coloured nudibranch, Chromodoris hami/toni, were 
collected off Aliwal Shoal using SCUBA. Extracts were found to contain four unusual 
chlorinated homo-diterpenes, hamiltonins A [33], B, C and D, and a new sesterterpene 
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hamiltonin E [34]85. The ability of nudibranchs to use dietary chemicals for defense was 
demonstrated with the additional isolation of the known toxins latrunculin A and B. An 
inspection of the nudibranch gut contents ~evealed spicules typical of the genus 
Latrunculia. LatruncLJlins A and B were previE>usly reported from the sponge Latrunculia 
magnifica86 and, as part of their biological activity, cause disruption of cytoskeletal 
proteins. 
1.3 THESIS OBJECTIVE 
This aim of the work presented in this thesis was to isolate and identify 
biologically active natural products from South African marine invertebrates. This 
rese?rch forms an integral part of a programme to ~ystematically collect, classify and 
screen South African marine invertebrates and their extracts for interesting chemistry 
and biological activity. Based on these results individual invertebrates are selected for 
further chemical analysis with the aim of discovering agents of potential pharmaceutical 
benefit. 
1.4 COLLECTION AND SCREENING 
Coastal southern Africa, from the Skeleton Coast of Namibia to southern 
Mozambique, has a remarkably rich and diverse marine fauna and flora with over 10 
000 species or almost 15 per cent of all the coastal marine species known worldwide87. 
The benthic environment of southern Africa is extremely varied with a high degree of 
endemism. Day reported that approximately 66 per cent of the benthic invertebrate 
species from False Bay are South African endemics88. A specific example is the 
octocoral cnidarians, which are probably the most extensively studied of the South 
African marine invertebrates, with at least 200 species and as high as 60-70 per cent 
endemism59. This provides an incredibly wealthy and unexplored natural resource for 
the possible discovery of new pharmaceuticals. 
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This research thesis describes the chemistry of selected marine invertebrates 
which have been collected from four different localities on the South African coast 
ranging from the subtropical conditions of the. Aliwal Shoal on the Natal coast to the 
warm temperate environment of the Tsitsikamma Marine Reserve in the southern Cape. 
A total of 350 different marine invertebrates were collected by the research group 
based at Rhodes University between 1992 and 1995. This relatively large collection 
shows the following phylogenetic distribution (FIGURE 1.3). ~ - ~ 
~ SPONGES 
~ SOFT CORALS 
EJ NUDIBRANCHS 
~ ASCIDIANS 
m GORGONIANS 
~ OTHER 
FIGURE 1.3 Phylogenetic distribution of the Rhodes University marine invertebrate 
collection between 1992 and 1995. 
Crude organic and aqueous extracts of each of these 350 marine invertebrates 
have been screened using both 1H NMR spectroscopy and antimicrobial activity 
assays. The simple, relatively inexpensive, antimicrobial bioassay is used by many 
marine natural product research groups as a primary screen for biological activity. 
Therefore, restricting an investigation by pursuing projects on the basis of good 
antimicrobial activity contains an increased risk of isolating previously described 
compounds. 
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For example, a grey-brown sponge, Ircinia species, collected in the Tsitsikamma 
Marine Reserve afforded the antimicrobial sesterterpene tetronic acid, variabilin [35]t. 
First isolated by Faulkner in 1973 from the sponge Ircinia variabilis89 , it has 
subsequently been- reported from oUler ircinia species90 as well as other sponge 
genera91 -93• 
OH 
o 
[35] 
Remarkably, the stereochemistry at the C-18 position remained undefined for 
a period of twenty years until there was a sudden recent renewed interest in this 
compound with two papers simultaneously reporting an 18S-configuration for samples 
of variabilin isolated from an Okinawan Amphidmedon species93 and from southern 
Australian sponges94• More recently the existence of 18R-variabilin in the Caribbean 
sponge, Ircinia felixOO has been reported. A matching optical rotation of variabilin from 
southern Australia94 and that from the South African Ircinia species suggests al) 18S-
configuration for the latter. 
OH 
[36] 
A further example of the discovery of a known antimicrobial compound, was the 
isolation of the polypropionate antibiotic pectinatone [36]*, from the marine mollusc 
Siphonaria concinna. This crystalline compound, containing a y-hydroxy-a-pyrone ring 
system, was previously isolated from skin extracts of Siphonaria pectinata95 and 
reported to have a 9S, 11 R, 13S stereochemistry". However, this was later revised to 
a 9S, 11 S, 13S stereochemistry based on X-ray diffraction analysis as well as 
degradative studies96. 
t and * -Unpublished results. Experimental details reported in chapter seven (section 7.2). 
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The following chapters provide a detailed description of twenty-one new compounds 
that have been isolated from South African marine invertebrates. Where possible every 
attempt has been made to explore the full ph~rmaceutical potential of each of these 
compounds. 
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CHAPTER TWO 
NEW ANTIMICROBIAL C13 AND C14 AMINES FROM A SOUTH 
AFRICAN MARINE ASCIDIAN PSEUDODISTOMA SPECIES 
20 
2.1 INTRODUCTION 
Ascidians belong to the phylum Chordata, which encompasses all vertebrate 
animals, and repr.asent the most highly ,evolved group of animals commonly 
investigated by the marine natural product researcher. In the early 1990's there was a 
surge of interest in ascidian chemistry largely due to the high incidence of biologically 
active metabolites produced by these organisms. The bioactivity of many ascidian 
extracts is often attributed to the specialised ability of ascidians to biosynthesise amino 
acid derivatives, containing as much as 89 per cent by mass of nitrogen97. 
Amongst the nitrogenous compounds produced by ascidians are a number of 
unsaturated acyclic amines and amino alcohols. Examples include the C12 and C14 
diene and triene amines [37] - [40] from an orange compound ascidian, Pseudodistoma 
novaezelandiae, collected from the North Island of New Zealand98. This ascidian was 
reported to be extremely abundant, reaching up to 25 per cent cover in shallow subtidal 
reefs. It is suggested that this profusion is probably due to a lack of predation or fouling 
caused by the presence of high levels of toxic amines in these invertebrates. 
[37] 
[39] 
[40] 1113 
[38] 
The cytotoxicity and antimicrobial activity displayed by the alcoholic extract of 
the Mediterranean ascidian, Pseudodistoma crucigaster, during a systematic screening 
exercise, led to its selection for further analysis. This analysis resulted in the isolation 
of three polyunsaturated amino alcohols, the crucigasterins [41] - [43t9• Difficulty was 
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experienced in separating the parent compounds. Although acetylation of a portion of 
a mixture of the amino alcohols improved the chromatographic separation, it was found 
that these compounds (both natural products and their acetyl derivatives), especially 
[41Jand [42], were blnstable when concentrat~d in a pure form, even below-20 °C. 
OH 
NH2 
~CH.z)5f 
~ 13 
OH 
[43] 
[41] 
[42] /117 
[44] /15 
[45] /14 
[46] /13 
The significant antifungal activity of the extract of an orange encrusting ascidian, 
Didemnum species, collected from the Great Barrier Reef, prompted a chemical 
investigation of the extract. The study resulted in the isolation and structural elucidation 
of the major antifungal compound [44too. Two minor congeners, [45] and [46], proved 
refractory to HPLC separation and so a portion of a mixture of these was treated with 
. ,,- .. 
di-tett-butyl dicarbonate followed by separation using HPLC and structural elucidation 
of the corresponding N-Boc derivatives. 
Amino alcohols are not only confined to ascidians and also occur in sponges of 
the genus Xestospongia101.102. As with the ascidians, the isolation of the parent amino 
alcohols from these sponges proved problematic. Gulavita and Scheuer101 relied on 
mild acetylation followed by HPLC in order to characterise the amino alcoholsfrom a 
Xestospongia sponge collected from Papua-New Guinea. Jimenez and C rews1 02, 
however, working with a sponge of the same genus collected from Fiji, managed to 
separate the amino alcohols in their native state using reverse phase HPLC, but this 
involved a slow flow rate (2 mL min-1) and long retention times (40-60 min). 
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Section 2.2 and 2.3 of this chapter describes the isolation and identification of 
four new antimicrobial, unsaturated amino alcohols, characterised as their acetyl 
derivatives [47] - [50], from the EtOAc extract of a South African marine ascidian, 
Pseudodistoma species 103. 
tJHAc 
~ 3 /"'-..,-;A... /"'-.. ,-;; 
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[48] 115 
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2.2 COLLECTION, EXTRACTION AND ISOLATION 
FIGURE 2.1 Colonial ascidian, Pseudodistoma species, collected from The KJ:l911.i~ 
the Tsitsikamma Marine Reserve. 
A pink-orange colonial ascidian, Pseudodistoma species (Family: Polyclinidae, 
Order: Aplausobranchia) (FIGURE 2.1), was collected in the Tsitsikamma Marine 
Reserve in May 1993 using SCUBA from depths of -20 to -30 m and stored frozen. A 
portion of this ascidian was subsequently freeze-dried (dry weight 256.9 g) and steeped 
in hexane, EtOAc and MeOH respectively. All three crude extracts showed strong 
antimicrobial activity against the Gram-positive bacteria Staphylococcus aureus and 
Bacillus subitilis, and Gram-negative bacteria Escherichia coli and Pseudomonas 
aeruginosa, with the greatest activity residing in the EtOAc extract. The antimicrobial 
activity guided chromatography of a portion of the EtOAc extract was performed 
according to SCHEME 2.1. 
24 
EtOAc extract 
(900 mg) I..------r--------il (a~ 
50",{, hexane/EtOAc EtOAc MePfI 
(180 mg) (40 mg) (319 mg) 
15% MeOH/CHCh 
(90 mg) 
PLEASE NOTE: 
I(b) 
MeOH 
(106 mg) 
I 
REPEAT OF ABOVE 
(1.07 g) 
~ 
(374 mg) 
I (c) 
(476 mg) 
~ 
(284 mg) 
(d) 
:> Use of this character in the above scheme and subsequent 
~ schemes indicates that a portion of the extract fraction was 
removed before proceeding. 
SCHEME 2.1 Chromatographic procedure for the isolation of compounds [47] - [50]. 
(a) flash chromatography (silica, 230-400 mesh, 150 g, elution sequence: 50% 
hexane/EtOAc; EtOAc; MeOH). (b) flash chromatography (silica, 230-400 mesh, 150 
g, elution sequence: 15% MeOH/CHCI3 ; MeOH). (c) acetylation (A~O, RT 12 h, 
pyridine). (d) HPLC (silica, 10 IJ, Whatman, EtOAc, 4 mL min-1). (e) HPLC (C18, 10 IJ, 
Phenomenex, 20% H20/MeOH, 4 mL min-1). (f) HPLC (C18, 10 IJ, Phenomenex, 30% 
H20/MeOH, 4 mL min-1). (g) HPLC (C18, 10 IJ, Phenomenex, 20% H20/MeOH, 4 mL 
min-1). (h) repeat of (g). 
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Although TLC suggested that the MeOH fraction, from flash chromatography, 
contained a single compound (106 mg), multiple resonances of varying intensity in the 
13C NMR spectrum of this fraction suggested a mixture. No normal or reverse phase 
- -
TLC conditions were found that could separate this mixture. The collapse of a broad 
singlet at 5 5.9 in the 1H NMR spectrum of this fraction upon the addition of 0 20, 
indicated the presence of hydroxyl groups. Esterification is a standard method whereby 
the negative contribution of lipophobic alcohol and/or amino funct1o~nalities to the 
overall chromatographic properties of a mixture can be reduced. Accordingly, 
acetylation of a portion of the extract yielded an oil which could be further 
chromatographed to yield compounds [47] - [50]. 
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2.3 STRUCTURE DETERMINATION AND STEREOCHEMISTRY 
2.3.1 Structure determination of the C13 and C14 amines [47] - [50]. 
~HAe 
5 13 
CAe 
[47] 
The major compound, 2-acetamido-3-acetoxy-5,13-tetradecadiene [47], was 
isolated as an optically active, stable, colourless oil. HREIMS established the molecular 
formula as C18H31N03 (m/z 309.2292, ~mmu -8). 13C-NMR data (TABLE 2.1) indicated 
two acetate carbonyl (5 169 and 171) and four olefinic (5114,124,135 and 139) 
resonances fulfilling the required four degrees of unsaturation implied by the molecutar 
formula. A further three methyl, seven methylene and two methine signals in !he"DEPT 
spectrum of [47] supported a simple, acyclic diacetoxy-tetradecadiene structure for this 
compound. The 13C chemical shifts of the two methine signals (5 76 and 47) were 
assigned to carbon atoms attached to acetoxy and acetamido functionalities 
respectively, while the olefinic methylene signal (5 114) in the DEPT spectrum placed 
one of the double bonds in a terminal position. 
The contiguous coupling sequence observed in the COSY spectrum of [47] 
(FIGURE 2.2) from the olefinic proton at 5 5.3 (1 H, dt, H-5) through the overlapping 
allylic methylene protons at 5 2.2 (2H, m, H-4), the acetoxy methine proton at 5 4.8 (1 H, 
m, H-3), the acetamido methine proton at 5 4.2 (1 H, m, H-2) to the terminal methyl 
protons at 5 1.1 (3H, d, J1.2 = 6.8 Hz, H-1) placed the second double bond at ~5 and 
established the C-2, C-3 acetamido-acetoxy substructure of [47]. An HMQC experiment 
enabled full assignment of all the 13C and 1H signals in concurrence with published data 
for substituted linear 2-amino-3-alcohols99.101. 
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FIGURE 2.2 COSY NMR (400 MHz, CDCI3) spectrum of compound [47]. 
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TABLE 2.11H and 13C NMR spectral data for compounds [47] and [48]. 
- [47] [48] 
< 
13C 1H 13C 1H 
1 18.4 q 1.09 d (6.8) 18.5 q 1.09 d (6.8) 
2 46.7 d 4.20m 46.8 d 4.21~m ~ 
-
3 76.1 d 4.82 m 76.1 d 4.82 m 
4 35.0 t 2.22 m 35.0 t 2.22 m 
5 123.9 d 5.30 dt (6.8,15.3) 123.9 d 5.30 dt (7.5,15.0) 
6 134.8 d 5.48 dt (6.9,15.3) 134.9 d 5.47 dt (6.7,15.1) 
7 32.5 t 1.95 m 31.9 t 2.01 m 
- -8 a29.0 t b29.5 t 
9 a28.9 t 1.36-1.25 m b29.3 t 
10 a28.9 t b29.2 t 1.30-1.23 m 
.' 
11 a29.3 t b28.9 t >." 
12 33.8 t 2.01 m 32.6 t 
13 139.2 d 5.79 dq 22.7 t 
14 114.1 t 4.94 dd 14.1 q 0.87 t (6.7) 
OCOCH3 170.6 s 170.6 s 
. "'- - . 
OCOCH3 23.4 q 2.06 s 23.4 q 2.06 s 
NHCOCH3 169.3 s 169.4 s 
NHCOCH3 21.0 q 1.98 s 21.0 q 1.98 s 
NH 5.50 br s 5.50 br s 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in CDCI3 with chemical 
shifts (0) quoted in ppm. Coupling constants in Hz are in parentheses. All assignments 
are supported by DEPT, COSY, HMQC and HMBC NMR experiments. Assignments 
with identical superscripts within a column may be interchanged. 
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OAe 
[48] 
- A molecular formula of C18H33N03 (m/z 311.2478, ~mmu +18) from HREIMS 
data, supported by a methyl triplet at (5 0.8 (3H, t, J13.14 = 6.7 Hz, H-14) in the 1H NMR 
spectrum of [48] (2-acetamido-3-acetoxy-5-tetradecene) indicated that it was a 
homologue of [47] with a saturated terminal double bond. The coupling observed from 
the olefinic proton at (5 5.3 (1 H, dt, H-S), through the overlapping methylene protons at 
(5 2.2 (2H, m, H-4) to the acetoxy methine proton at-(5 4.8 (1 H, m, H-3) in the COSY 
spectrum of [48] indicated that the double bond was homoallylic to C-3 and, therefore, 
situated at C-5. 
OAe 
[49] 
Compound [49], 1-acetamido-2-acetoxy-4,12-tridecadiene, was isolated as an 
optically active, stable, colourless oil. The molecular formula C17H29N03 (295.2156, 
~mmu -9) established by HREIMS suggested that this compound was also homologous 
with [47] but with one carbon atom less in the unsaturated alkyl chain. These HREIMS 
data were complemented by the 13C NMR data of [49] (TABLE 2.2). The absence of 
the terminal methyl doublet at (5 1.1 in the 1H NMR spectrum and the presence of an 
amino-methylene signal at (5 43 in the 13C NMR spectrum of [49] placed the acetamido 
group at C-1. 
30 
OAe 
[501 
As discussed earlier for the homologous compounds [47] and [48], a molecular 
formula of C17H31N03 (297.2305, llmmu -1) from HREIMS data indicatln-g two additional 
protons, together with a methyl triplet at 5 0.9 (3H, t, J12,13 = 6.6 Hz, H-13) in the 1H 
NMR spectrum of [50], implied that this compound was a homologue of [49] with a 
saturated terminal double bond. 
~HAc 
S 13 
OH 
[51] 
An attempt was made to isolate the parent amino alcohol of [47] by refluxing in 
strong base. This procedure resulted in a mixture of products with column 
chromatography yielding only the monoacetate compound [51] in a pure form. The 
. "'- - . 
upfield shift of the H-3 proton signal together with the absence of the OCOCH3 singlet 
at 5 2.06 and the presence of the NHCOCH3 singlet at 5 1.98 in the proton NMR 
spectrum of [51] indicated that only the O-acetoxy group had been removed. 
2.3.2 Stereochemistry of the C13 and C14 amines [47] - [50]. 
The modified Karplus equation requires J = 12-18 Hz for an E stereochemistry 
and J = 7-11 Hz for a Z stereochemistry in the vicinal coupling of alkenes 104, hence the 
assignment of an E stereochemistry at lls in [47] and [48] and 114 in [49] and [50] 
followed from the JS,6 = 15 Hz and J4,s = 15 Hz coupling constants respectively. 
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TABLE 2.2 1H and 13C NMR spectral data for compounds [49] and [50]. 
-
[49] [50] 
"< 
13C 1H 13C 1H 
1 42.6 t 3.40 m 42.7 t 3.41 m 
2 73.0 d 4.90m 73.0d 4.91 rp_ ~ 
-
3 35.3 t 2.25 t (6.8) 35.3 t 2.26 t (6.7) 
4 123.6 d 5.31 dt (7.1,15.3) 123.6 d 5.31 dt (7.1, 15.2) 
5 134.9 d 5.48 dt (6.9, 15.3) 135.0 d 5.50 dt (8.2, 15.2) 
6 32.5 t 1.98 m 31.9 t 1.98 m 
7 a29.0 t b29.4 t 
- "8 a28.9 t 1.38-1.26 m b29.4 t 
9 a28.9 t b29.3 t 1.31-1.25 m 
10 29.3 t b29.2 t 
11 33.8 t 2.02 m 32.6 t 
."" 
.' 
12 139.1 d 5.79 dq 22.7 t 
13 114.1 t 4.95m 14.1 q 0.87 t (6.6) 
OCOCH3 171.1 s 171.1 s 
OCOCH3 23.2 q 2.05 s 23.2 q 2.05 s . "- - . 
NHCOCH3 170.1 s 170.1 s 
NHCOCH3 21.1 q 1.96 s 21.1 q 1.96 s 
NH 5.70 br s 5.69 br s 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in CDCI3 with chemical 
shifts (6) quoted in ppm. Coupling constants in Hz are in parentheses. All assignments 
are supported by DEPT, COSY, HMQC and HMBC NMR experiments. Assignments 
with identical superscripts within a column may be interchanged. 
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Various approaches have been used in assigning the relative and absolute 
stereochemistry at chiral centres in amino alcohol compounds. The relative 
configuration in aliphatic 2-amino-3-alcohol. compounds can be established by 
preparing oxazolidinone derivatives of these Compounds and examining the cis or trans 
orientation of the C2 - C3 bond using NOE or coupling constant measurements from the 
NMR spectra of the derivatives . 
.0 (CH~~ 
[52] [53] 
Comparison of the NMR spectra of the two parentamino alcohol compounds 
[52] ·and [53], isolated by Gulavita and Scheuer101 from a sponge of the genus 
Xestospongia, implied that the compounds were C-3 epimers. The 2R*, 3R* or 2S*, 3S* 
relative stereochemistry of the major epimer [52] was established from the significant 
NOE values between H-2 and CH2-4 and between Me-1 and H-3 in its oxazolidinone 
derivative (FIGURE 2.3). 
1-I-2/CHz-4 
CQH H~c~)~ 
1'; 1; 
V 
Me-1 11-1-3 
FIGURE 2.3 NOEs observed in the oxazolidinone derivative of [52]. 
The minor epimer [53], therefore, had a relative stereochemistry of 2R*, 3S* or 
2S*, 3R*. The absolute stereochemistry was determined by degradation of [52] to L-
alanine and comparison of the HPLC retention times of this with authentic standards. 
Based on this HPLC method it was proposed that n-12 fatty acids and L-alanine [54] 
are the biosynthetic precursors of the Xestospongia amino alcohols and established a 
2S, 3S and a 2S, 3R configuration for [52] and [53] respectively. 
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[54] 
~ 
~CHV~ 
,\" 11 
. OH 
[55] 
Jimenez and Crews102 used the derivatisation of xestaminol A [55] to its 
oxazolidinone in order to establish the relative stereochemistry of -this compound. 
Interpretation here, however, was based on coupling constants rather than observed 
NOEs, and a cis H-2/3 configuration was assigned from the J2,3 = 7.5 Hz coupling 
constant (trans configuration requires J2•3 = 4.1 - 5.1 Hz) obtained after spin decoupling 
of the terminal methyl doublet (FIGURE 2.4). The coupling constant was accordingly 
used to propose a 2S*, 3R* relative stereochemistry for [55]. 
FIGURE 2.4 J2,3 coupling in the oxazolidinone derivative of [55] (Me-1 decoupled). 
5 7 
[41] [56] 
The amino alcohol portion in [41] ([a]~ +45°), isolated from Pseudodistoma 
crucigaste,ss, was assigned a 2R, 3S absolute stereochemistry based on the chiral GC 
comparison of methyl-3-hydroxy-4-aminopentanoate [56], a chemical degradation 
product of [41], with a synthetic sample prepared from L-alanine [54]. This led to the 
suggestion that these compounds were, in fact, biosynthesised from O-alanine. 
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N~ 
~CHz)V 
~ 13 
6H 
[43]' . 
The stereochemistry of the amino alcohol [43] ([aJ~ +36°), also from P. 
crucigaste,ss, could not be determined using the same degradative J~c.hnique due to 
the difference in substitution at C-4. However, the stereochemistry was tentatively 
assigned as 2R, 3S because, as with [41], [43] exhibited a positive optical rotation. 
This reasoning must be questioned considering the fact that the diacetyl derivatives of 
the C-3 epimers, [52] ([aJ~ +1 YO) and [53] ([aJ~ +51 0), isolated by Gulavita and 
Scheuer101 , also have positive optical rotations even though they possess different 
stereochemistries. 
~HAc 
~ 3 /'..... .. ;;........ /'......-:/ 
.,/ 2 ~ 0-( liCL.L'_ 0-
1 ~ 5 I fL./":) 13 
OAe 
[57] tJ,,5, ~3 
[58] tJ,,5 
The relative stereochemistry of the parent compounds of [47] and [48] fram the 
South African ascidian, Pseudodistoma species, was determined via the formation of 
oxazolidinone derivatives. Treatment of a portion of a mixture of the amino alcohols 
obtained from flash chromatography with 1, 1-carbonyl-di-imidazole followed by 
extensive normal and reverse phase HPLC of the reaction products gave the 
oxazolidinones [57] and [58]. Proton spin decoupling of the C-1 methyl group signal 
at (5 1.25 in the 1 H NMR spectra of [57] and [58] established a J2,3 = 6,1 Hz for both 
compounds, thus confirming that the two compounds have the same C-2, C-3 
stereochemistry. Although the coupling of J2,3 = 6,1 Hz suggests a trans configuration 
when compared to the J2,3 = 7.5 Hz coupling in the cis configuration of xestaminol A 
oxazolidinone (FIGURE 2.4), it was still considered large for a trans configuration (trans 
usually requires J2,3 = 4.1-5.1 Hz) and hence not conclusive. However, in the ROESY 
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NMR spectrum of [57] (FIGURE 2.5) a significant NOE between H-2 and CH2-4, 
between Me-1 and H-3 and the total absence of any NOE between H-2 and H-3 (see 
hatched area in FIGURE 2.5) placed H-3 and the C-1 methyl group on the same side 
- -
of the oxazolidinone ring. This observatiori' implied that the compound was a trans 
isomer with a 2S*, 3S* or 2R*, 3R* relative stereochemistry. Extension of the 
biosynthetic argument of Gulavita and Scheuer101 to include similar ascidian 
compounds intimates a 28, 38 stereochemistry for [47] and [48]. 
I 
I 
~ 
2/4 
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I I 
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.. ... 
1 
3/1 
I' 
FIGURE 2.5 ROESY NMR (400 MHz, CDCI3) spectrum of compound [57]. 
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Searle and Molinski1°O showed that the stereochemistry of aliphatic 1-amino-2-
alcohol compounds can be effectively determined using the circular dichroic exciton 
coupling method of Harada and Nakanishi105; CD spectroscopy of optically active 
unsaturated organic compounds is a powerful method of studying the 3-D structure of 
these molecules. Circular dichroism results from the interaction of the individual 
chromophores of each molecule with an electromagnetic field of light105. This interaction 
~- ~ 
causes a "split Cotton effect" due to the chiral exciton coupling. The absolute 
configuration of a compound can thus be determined by the positive or negative sign 
of this Cotton effect. The successful application of the dibenzoate chirality method to 
2-amino-1-butanol by Nagai and co-workers106 prompted Molinski to use this method 
for compound [44] from the ascidian, Didemnum species. 
1 5 ~(CHV~ 
OH 
[44] 
A negative bisignate Cotton effect observed in the CD spectrum of me' N,O-
dibenzoyl derivative of [44] correlated with a negative helicity from exciton coupling 
theory and, hence, an R configuration for [44]. Isolation difficulties encountered with 
the parent amino alcohol of [49], from the South African ascidian, Pseudodistoma 
species, prevented the application of the same CD method to this compound .. An 
attempt to isolate the N,O-dibenzoyl derivative of [49] by HPLC after treating a portion 
of a mixture of the amino alcohols with benzoyl chloride and DMAP failed, with only the 
monobenzoyl derivative (established by CIEIMS) being isolated in pure form. 
1 • , 
A~(f'LL\~ e... I 4 \~ 215 12 
OAe 
[49] ~4, A2 
[50] ~4 
1 
~0..../ Ae. • • I 4 (C~)5 1 2 
OAe 
[59] 
Although the stereochemistry at C-2 in [49] and [50] remains unassigned, 
catalytic hydrogenation of each compound gave the same optically active product [59], 
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[a]~ _9°, thus establishing the same stereochemistry at the chiral centre in thesa 
compounds. 
2.4 BIOLOGICAL ACTIVITY 
A variety of biological activities have been reported for unsaturated amino 
alcohols including activity against parasites, the enzyme reverse transcriptase102, 
microbes99 and fungi1oo,101. Compounds [47] - [50] together with various derivatives 
were tested for antimicrobial activity against the Gram-positive Bacillus subtilis and 
Gram-negative Escherichia coli bacteria in the agar plate disc diffusion assay (TABLE 
2.3). 
TABLE 2.3 Zone of inhibition diameters measured in the screening of the amino 
alcohol compounds and their derivatives for antimicrobial activity. 
SAMPLE B. subtilis E.coli 
mixture of parent amino alcohols 14.5* 12.0* 
semi-pure parent of [47] 10.5 10.0 
hydrogenated semi-pure parent of [47] 10.5 9.0 . "- - . 
[47] - sl 
[48] - 9.0 
[49] 11.0 sl 
[50] 12.0 sl 
hydrogenated [47] sl sl 
hydrogenated [49] sl sl 
[57] - -
[58] - -
gentamycin standard 19.0 19.0 
*Inhibition zone diameters in mm, disc size = 8.0 mm and "sl" indicates slight activity 
(8.0-9.0 mm). Samples tested at 100 I-Ig disc·1. Gentamycin standard = 10 I-Ig disc·1. 
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Surface active agents (detergents) containing a "lipophobic head" and a 
"lipophilic tail" may have an affinity for adsorption into a cell membrane, causing 
disruption of cell membrane integrity and sUbsequent cell death 107. It is this amphiphilic 
nature of the amino-alcohol metabolites which is therefore probably responsible for 
their biological activity and accounts for the lack of predation and fouling experienced 
by the producer organism. Expanding on the theory proposed by Munro and co-workers 
for the antimicrobial activity of aliphatic amines98, it is the combination of a*hydrophobic 
alkyJ chain, a basic amino group and a polar hydroxyl group which imparts semi-
quantitative antimicrobial properties to the unsaturated acyclic amino alcohol 
compounds. The testing of a series of synthetic 2-aminoalkanes found that the greatest 
antimicrobial activity and strongest detergent-like behaviour was caused by C13 - C16 
compounds108. From the mode of action of surfactants, it stands to reason, that a 
reduction in the basicity of the amino, and in the polarity of the alcohol groups, should 
diminish bioactivity. This was corroborated by the reduced antimicrobial activity 
observed with the acetylated compounds [47] - [50] and the total loss of activity with 
the oxazolidinone derivatives [57] and [58] (TABLE 2.3). 
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CHAPTER THREE 
NEW ALKALOIDS FROM A SOUTH AFRICAN LATRUNCULID 
SPONGE 
40 
3.1 INTRODUCTION 
Sponges of the family Latrunculidae hav~ recently been a focus of attention by 
taxonomistst . It is believed that in several instances Latrunculid sponges have been 
misidentified in papers detailing the isolation of their secondary metabolites and, as a 
result, the taxonomy of this family is presently being revised. This revision will 
encompass morphologic, chemotaxonomic, biosynthetic and DNA seq~ncing data:!:. 
Three distinct chemical groups are evident in Latrunculid sponges: 
(a) Terpene and related compounds found in the Indo-Pacific genera Diacarnus 
and Sigmosceptrella. These compounds include the sigmosceptrellins109, trunculins110 
and_other cyclic peroxides111 . An example is sigmosceptrellin A [60]109. 
[60] [61] [62] 
(b) Latrunculins and related compounds from the Indo-Pacific genera 
Negombata and Hyatel/a. The latrunculins A [61] and 8 [62t6,112 were reported as 
being the first known 2-thiazolidinone-bearing marine macrolides and were found, as 
part of their biological activity, to cause major alterations in the cytoskeletal protein 
actin. 
t Presentation at the 8th International Conference on Marine Natural Products, Tenerife (Sept. 1995). 
:t: Personal communication with Michelle Kelly-Borges, The Natural History Museum, London. 
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(c) Discorhabdin and related compounds from the warm-temperate to Antarctic 
genera Latrunculia type 1 and 2, Zyzzya and Batzel/a. It is these compounds which are 
the focus of this chapter. 
The discorhabdins are dark pigments characterised by an iminoquinone 
chromophore, an unsaturated spiro-cyclohexanone system and a 
pyrrolo[1 ,7]phenanthroline ring system. The first example of this group of compounds 
waS the highly cytotoxic pigment discorhabdin C [63] isolated by Munro and co-
workers113 from a sponge of the genus Latruncu/ia. This compound was soon followed 
by the identification of two other major pigments, discorhabdin A [64] and B [65]114, 
from related sponges of the same genus. 
o o o 
[63] [64] [65] 
Ironically, the structure of prianosin A, identical to [64], from an Okinawan 
marine sponge Prianos me/anos (possibly a misidentified Zyzza sponge)t was 
simultaneously published by Kobayashi and co-workers115. As expected, the 
spectroscopic and bioactivity data of prianosin A were consistent with those of 
discorhabdin A [64]. 
Further antitumour alkaloids isolated by these two research groups include 
discorhabdin 0 [66] from the sponges Latruncu/ia brevis and Prianos species116, and 
prianosins B [67], C [68] and 0 [69] from Prianos me/anos117. 
t Michelle Kelly-Borges - personal communication. 
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[66] R = H 
[70] R = OH 
o 
[67] 
OH 
[68] R = OH 
[69] R = H 
The aminophenol moiety in prianosin 0 [69] is the reduced form of the 
iminoquinone functionality of discorhabdin 0 [66]. Considering that both were isolated 
independently from what was believed to be the same species of sponge118 collected 
from Okinawa led to a re-examination and revision of the structures of prianosins C and 
0 119. The original structural elucidation of prianosins C [68] and 0 [69] was performed 
on their acetylated derivatives. It seems that during the esterification reastion, the 
acetyl groups were first introduced at the N-9 and N-13 positions with a subsequent 
reduction of the iminoquinone occurring to give a phenolic group at C-11. Possible 
steric hinderance from the acetyl groups at N-9 and N-13 prevented acetylation of the 
phenolic moiety. Without prior knowledge of the esterification induced reduction Jt_ was 
incorrectly assumed that the aminophenol was a natural product. The revised structures 
of prianosins C and 0 are shown as [70] and [66] respectively. 
Several highly functionalised pyrroloquinoline alkaloids, the batzellines A [71], 
8 [72] and C [73] and isobatzellines A [74], 8 [75], C [76] and 0 [77], were isolated 
from a deep water sponge Bafzella species 120.121. The two alkaloid groups, batzellines 
and isobatzellines, possess the same pyrrolo[4,3,2-de]quinoline ring system with the 
isobatzellines containing an aminoiminoquinone moiety instead of the aminoquinone 
functionality of the batzellines. Suprisingly, only the isobatzellines exhibit cytotoxic and 
moderate antifungal activity. Structurally related pigments, the damirones A [78] and 
8 [79], have been isolated from the Palauan sponge Damiria species122• The structures 
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of these compounds were determined by comparison of their spectral data with those 
of the batzellines. 
CI 
[71] R = Me X = SMe 
[72] R = H X = SMe 
[73] R = Me X = H 
[74] X1 = SMe X2 = CI 
[75] x1 = SMe x2 = H 
[76] X1 = H X2 = CI 
[77] X1 = SMe x2 = CI tl3 
I 
Me 
[78] R1 = Me 
[79] R1 = H 
Ireland and co-workers 123 discovered that pyrroloiminoquinone alkaloids are not 
confined to the phylum Porifera with the isolation of wakayin [80] from the ascidian 
Clavelina species. This compound displayed strong in vitro cytotoxicity against the 
human colon tumour cell line HCT116 and inhibited the topoisomerase II enzyme. 
o 
[80] 
Topoisomerase II enzymes control the topological state of DNA by mediating 
DNA interconversions and are therefore implicated in a number of vital cellular 
processes including DNA replication, DNA transcription and chromosomal 
segregation 124. The nature of this function makes the inhibition of the topoisomerase 
II enzyme an important target for the discovery of new anticancer drugs. 
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[81] R1 = Me R2 = H 
[82] R1 = Me R2 = H t,,3 
[83] R1 = H R2 = Me 
[86] 
H 
N 
OH 
[84] R1 = H R2 = H 
[85] R1 = Me R2 = H d 0 
[88] R1 = Me R2 = Me d 0 
o 
o 
Br 
[87] 
The isolation of the makaluvamines A [81], B [82], C [83], 0 [84], E [85] and F 
[86], makaluvone [87] and the known compounds discorhabdin A [64] and damirone 
B [79] from the Fijian sponge Zyzzya cf. marsailis125, represented the first example of 
the co-occurrence of unfunctionalised pyrroloiminoquinones with the highly elaborated 
discorhabdin A. The isolation of, in particular, makaluvamines 0 [84] and F [86] 
suggests a plausible biosynthetic interrelationship within the pyrroloiminoquinone family 
of compounds. Makaluvamine G [88], from an Indonesian sponge Histodermella 
species 126, was reported as being biogenetically derivable from tryptamine and tyramine 
and structurally related to the discorhabdins. 
From recent studies on the biosynthesis of discorhabdin B [65]127, which occurs 
in the New Zealand sponge Latrunculia species B, Munro and co-workers have 
proposed a loose biogenetic pathway which interrelates the discorhabdin and 
makaluvamine alkaloids (SCHEME 3.1). 
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o 
Suphur insertion? ~ 
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ascorhabdin C [63] ascorhabdin B [65] 
OH ,. 
SCHEME 3.1 Postulated biogenesis of the discorhabdins by Munro and co-workers 127. 
This pathway utilises the amino acids tryptophan and phenylalanine (via 
tryptamine and tyramine) as the precursors of the pyrroloiminoquinone backbone. 
Tryptamine, after undergoing appropriate functional changes and oxidation, 
incorporates tyramine, thereby generating makaluvamine D. Sulphur insertion into, 
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and/or ring closure of, makaluvamine D, together with other functional modifications is 
the basis by which makaluvamine F, discorhabdin Band discorhabdin C are formed. 
Evidence for the viability of this scheme was. provided by a sponge tissue culture 
experiment performed by Munro and co-workers127. In this experiment tissue'from the 
sponge Latrunculia species B was incubated in the presence of radioactive-labelled 
phenylalanine and it was found that the tissue used this radioactive-labelled 
phenylalanine in the biosynthesis of discorhabdin B. Munro et al. also cOnsidered the 
origin of the biosynthetic pathway taking into account the fact that there are three 
recognised means by which sponge cells can produce secondary metabolites. The 
production of these metabolites can be a property of the sponge cells themselves, can 
be generated exclusively by parasitic or commensal micro-organisms, or can be the 
result of a metabolic co-operation between the sponge cells and symbiotic micro-
organisms. To address this problem the same tissue culture technique was used, 
however, in this experiment the sponge tissue was pre-treated with a broad spectrum 
antibiotic prior to exposure to radioactive-labelled phenylalanine and then, after 
exposure, the tissue was incubated in the presence of the antibiotic. Results.of the 
".:. 
experiment demonstrated that the radioactive-labelled phenylalanine was still 
incorporated into discorhabdin B by the sponge tissue and this suggested that 
participation of symbiotic bacteria in the biosynthesis of the discorhabdins is not 
required. 
In the same paper by Munro and co-workers, describing their biosynthetic 
studies of discorhabdin B127, it is reported that at least thirteen discorhabdins (A - M) 
have thus far been isolated by this research group. With the data of a number of these 
compounds (discorhabdin G - M) unpublished, it is obvious that care is needed in the 
naming of new discorhabdin compounds to avoid confusion. Overlap has already 
occurred with the paper of Baker et al. describing the isolation of discorhabdin G 
[89]128, a previously unreported pigment from the Antarctic sponge Latrunculia apicalis. 
The structure of Baker's discorhabdin G differs substantially to that of Munro's as yet 
unpublished discorhabdin Gt. 
t Dr Murray Munro - personal communication. 
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o 
[89] 
The considerable biological activity and unique nature of 1ne highly fused 
skeleton in these marine alkaloids has inspired several groups to undertake synthetic 
studies on these compounds. Examples include reports of the total syntheses of 
discorhabdin C [63]129 and the makaluvamines A [81] - E [8St30. In order to explore 
the structural features responsible for the biological activities of the discorhabdins, 
Munro and co-workers made a series of derivatives of discorhabdin C. These were 
evaluated in a wide range of screens for sele9tive cytotoxicity, antifungal and 
antimicrobial activity131. 
[90] R = H 
[91] R=Me 
OH 
Br 
o 
o 
[92] 
Br 
Br Br 
OH -' 
[93] 
Section 3.2 and 3.3 of this chapter describe the isolation and structure 
determination of four new pyrroloiminoquinone alkaloids, the tsitsikammamines A [90] -
D [93], from a South African Latrunculid sponge. Initial taxonomic studies indicate that 
this sponge is a new genus of Latrunculid sponge with morphological characteristics 
intermediate between those of Zyzzya and Latrunculia species;. 
:t: Michelle Kelly-Borges - personal communication. 
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3.2 COLLECTION, EXTRACTION AND ISOLATION 
FIGURE 3.1 A new genus of Latrunculid sponge collected from Rheerders Reef in the 
Tsitsikamma Marine Reserve. 
A brown nodular Latrunculid sponge (FIGURE 3.1) was collected in the 
Tsitsikamma Marine. ~eserve using SCUBA from a depth of -20 m in May 1993. A 
second collection of this sponge was made in May 1995. Several frozen sponges from 
the former collection were freeze~ried (dry weight 287.5 g) and steeped in 
MeOH/CHCI3 (1:1) to yield 15.5 g of extract. The crude extract (tested at 250 I-Ig dis<?-1) 
displayed potent antimicrobial activity against Bacillus subitilis, Staphylococcus aureus 
and Escherichia coli equal to and exceeding that of the gentamycin standard (10 1-19 
disc-1). Unfortunately, the dark sponge extract showed extremely unfavourable solubility 
properties in both aqueous and organic solvents, however, aqueous solubility 
improved dramatically on the addition of a few drops of trifluoroacetic acid (TFA). The 
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improved aqueous solubility is attributed to protonation of the imine functionality. The 
bioassay directed fractionation of the crude extract (SCHEME 3.2 and SCHEME 3.3) 
led to the isolation of the strongly antimicrobial pigments, tsitsikammamine A [90] - 0 
[93] as their TFA salts. 
Initial Sep-Pak cartridge column chromatography of the crude sponge extract 
(SCHEME 3.2) revealed that approximately one third of the extract was~aCI and one 
fifth was undesirable fatty acids and sterols, leaving only a small fraction containing the 
potent antimicrobial compounds. Thus, to improve yields, the fractionation procedure 
was repeated with a larger portion of crude extract and a partitioning step to remove 
the undesirable lipophilic constituents (SCHEME 3.3). Although several different HPLC 
columns under varying conditions were used in SCHEME 3.3 to optimise the separation 
of compounds [90] - [93] it was generally found that these compounds show poor 
resolution and peak shape with HPLC separation. 
1:1 CHCI:3 : MeOH extract 
(1.4 g) 
I 
H20 
(464 mg) 
NaCI 
\(a) 
I I 
4:6 3:7 MeOH 
(270 mg) (103 mg) (25 mg) 
\ \ 
I(b) 
(C)I I 
[91] 
[90] 8.9mg 
7.9mg 0.045% 
0.040% 
SCHEME 3.2 Chromatographic procedure for the isolation of compounds [90] and [91]. 
(a) cartridge column (C18, 10 g, Waters Sep-Pak, gradient elution: H20 to MeOH I 
0.05% TFA). (b) HPLC (C8, 10 JJ, Phenomenex, RI detection, 25% MeCN/H20 I 0.05% 
TFA, 4 mL min-1). (c) HPLC (C8, 10 JJ, Phenomenex, RI detection, 22.5% MeCN/H20 
10.05% TFA, 4 mL min-1). 
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I 
H20 
(1.8 g) 
NaCI 
1:1 CHCI3 : MeOH extract 
(8.0 g) 
.1(0) 
. (b) 
6:4 4:6 2:8 
(650 mg) (82 mg) (23 mg) 
I (c) 
I I I 
H20 7.5:2.5 7:3 6.5:3.5 MeOH 
JOJ J1J 
(7.5 mg) (26.7 mg) 
(257 mg) (227 mg) (63 mg) 
(d) r-----'-I_---, 
(e) 
[93J 
5.7mg 
0.019% 
J2J 
(16.2 mg) 
[92J 
63.2 mg 
0.056% 
I 
MeOH 
(37 mg) 
SCHEME 3.3 Chromatographic procedure for the isolation of compounds [92] and [93]. 
(a) solvent partioning (organic layer: 33% EtOAc/hexane and aqueous layer: .. H 20 / 
0.1 % TFA. Aqueous layer was concentrated and fractionated further). (b) 'cartridge 
column (C18, 10 g, Waters Sep-Pak, gradient elution: H20 to MeOH / 0.05% TFA). (c) 
cartridge column (C18, 10 g, Waters Sep-Pak, gradient elution: 5% MeOH/H20 to 50% 
MeOH/H20 / 0.05% TFA). (d) various combinations of analytical and pilot-scale semi-
prep. HPLC in order to optimise furtherfractionation (C18, C8 and CN columns; Ri and 
UV detection; varying solvent combinations of MeCN, MeOH and H20 at pH 3 with TFA; 
varying flow rates). (e) HPLC (C8, 10 1-1, Phenomenex, UV detection 356 nm, 20% 
MeCN/H20 at pH 3 with TFA, 4-6 mL min-1). 
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3.3 STRUCTURE DETERMINATION 
3.3.1 Tsitsikammamine A [90]. 
o 
OH 
[90] 
_ . HRFAB mass spectral analysis indicated a protonated molecular ion at m/z 
304.1087 (/1 -0.1 mDa) thus establishing the molecular formula of [90] as C1sH14N302' 
The 13C NMR spectrum of [90] revealed sixteen distinct carbon resonances. The 
molecular formula implied that two resonance pairs overlapped while the absence of 
- ".-:.. 
ten 13C signals from the DEPT NMR spectrum of [90] supported the presence of ten 
quarternary carbons (TABLE 3.1). Compound [90] gave a very simple 1H NMR 
spectrum (FIGURE 3.2) which belied the complexity of its molecular structure. 
NH-12 
NH-1 
18 17 
20 21 
~3 
2 
5 
4 
., i" ""'j' ". i, j 'I' i" i • i 'I i" i \."""",." ii' i' i ,"" iii "1 i, i' i i j I., i I (., j" i I' i. I ill. it •• , i I 
ppm 12 11 10 9 B 7 6 5 4 3 
FIGURE 3.2 1H NMR (400 MHz, DMSO-ds) spectrum of [90]. 
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TABLE 3.1 NMR spectral data for tsitsikammamine A [90]. 
13C 1H COSY to HMBC to 
NH-1 13.01 br s 
"~ r 
H-2,*H-4 C3,C8 
2 123.1 d 7.10 d (1.8) NH-1, *H-4 C3,C8,C9 
3 119.2 s 
..-- ~ 
4 17.6 t 2.93 t (7.8) H-5,*H-2,*NH-1 C2, C3, C8 
- 5 45.0 t 3.85 t (7.8) H-4 C3,C7 
7 156.8 s 
8 120.7 s 
9 127.8 s 
10 166.3 s 
-11 134.6 s 
NH-12 13.28 br s H-13 
13 125.0 d 7.16d(2.5) NH-12 C11, C15, C16 
14 122.4 s " 
'_. 
15 113.5 s 
16 127.2 s 
17 116.2 d 6.87 d (8.4) H-18 C14,C19, C21 
18 128.9 d 7.37 d (8.4) H-17 C16, C19+ C20 
19 157.6 s 
20 128.9 d 7.37 d (8.4) H-21 C16,C18, C19 
21 116.2 d 6.87 d (8.4) H-20 C14,C17,C19 
* Long-range COSY coupling. 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in DMSO-ds with 
chemical shifts (6) quoted in ppm. Coupling constants in Hz are in parentheses. 
The spin systems comprising 6 13.01 (1 H, br s, NH-1) coupled to 6 7.10 (1 H, d, 
J = 1.8 Hz, H-2) and the mutually coupled methylene signals at 6 2.93 (2H, t, J = 7.8 
Hz, H-4) and 6 3.85 (2H, t, J = 7.8 Hz, H-5) were established by a COSY NMR 
experiment. These systems, together with the pyrroloiminoquinone 13C NMR 
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resonances at 5 166 (C-10), 157 (C-7), 128 (C-9) and 121 (C-8), are characteristic of 
the discorhabdin compounds A - 0 113,114,116. The pyrroloiminoquinone substructure of 
[90] therefore accounted for eight of the fourteen degrees of unsaturation implied in the 
mofecular formula. -
Two mutually coupled two-proton doublets at 5 6.87 (2H, d, J = 8.4 Hz, H-17 and 
H-21) and 5 7.37 (2H, d, J = 8.4 Hz, H-18 and H-20) each attachetl to carbons 
res9nating at 5 116 and 5 129, respectively, in addition to two quarternary carbon 
signals at 5 127 (C-16) and 5 158 (C-19), suggested that [90] contained a para-
substituted phenol125. The phenolic substituent accounted for a further four degrees of 
unsaturation. The two remaining degrees of unsaturation are therefore represented by 
an olefinic moiety (5 125 and 122) and a fifth cyclic system. The COSY spectrum of 
[90] revealed a further spin system comprising 5 13.28 (1 H, br s, NH-12) coupled to 5 
7.16 (1 H, d, J = 2.5 Hz, H-13) which suggested the possibility of a second 2,3,4-
trisubstituted pyrrole ring system. This bispyrrolbiminoquinone substructure was 
supported by the two and three bond correlations observed in the HMBC"NMR 
experiment of [90] (FIGURE 3.3). The three bond correlations between the H-13 vinylic 
proton and the C-11 and C-15 quinone carbon atoms (5135 and 114 respectively) in 
the HMBC spectrum (FIGURE 3.4) proved crucial in placing the second pyrrole ring in 
a fused postion at C-11, C-15. Three bond correlations between the H-17 and H-21 
. ,,- .. 
aromatic protons and 5 122.4(C-14) and between the H-13 pyrrole proton and 5 127.2 
(C-16) (FIGURE 3.4) clearly placed the para-substituted phenol at C-14. 
FIGURE 3.3 HMBC NMR correlations in the bispyrroloiminoquinone substructure. 
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FIGURE 3.4 HMBC NMR (400 MHz, DMSO-ds) spectrum of tsitsikammamine A [90]. 
It is interesting to note that the makaluvamines 0 [84], E [85] and G [88] all 
contain a para-substituted phenol attached to a pyrroloiminoquinone moiety. However, 
[90] is the first example from the Porifera where ring closure has occurred to create a 
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bispyrroloiminoquinone system. This ring closure is not unique and wakayin [80], 
isolated from the ascidian Clavelina species123, contains a bispyrroloiminoquinone 
substructure with an indole substituent. The e~istence of [80] in an ascidian, and the 
isoration of [90] from a sponge, possibly questions Munro's suggestion 127 that the 
pyrroloiminoquinone compounds are exclusively products of sponge cell secondary 
metabolism rather than that of a symbiotic organism which might occur in selected 
sponges and ascidians. 
3.3.2 Tsitsikammamine B [91]. 
OH 
[91] 
Tsitsikammamine B [91] gave a protonated molecular ion at m/z 318.1252 (lJ. -
0.9 mDa) in its HRFAB mass spectrum, which is consistent with the molecular formula 
C19H1SN302. The same major chromophores in the UV spectrum of [90] were evident 
in the UV spectrum of [91] (FIGURE 3.5) suggesting a common skeletal structure. The 
coupled methylene signals at 6 2.91 (2H, t, J = 7.8 Hz, H-4) and 6 3.82 (2H, t, J = 7.8 
Hz, H-5), the iminoquinone 13C resonances at 6 166.8 (C-10) and 6 156.2 (C-7) 
(TABLE 3.2), the proton signals at 613.28 (1H, br s, NH-12) and 6 7.16 (1H, s, H-13), 
and the two mutually coupled two-proton doublets at 6 6.86 (2H, d, J = 8.1 Hz, H-17 
and H-21) and 6 7.36 (2H, d, J = 8.1 Hz, H-18 and H-20) in [91] were also consistent 
with a para-phenoxy substituted bispyrroloiminoquinone structure. 
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242nm 
288.8 
2.88 242nm 
1.88 
8.88 
288.8 
377nm 
188.8 
Jtavelength (nn) 
[90] 
374nm 
188.8 
Jtavelengtll (nn) 
[91] 
FIGURE 3.5 UV spectra (in MeOH) of [90] and [91]. 
688.8 
688.8 
The absence, however, of the NH-1 resonance in the 1H NMR spectrum of [91], 
together with the collapse of the H-2 vinylic doublet in [90] into a one proton singlet at 
07.11 (1 H, s, H-2) in [91], and the additional methyl resonance at 03.92 (3H, 5, N-Me), 
placed a methyl substituent at N-1 in this compound. 
57 
TABLE 3.2 NMR spectral data for tsitsikammamjne B [91]. 
-
13C "~ r 1H HMBC to 
2 12B.0 d 7.11 s C3, CB, C9, N-Me 
3 11B.7 s 
-- ~ 
4 17.6 t 2.91 t (7.B) C3,C5,CB 
-
5 44.7 t 3.B2 t (7.B) C3,C4,C7 
7 156.2 s 
B 120.7 s 
9 126.4 s 
10 166.B s 
-
11 134.6 s 
NH-12 13.2B br s 
13 125.2 d 7.16 s C11,_C15,G16 
14 122.4 s 
15 113.3 s 
16 127.1 s 
17 116.3 d 6.B6 d (B.1) C14, C19, C21 . 
1B 129.0 d 7.36 d (B.1) C16,C19, C20 
19 157.6 s 
20 129.0 d 7.36 d (B.1) C16, C1B, C19 
21 116.3 d 6.B6 d (B.1) C14,C17,C19 
N-Me 35.B q 3.92 s C2,C9 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in DMSO-ds with 
chemical shifts (0) quoted in ppm. Coupling constants in Hz are in parentheses. 
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FIGURE 3.6 HMBC NMR (400 MHz, DMSO-ds) spectrum of tsitsikammamine B [91]. 
Three bond correlations observed in the HMBC NMR spectrum of [91] (FIGURE 
3.6), from the N-methyl protons to C-2 and C-9 in the pyrrole ring, confirmed the 
position of the methyl group at N-1. The occurrence of a methyl group at N-1 is a 
structural feature consistent with several of the makaluvamine compounds 125,12S. 
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3.3.3 Tsitsikammamine C [92]. 
Br 
Br 
[92] 
Tsitsikammamine C [92] showed a protonated molecular ion at m/z 539.8544 in 
its HRFAB mass spectrum, consistent with the molecular formula C1sH13N302Br3 (6. +1.4 
mDa). The 13C NMR spectrum of [92] (FIGURE 3.7) in conjunction with a DEPT NMR 
experiment revealed the presence of four methylene (017.5 - 44.5), two overlapping 
methine (0 151) and twelve quarternery carbons (TABLE 3.3). Based on the previous 
observations for pyrroloiminoquinone structures, the spin system comprising.o"2.71 
(2H, t, J = 7.4 Hz, H-16) coupled to 0 3.71 (2H, t, J = 7.4 Hz, H-17) further coupled to 
08.22 (1 H, br s, NH-18) together with the 13C NMR resonances at 0 164 (C-11), 152 
(C-19), 124 (C-12) and 124 (C-21) supported the presence of a pyrroloiminoquinone 
substructure in [92]. 
~\" .... oUt 1>,' i.lJl .1. 
" 
~ ' ...... .u1w 
, .,. 
",' "r 
... ,\ I 
" 
'l' . 
."'" 
"WI' 'IT" 01' 
I I I I I I I I I I I I I I I I I I I I I I I I I I I 
ppm 150 125 100 75 50 25 
FIGURE 3.7 13C NMR (100 MHz, DMSO-ds) spectrum of [92]. 
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TABLE 3.3 NMR spectral data for tsitsikammamine C [92]. 
13C 1H COSY to HMBC to 
-
"~ F 
1 150.9 d 7.705 C2,C3,C5,C6,C7, C20 
2 122.65 
3 171.2 5 
-- - _Q 
4 122.65 
-
5 150.9 d 7.705 C1,C2,C3,C6,C7,C20 
6 44.55 
7 33.5 t 2.02 br 5 H-8 C1, C5, C6, C20 
8 38.3 t 3.63 br 5 H-7, NH-9 
NH-:9 10.27 br 5 H-8. 
-
10 151.55 
11 164.35 
12 124.1 5 .' 
'.' 
14 112.55 
15 119.85 
16 17.5 t 2.71 t (7.4) H-17 C14, C15, C17, C21 
17 43.4 t 3.71 t (7.4) H-16, NH-18 C15, C19 . "- - , 
NH-18 8.22 br 5 H-17 
19 152.05 
20 91.75 
21 124.25 
Spectra were recorded at 400 MHz for 1 Hand 100 MHz for 13C in DMSO~d6 with 
chemical shifts (6) quoted in ppm. Coupling constants in Hz are in parentheses. 
However, the presence of an additional fused piperidine ring spin system with 
62.02 (2H, br 5, H-7) coupled to 6 3.63 (2H, br 5, H-8) and further coupled to 6 10.27 
(1 H, br 5, NH-9) in the COSY NMR spectrum of [92] suggested that the iminoquinone 
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existed within a phenanthroline ring system which is a structural feature common to all 
the discorhabdins. Therefore, based on this association, further structural elucidation 
was achieved by comparison of the spectral data of [92] with those of discorhabdin C 
- ' 
[63], the structure of which was determined by X-ray analysis 113. A sharp two-proton 
vinylic singlet resonating at (5 7.70 (2H, s, H-1 and H-5), which gave a three bond 
HMBC correlation to a carbonyl 13C NMR resonance at (5 171 (C-3) in the HMBC NMR 
spectrum of [92], pointed to the existence of a symmetrical unsaturated spiro-
cyctohexanone system in this compound. Comparison of the 1H and 13C NMR chemical 
shifts of this system with those of discorhabdin C113 revealed that [92] had an 
equivalent 2,4-dibromocyclohex-1,4-dien-3-one moiety attached at C-6. Further 
comparison of the NMR and HRFAB mass spectral data with those for discorhabdin C 
clearly showed that the only difference between the two compounds was an additional 
bromine substituent in [92] at the expense of a proton. A three bond correlation from 
the H-16 methylene protons to the quaternary C-14 carbon signal in the HMBC 
spectrum, the absence of an olefinic proton singlet at (5 7.22 (H-14) in the 1H NMR 
spectrum of [92], and the upfield shift of the C-14 13C NMR signal fwm ~.128 for 
discorhabdin C to (5 113 for [92], placed the bromine at the C-14 position and 
completed the assignment of tsitsikammamine C. This is the first example of a 
discorhabdin compound with a substituent at position-14. 
3.3.4 Tsitsikammamine 0 [93]. 
o 
Br 
Br 
[93] 
A protonated molecular ion at m/z 541.8710 in the HRFAB mass spectrum of 
[93] indicated a molecular formula of C1sH1SN302Br3 (6 +0.4 mDa). Comparison with the 
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molecular formula of compound [92] revealed that the only difference between the two 
compounds was an additional two protons in [93]. Comparison of the 13C NMR data of 
[93] (TABLE 3.4) with those for [92] showed th,e absence of a carbonyl resonance at 
- -
6 171.2 (C-3) and the presence of an oxymethine signal at 0 70.7 which correlated to 
a one proton doublet at 6 4.67 (1 H, d, J = 8.2 Hz, H-3) in the HMQC NMR spectrum of 
[93]. This proton doublet was in turn strongly coupled to an exchangeable single proton 
doublet at 0 6.20 (1 H, d, J = 8.9 Hz, OH-3) in the COSY NMR spectrum of [93]. 
Addition of 0 20 to the NMR sample caused the doublet at 0 6.20 to disappear and the 
doublet at 6 4.47 to coalesce into a sharp singlet (FIGURE 3.8). The above implied the 
presence of a 2,4-dibromo-3-hydroxy-cyclohex-1 ,4-diene moiety in [93] and this was 
confirmed by the two bond correlations from H-3 to C-2 and C-4 in the HMBC spectrum. 
OH-3 
ppm 
'-v"'-
i i i i 
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I 
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I 
6.0 
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FIGURE 3.8 Comparative 1H NMR (400 MHz, OMSO-ds) spectra of [93]. (a) before 
addition of 0 20. (b) after addition of 0 20. 
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TABLE 3.4 NMR spectral data for tsitsikammamine 0 [93]. 
13C 1H COSY to HMBC to 
-
-< 
1 134.0 d 6.36 s H-3 C2,C3,C4,C5,C6,C20 
2 124.4 s 
3 70.7 d 4.67 d (8.2) H-1, H-5, OH-3 C~.C4 
4 124.4 s 
-
5 134.0 d 6.36 s H-3 C1,C2,C3,C4,C6,C20 
6 41.9 s 
7 34.7 t 1.87 br s H-8 C1,C5,C6,C20 
8 38.1 t 3.51 br s H-7, NH-9 
NH-9 10.07 br s H-8 
10 151.5 s 
11 164.3 s 
12 124.1 s " 
._-
14 112.5 s 
15 119.8 s 
16 17.7 t 2.71 t (7.4) H-17 C14, C15, C17, C21 
17 43.6 t 3.78 t (7.0) H-16, NH-18 C15, C19 . "'- - . 
NH-18 7.76 br s H-17 
19 152.0 s 
20 96.0s 
21 124.2 s 
OH-3 6.20 d (8.9) H-3 
Spectra were recorded at 400 MHz for 1 Hand 100 MHz for 13C in DMSO-ds with 
chemical shifts (6) quoted in ppm. Coupling constants in Hz are in parentheses. 
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The presence of the makaluvamine-like compounds [90] and [91] together with 
the discorhabdin-like compounds [92] and [93] in this Latrunculid sponge supports 
Ireland's contention125 that the less functionalised makaluvamines provide a logical 
- -
biosynthetic pool fo(interrelation with the more highly elaborated discorhabdin family 
of compounds. The co-occurence of the new compounds [90] - [93] in this South 
African Latrunculid sponge has provided support for the sponge's classification as a 
new genus. 
3.4 BIOLOGICAL ACTIVITY 
The pyrroloiminoquinone alkaloids exhibit a wide range of biological activities 
incllJding antiviral activity114, antimicrobial activity114,123,128, induced Ca2+ release from 
the sarcoplasmic reticulum117, inhibition of the topoisomerase II enzyme123,125,126, and 
in vitro cytotoxicity against a number of cell lines including murine leukaemia114,115,1~6, 
human epidermoid carcinoma117,126, human colon tumour123,125,126, human lung cancer126 
and human breast cancer126 cell lines. 
Of all the crude extracts of the 350 different marine invertebrates collected by 
the research group at Rhodes University between 1992 and 1995 that were screened 
for antimicrobial activity, the crude extract of the Latrunculid sponge collected from the 
Tsitsikamma Marine Reserve exhibited the greatest antimicrobial activity. The crude 
extract (MeOH/CHCI3) of this Latrunculid sponge displayed potent activity against the 
bacteria Bacillus subtilis, Staphylococcus aureus and Escherichia coli equal to and 
exceeding that of the gentamycin standard (TABLE 3.5). Fractionation of this extract 
led to the isolation of tsitsikammamines A [90] - C [92] as pure compounds. 
Antimicrobial testing of these pure compounds indicated that they contributed largely 
to the potent antimicrobial activity of the crude extract against the Gram-positive 
bacteria B. subtilis and S. aureus (TABLE 3.5). However, these compounds exhibited 
only a slight activity against the Gram-negative bacterium E. coli suggesting either that 
other compounds in the crude extract are responsible for this activity or that this activity 
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is synergistic and only observed when a combination of compounds [90] - [92] is 
present. 
TABLE 3.5 Zone of inhibition diameters measured in the antimicrobial disc' assay of 
the crude extract of the Latrunculid sponge and of the tsitsikammamines 
A [90] - C [92]. 
- SAMPLE B. subtilis S. aureus E.coli 
Testing at 250 I-Ig disc-1: 
crude extract 23.0* 25.0* 21.0* 
standard 23.0 23.5 19.0 
Testing at 100 1-19 disc-1: 
[90] 18.0 22.5 sl 
[91] 18.0 23.0 sl 
[92] 18.5 27.0 sl 
.' 
. ~. 
standard 20.0 24.5 22.0 
Testing at 50 1-19 disc-1: 
[90] 17.0 19.0 sl 
[91] 17.5 19.0 sl 
. '- ~ , 
[92] 18.0 25.0 sl 
standard 22.0 24.0 21.0 
Testing at 10 1-19 disc-1: 
[90] 12.0 11.0 -
[91] 11.0 10.5 -
[92] 14.0 23.5 
-
standard 20.5 24.0 20.5 
*Inhibition zone diameter in mm, disc diameter = 8.0 mm and "sl" indicates slight activity 
(8.0 - 9.0 mm). Standard = gentamycin 10 I-Ig disc-1. 
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Tumour cells often have a defective ability to repair damage to DNA compared 
to normal cells, therefore, compounds with selective toxicity towards repair deficient 
cells might be potential anticancer agents132. A l'Dechanism-based yeast bioassay which 
can selectively detect agents causing DNA-damage in the repair deficient cells is 
employed by SKB in the search for potential anticancer agents from natural sources 132. 
With the deletion of the DNA topoisomerase I gene, the assay can be used todetect 
agents which produce DNA damage specifically by interacting with DNA 
topeisomerases and can even differentiate between a DNA topoisomerase I and a DNA 
topoisomerase " inhibitor. 
In previous communications 123,125 Ireland has reported the ability of 
pyrroloiminoquinones, specifically wakayin [SO] and the makaluvamine-type 
compounds [S1] - [87], to inhibit the topoisomera_se " enzyme. This prompted an 
exploration of this activity in the tsitsikammamines. Interestingly, screening of the 
tsitsikammamines A [90] - D [93] in SKB's mechanism-based yeast bioassay showed 
no evidence that these compounds produce DNA damage and, by inference",these 
compounds, therefore, are not topoisomerase inhibitors. In this assay the 
tsitsikammamines were shown to be antifungal. Deletion of the topoisomerase I gene 
in the assay had no effect on the antifungal activity which suggests that the antifungal 
activity of these compounds is not by interaction with topoisomerase I but by an 
unknown mechanism. Work is presently in progress at SKB to investigate the 
mechanism of antifungal activity of compounds [90] - [93]. 
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CHAPTER FOUR 
NEW METABOLITES FROM THE SOUTH AFRICAN SOFT CORAL 
CAPNELLA THYRSOIDEA 
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4.1 INTRODUCTION 
Advances in underwater diving technolQgy in the latter half of this century have 
enabled man to cfosely study and survey ·the marine reef environment. In early 
investigations of reef communities several important observations concerning the 
alcyonaceans (soft corals) were made and these have directly influenced the marine 
chemist. The fact that alcyonaceans seemed to be the largest singlercontributor to the 
biomass of many Indo-Pacific reefs, that they had a notable ability to discourage algal 
and microbial growth and prevent the settlement of larvae, and that they experience an 
extremely low incidence of predation 133, inspired marine chemists to target the soft 
corals as one of the first marine invertebrate groups for systematic chemical scrutiny. 
It was soon discovered that the alcyonaceans constitute a rich source of terpenoids and 
polyhydroxysterols 133. 
In 1992 Coli reviewed the chemistry and chemical ecology of the Alcyonacea83 
(true soft corals), of which there are three large multigeneric families: the Alcyoniidae, 
Nephtheiidae and Xeniidae. In reviewing the distribution of terpenes within the different 
soft coral genera and families, Coli reported that the distribution of terpenes in the soft 
coral genus Capnella (Family: Nephtheiidae) was limited to sesquiterpenes. This 
conclusion was reached from reviewing the chemical investigations conducted on a 
single species of Capnella soft coral, i.e. C. imbricata. 
OH 
HO 
[94] [95] [96] 
In 1974 a new tricyclic sesquiterpene [94], was isolated from the soft coral 
Capnella imbricata134. This compound is a trihydroxy derivative of what is now termed 
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the capnellane skeleton [95]. Further research of the same species of soft coral yielded 
five additional sesquiterpenes 135-137 all containing' the three 5-membered fused ring 
(capnellane) skeleton, and precapnelladiene [96]138, a possible biosynthetic precursor 
- . 
of the capnellane skeleton. Paradoxically,' in 1985 it was reported that the major 
compounds in living colonies of Capnella imbricata were acetylated capnellenes 139 and 
it was thus surmised that the previously reported capnellene polyols were artifacts from 
,..-- ~ 
hydrolysis during the sun-drying of the animals. 
During the course of a marine invertebrate sampling expedition in the 
Tsitsikamma Marine Reserve in May 1993, the soft coral Capnel/a thyrsoidea was 
collected. This soft coral is apparently endemic to South Africa and is one of the most 
common soft corals found off the SOi.Jth African coast59. The soft coral exists as several 
phenotypic colour variantst. Section 4.2 and 4.3 ofthis chapter details the chemical 
analysis of extracts of two clearly distinguishable bright yellow and grey colour variants 
of Capnella thyrsoidea84. The study resulted in the isolation and identification of three 
pregnadiene steroids and four xenicane diterpene metabolites. 
[97] R = H 
[98] R = OAc 
R 
[99] R = OAc 
The pregnadiene compound [97], isolated from the yellow colour variant, was 
found to be identical with a previously isolated pregnadiene steroid from an Australian 
Capnella species (C. erecta)140 and from an unidentified soft coral from Canton 
Island141. Two new pregnadiene steroids [98] and [99] were isolated and identified from 
the grey colour variant of C. thyrsoidea. Naturally occurring pregnane-derived steroids 
from the marine environment141-144 are reported to be rare 140. 
t Personal communication with Dr Gary Williams, California Academy of Sciences. 
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[100] [101] 
[102] [103] 
The crude extracts of the yellow and grey colour variants of C. thyrsoidea also 
yielded a series ofxenicane diterpene compounds, the tsitsixenicins A [100],8 [101], 
C [102] and 0 [103]. Xenicane diterpenes are predominantly found in soft corals of the 
genera Xenia145-159 and Anthelia63.64.160 (Family: Xeniidae) and at one stage it was 
believed that the xenicane diterpenes were produced exclusively by the family 
Xeniidae. More recently, however, xenicane diterpenes have been isolated from the 
soft coral families Helioporiidae161 and Alcyoniidae63, and also from a number of 
gorgonians of the genus Acalycigorgia162-164. 
The xenicane diterpenes isolated from the above marine invertebrates have 
been divided into three structural groups: the xenicins and xeniolides (numbering 
approximately fifty-two and eighteen respectively) both of which contain a 2-
oxabicyclo[7.4.0]tridecane ring system, and the xeniaphyllanes (numbering 
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approximately fifteen) which possess a bicyclo[7.2.0]undecane structure. Xenicin 
[104]145, xeniolide A [105]147 and xeniaphyllenol [106]146 provide an example of each 
group respectively. 
..... 
",OAe 
· .... "'OAe 
[104] [105] 
[106] 
Xenicane diterpene compounds have never before been reported from the soft 
coral family Nephtheiidae and so the tsitsixenicins represent the first examples from 
this soft coral family. The discovery of these diterpenes is at variance with Coli's 
generalisation83 that the distribution of terpenes in Capnel/a species is limited to 
sesquiterpenes and a revision of the chemotaxonomy of this genus is required. 
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4.2 COLLECTION, EXTRACTION AND ISOLATION 
FIGURE 4.1 Yellow colour variant of the soft coral Capnel/a thyrsoidea collected from 
Rheerders Reef in the Tsitsikamma Marine Reserve. 
The clearly distinguishable bright yellow (FIGURE 4.1) and grey colourmorphs 
of the soft coral Capne/la thyrsoidea were collected using SCUBA at a depth of -30 m 
in the Tsitsikamma Marine Reserve in May 1993 and recollected in May 1994. The 
frozen yellow and grey colour variants were freeze-dried (dry weights 618 g and 207 
g respectively) and steeped in EtOAc. The separate EtOAc extracts were concentrated 
under reduced pressure to give dark brown oils (16.0 g and 4.7 g respectively). These 
we're screened by 1H NMR spectroscopy and although the 1H NMR spectra were 
similar, significant differences in the series of peaks occurring between 6 4.8 and 7.2 
precluded the combining of the two extracts. Fractionation of each extract was 
conducted according to SCHEME 4.1 and SCHEME 4.2 respectively. 
73 
YELLOW COLOURMORPH 
EtOAc extract 
(2.10 g) 
~ 
(956.7 mg) 
I (a) 
20% EtOAc I hexane 
(139.4 mg) 
50% EtOAc I hexane EtOAc 
I(b) 
[97] 
80.2 mg 
0.14% 
AFTER RECOLLECTION 
EtOAc extract 
(13.9 g) 
~ 
(6.0 g) 
I (c) 
I 
20% EtOAc I hexane 
(1.26 g) 
50% EtOAc I hexane EtOAc 
I(d) 
mother liquor 
(767.3 mg) 
~ 
(134.3 mg) I (e) 
(65.6 mg) I (f) 
(36.3 mg) I (g) 
[100] 
23.3 mg 
0.06% 
[97] 
crystalline steroid 
(492.4 mg) 
SCHEME 4.1 Chromatographic procedure for the isolation of compounds [97] and 
[100] from the yellow colour variant. (a) flash chromatography (silica, 230-400 mesh, 
150 g, elution sequence: 20% EtOAc/hexane; 50% EtOAc/hexane; EtOAc). (b) HPLC 
(silica, 10 1-1, Whatman, 7.5% EtOAc/hexane, 4 mL min-1). (c) repeat of (a). (d) 
recrystallisation from hexane. (e) HPLC (C18, 101-1, Phenomenex, 15% H20/MeOH, 4 
mL min-1). (f) HPLC (silica, 10 1-1, Whatman, 5% EtOAC/hexane, 4 mL min-\ (g) HPLC 
(silica, 10 1-1, Whatman, 15% etherlisooctane, 4 mL min-1). 
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I (870 rng) 
~ 
(208 rng) 
I 
I(e) 
(75 rng) I(f) 
I I I 
[99] [100] 
4.8rng 67.8 rng 
0.02% 0.3% 
I 
GREY COLOURMORPH 
EtOAc extract 
(4.72 g) 
t· 
(2.0 gj 
I (a) 
1 (88 rng) [98] 
7.5rng 
0.009% 
I(g) 
I 
[101] 
5.6rng 
0.03% 
(291 rng) 
I(b) 
(196 rng) 
I (c) 
1 . (20.7 rng) 
J(d) 
1 
[102] 
5.9rng 
0.006% 
chOle~ter 01 
g) (132.0 rn 
I 
[103] 
8.3rng 
0.009% 
SCHEME 4.2 Chromatographic procedure for the isolation of compounds [98] - [103] 
from the grey colour variant. (a) flash chromatography (silica, 230-400-mesh,150 g, 
20% EtOAc/hexane). (b) repeat of (a). (c) HPLC (silica, 10 ~, Whatman, 15% EtOAc 
/hexane, 4 mL min-1). (d) HPLC (C18, 10~, Phenomenex, 30% H20/MeCN, 4 mL min-1). 
(e) HPLC (silica, 10 ~, Whatman, 8% EtOAc/hexane, 4 mL min-1). (f) HPLC (C18, 10 
~, Phenomenex, 25% H20/MeCN, 4 mL min-1). (g) HPLC (C18, 10 ~, Phenomenex, 
27.5% H20/MeCN, 4 mL min-1). 
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4.3 STRUCTURE DETERMINATION AND STEREOCHEMISTRY 
4.3.1 Structure determination of the pregnadiene steroids [97], [98] and [99]. 
[97] 
HREIMS data established. the molecular formula of [97] as C21 H300 (rn/z 
298._2313, ~mmu +17). The absorbance at 1674-cm-1 in the IR spectrum of [97], 
together with two olefinic proton doublets at (5 7.13 (1 H, d, J1,2 = 10.2 Hz, H-1) and (5 
5.83 (1 H, d, J1.2 = 10.0 Hz, H-2) situated at low field in the 1H NMR spectrum of [97] 
(FIGURE 4.2), suggested the presence of an a,~-unsaturated ketone charastetistic of 
1-en-3-one steroids. A complex series of signals at (55.74 (1 H, ddd, J = 8.8, 10.8, 16.5 
Hz, H-20), 4.95 (2H, m, H-21) and 1.95 (1 H, m, H-17) were assigned to the protons of 
an exocyclic vinylic group at C-17. Two three proton singlets at (50.61 (3H, s, H3-18) 
and 1.00 (3H, s, H3-19) were ascribed to the C-18 and C-19 methyl ~~oqps 
respectively. The above data, together with a combination of COSY, HMQC and HMBC 
NMR experiments, enabled complete structural elucidation of [97] which was identical, 
by comparison of 13C NMR data (TABLE 4.1), melting point and optical rotation, with 
5a-pregna-1 ,20-dien-3-one previously isolated from C. erecta140 and an unidentified 
soft coral141. 
The distinctive pair of doublets at (5 7.13 (H-1) and 5.83 (H-2), triplet of doublets 
at (5 5.74 (H-20) and two proton multiplet at (5 4.95 (H2-21) can be used to identify 
pregna-1 ,20-dien-3-one type compounds in crude extracts or chromatography fractions. 
Although no additional pregna-1 ,20-dien-3-one or similar compounds were evident in 
the 1H NMR spectra of the remaining yellow colour variant chromatography fractions, 
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the 1H NMR spectra of two fractions from the flash chromatography of the grey colour 
variant revealed the presence of these compounds. Both fractions were 
chromatographed further to yield the new compounds [98] and [99]. 
OAe 
[98] 
A molecular formula of C23H3203 (mlz 356.2338, ~mmu -13) from HREIMS data 
and an acetate methyl singlet at 5 2.02 in the 1H NMR spectrum of [98] (FIGURE 4.3) 
confirmed that this compound was a monoacetoxy derivative of [97]. The position of the 
acetoxy group at C-16 followed from the coupling observed between H-16 (5 5.11, 1H, 
m) and H-17 (5 2.15, 1 H, dd, J1S,17 = 4.1 Hz, J17,20 = 7.7 Hz) in the COSY NMR .spectrum 
of [98] and established the structure of [98] as 16~-hydroxy-5a-pregna-1,20-dien-3-one 
16-acetate. The methodology used to establish the stereochemistry of the acetoxy 
functionality at C-16 is described in section 4.3.2. 
[99] 
HREIMS established the molecular formula of the third pregnadiene compound 
[99] as C2sH3S04 (mlz 400.2609, ~mmu -4). The two acetate methyl proton singlets at 
5 2.02 and 2.04 in the 1H NMR spectrum of [99] (FIGURE 4.4) and the similarities 
observed between the spectral data of [99] and compounds [97] and [98] supported 
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a diacetoxy 5a-pregna-1,20-diene structure for this compound with one of the acetoxy 
groups at C-16 as in [98]. The second acetoxy group was unequivocally placed at C-3 
based on the absence of the characteristic a,~-unsaturated carbonyl signal at 0 200 
- -
in the 13C NMR sp-ectrum of [99] and the' coupling observed between'the H-3 
oxymethine proton at 05.15 (1 H, m, H-3), the olefinic proton at 05.60 (1 H, ddd, J24 = 
1.2 Hz, J2•3 = 5.5 Hz, J1.2 = 10.0 Hz, H-2) and the methylene protons at 0 1.53 and 1.81 
(2H, m, Ha-4 and He-4) in the COSY NMR spectrum of this compound'. These data 
verified 3a, 16~-dihydroxy-5a-pregna-1,20-diene 3,16-diacetate as the structure for 
[99]. The methodology used to establish the stereochemistry of the acetoxy 
functionalities at C-3 and C-16 is discussed in section 4.3.2. 
Although there was no evidence of [97] in any of the chromatography fractions 
from the grey colour variant of C. thyrsoidea, biosynthetic arguments and comparible 
spectral data exhibited by compounds [97] - [99] suggest a common 5a-pregnadiene 
parent structure for [98] and [99]. 
19 
18 
21 
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FIGURE 4.2 1H NMR (400 MHz, CDCI3) spectrum of [97]. 
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FIGURE 4.3 1H NMR (400 MHz, CDCI3) spectrum of [98]. 
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FIGURE 4.4 1H NMR (400 MHz, CDCI3) spectrum of [99]. 
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TABLE 4.1 13C NMR (100 MHz, CDCI3) data for [97] - [99] and [107] - [108]. 
- [97] [98] 
-
{99] [107] [108] 
1 158.5 d 158.0 d 142.0 d 158.2 d 140.3 d 
2 127.4 d 127.5 d 122.5 d 127.5 d 126.2 d 
3 200.1 s 200.0 s 67.3 d 200.1 s ~ 64.4 d ~ -
4 40.1 t 40.1 t 31.8 t 41.0 t 31.9 t 
-
5 44.4 d 44.4 d 39.6 d 44.4 d 39.0 s 
6 27.2 t 27.5 t 27.6 t 27.6 t 27.9 t 
7 31.4 t 31.2 t 31.7 t 31.3 t 29.7 t 
8 35.8 d 35.3 d 35.3 d 35.6 d 35.4 d 
9 50.3 d 50.3 d 51.0 d 50.3 d 51.3 d 
-
10 39.1 s 39.1 s 37.9 s 39.9 s 38.3 s 
11 27.6 t 33.8 t 33.9t 35.3 t 34.8 t 
12 37.4 t 37.2 t 37.3 t 37.3 t 35.7" t 
13 43.7 s 44.2 s 44.2 s 44.9 s 45.0 s 
14 55.6 d 53.3 d 53.4 d 53.2 d 53.4 d 
15 20.8 t 20.4 t 20.2 t 20.4 t 20.3 t 
16 24.7 t 78.4 d 78.5 d 76.5 d 76.6 d 
. "'- - . 
17 55.3 d 61.6 d 61.6 d 66.2 d 66.3 d 
18 13.0 q 14.2 q 14.2 q 14.4 q 14.4 q 
19 13.0 q 13.1 q 13.9 q 13.1 q 13.9 q 
20 139.5 d 135.9 d 136.1 d 136.8 d 136.9 d 
21 114.7 t 117.0 t 166.8 t 117.2 t 116.9 t 
COCH3 21.2 q 21.3 q 
21.5 q 
COCH3 171.1 s 171.1 s 
170.1 s 
All assignments are supported by DEPT, COSY, HMQC and HMBC NMR experiments. 
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4.3.2 Stereochemistry of the pregnadiene steroids [98] and [99]. 
[97] R = H 
[98] R = OAe 
[107] R = OH 
[99] R = OAe 
[108] R = OH 
R 
The 16~ stereochemistry of the acetoxy in [98] was suggested from selected 
NOEDS NMR experiments. Irradiation of the H-17 signal resulted in significant 
enhancement of the H-16 signal while irradiation of H-16 caused enhancement of H-17 
and H-15a. Confirmation of this stereochemistry was obtained by saponifying 198] to 
give 16~-hydroxy-5a-pregna-1 ,20-dien-3-one [107]. The v-gauche effect of the hydroxy 
group( s) in hydroxylated steroid molecules is a useful tool for the stereochemical 
elucidation of these compounds 165. A V-hydroxy substituent effect, due to the 16~­
hydroxyl functionality, causes an upfield shift (-3 ppm) of the C-20 signal in the 13C 
NMR spectrum of [107] relative to [97]. In addition the 13C chemical shift of the C-18 
methyl, which is nearly 1 ,3-synperiplanar to the 16~-hydroxy group, is affected by a 
small 5-hydroxy substituent effect and is shifted marginally downfield (+1 ppm)165 
(TABLE 4.1). 
LiAIH4 reduction of [99] gave the diol [108]. The 1H NMR spectrum of [108] 
contained a broad triplet at 5 4.1 (Wx = 10 Hz) assigned to a 3~ proton141 (a 3a proton 
requires Wx = 25 HZ)166 thus confirming the a-configuration of the oxygen functional 
group at C-3. The 16~ orientation of the second acetoxy group in [99] was established 
using the same techniques and associated arguments presented for [98]. 
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4.3.3 Structure determination of the tsitsixenicins A [100] - 0 [103]. 
17 
16 
18 
19 
[100] 
HREIMS data established the molecular formula of tsitsixenicin A [100] as 
C24H340S (mlz 402.2398, Llmmu -8 ). The two acetate carbonyl (0 169 and 170) and 
eight olefinic (0 113, 116, 119, 124, 134, 136, 143 and 149) resonances in the 13C NMR 
spectrum of [100] (FIGURE 4.5) accounted for six of the eight degrees of unsaturation 
implied by the molecular formula. The remaining two degrees of unsaturation ther.efore 
required a bicyclic diterpene skeleton for this compound. 
carbonyl 
region 
I 
ppm 
I 
160 
I 
150 
'0,. 
I 
140 
olefinic region 
I 
130 
I 
120 
. -
FIGURE 4.5 Partial 13C NMR (100 MHz, CDCI3) spectrum of tsitsixenicin A [100]. 
82 
The 1H and 13C NMR data of [100] (TABLE 4.2), supported by an HMQC NMR 
experiment (FIGURE 4.6), revealed the presence of one acetylated hemi-acetal at OH 
5.75 (1 H, d, J1,11a = 3.6 Hz, H-1) and Oc 92, an olefinic methylene group at OH 4.91 and 
4.78-(2H, br s, H-19 and H-19') and Oc 113, th~ee vinylic methyl groups at OH 1;64 (3H, 
br s, H-16), 1.67 (6H, br s, H-17 and H-18) and Oc 17, 18 and 25 and an enol ether 
methine proton at OH 6.52 (1H, d, J34a = 1.9 Hz, H-3) and Oc 143. 
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FIGURE 4.6 HMQC NMR (400 MHz, CDCI3) spectrum of tsitsixenicin A [100]. 
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TABLE 4.2 NMR spectral data for tsitsixenicin A [100]. 
13C 1H 
1 92.3 d 
"~ -r 
5.75 d (J111a 3.6) 
3 142.6 d 6.52 d (J3,4a 1.9) 
4 116.1 s 
,..- - ~ 
4a 39.7 d 2.29m 
-5,5' 32.3 t 2.08 m, 1.22 m 
6,6' 39.7 t 2.19 m, 2.07 m 
7 134.4 s 
8 124.3 d 5.37 dd (8.0, 9.5) 
9,9' 25.5 t 2.43 m, 2.07 m 
10; 10' 35.9 t 2.31 m, 2.07 m 
11 149.3 s 
11 a 50.1 d 1.96 br s 
.' 
12 74.7 d 5.25 t (J12,13 7.6) . ~. 
13, 13' 31.4 t 2.43 m, 2.31 m 
14 118.9 d 4.97 t (6.9) 
15 135.6 s 
. ,,-. -
16 18.1 q 1.64 br s 
17 25.7 q 1.67 br s 
18 17.0 q 1.67 br s 
19, 19' 113.4 t 4.91 br s, 4.78 br s 
COCH3 21.5 q 2.07 s 
21.0 q 2.01 s 
COCH3 169.5 s 
170.2 s 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in CDCI3 with chemical 
shifts (5) quoted in ppm. Coupling constants in Hz are in parentheses. 
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The contiguous coupling sequence observed in the COSY NMR spectrum of 
[100] from the hemi-acetal proton at (5 5.75 (1H, d, J = 3.6 Hz, H-1) through the methine 
protons at (5 1.96 (1 H, br s, H-11 a) and (5 2.29 (1 H, m, H-4a) and finally through weak 
allyfic coupling to the enol ether proton at (5 6.q2 (1 H, d, J3,4a = 1.9 Hz, H-3) suggested 
that one of the rings in the bicyclic structure was a 1-acetoxydihydropyran moiety. 
Prominent correlations in the HMBC NMR spectrum of [100] from H-3 to C-1, C-4 and 
C-4a (FIGURE 4.7A) further supported this structural assignment. -
A 8 
FIGURE 4.7 Selected HMBC NMR correlations in compound [100]. 
20-NMR spectral analysis of [100] also indicated the presence of a 1-acetoxy-4-
. ,,- .. 
methyl-pent-3-ene fragment which was placed at C-4 on account of HMBC correlations 
from the acetoxy methine proton at (55.25 (1H, t, J12,13 = 7 Hz, H-12) to carbons at (5 
143 (C-3) and 116 (C-4) (FIGURE 4.78). The 1-acetoxydihydropyran ring system and 
associated six carbon side chain is characteristic of xenicane diterpenes containing a 
2-oxabicyclo[7.4.0]tridecane structure. The remaining protons and carbon atoms could 
thus be assigned to a nine-membered ring with an exocyclic methylene functionality 
and a vinylic methyl group from the 20-NMR data of [100] and by comparison of the 1 H 
and 13C NMR spectral data of [100] with published values for these 
compounds 149,157,160,162-164. Tsitsixenicin A was also isolated from the grey colour variant 
and this was found to be identical (NMR, [0]0) with [100] obtained from the yellow 
colour variant. 
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17 C~Me 
16 
18 
19 
[101] [109] 
The molecular ion at m/z 418.2378 (6mmu +23) in the HREIMS spectrum of 
tsitsixenicin B [101] is compatible with the molecular formula C24H340e and this 
corresponds to the addition of a single oxygen atom to [100]. The 13C NMR data of 
[101] (TABLE 4.3) were consistent with that of [100] E3xceptfor the replacement of the 
~7-trisubstituted double bond with an oxirane ring. A DEPT NMR experiment confirmed 
the quartenary character of the epoxy carbon atom at 0 59 (C-7) while an HMQC NMR 
experiment assigned the prominent oxymethine doublet of doublets at 0 2.98 (1H, dd, 
J = 3.2, 10.8 Hz, H-8) in the 1H NMR spectrum to the carbon atom at 0 62 (C-8). The 
position of the epoxy methine proton at C-8 was confirmed by comparison of the 
spectral data of [101] with that reported for acalycigorgan B [109]164. Two and three 
bond correlations between the C-18 methyl protons and C-7 and C-8 respectively in the 
HMBC NMR spectrum oftsitsixenicin B [101] provided further evidence for the position 
of the epoxide functionality. 
19 
[102] [103] 
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HREIMS established the molecular formulae of tsitsixenicins C [102] and 0 
[103] as C24H3207 (llmmu +13) and as C24H320S (llmmu -25) respectively. The 13C NMR 
data of compounds [102] and [103] (TABLE 4.3) indicated the same basic xenicane 
diterpene skeleton e-stablished for compourids [100] and [101] with the differences 
confined to the six carbon side-chain at C-4 and the substitution pattern around the 
nine-membered ring. One of the two acetoxy groups, evident from the 1 Hand 13C NMR 
spectra of compounds [102] and [103], was situated at 093 (C-1) while the second 
acetQxy was placed at C-7 from an HMBC correlation (FIGURE 4.8) between th'e C-18 
methyl protons at 0 1.61 (3H, s, H-18) and the quarternary oxygenated carbon atom 0 
84 (C-7). 
13C 
12 ~15 
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FIGURE 4.8 HMBC NMR (400 MHz, CDCI3) spectrum of tsitsixenicin C [102]. 
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The 6 8-position of the endocyclic olefin in [102] and [103] followed from a two 
bond HMBC correlation between the vinylic proton at 55.40 (1 H, d, J89 = 11.9 Hz, H-8) 
and C-7. The spectral data of tsitsixenicin C and D suggested that the differences 
between these two compounds were limitea to the side chain at C-4. The 13C NMR 
resonance at 582 and a hydroxyl absorbance (3620 cm-1) in the IR spectrum of [102] 
indicated the presence of a tertiary hydroxyl group in this compound. This functionality 
-~ ~ 
was placed at C-15 in [102] from the two bond HMBC correlations observed between 
the'C-16 and C-17 methyl group protons at 51.40 (3H, s, H-16) and 51.39 (3H, s, H-
17) respectively and the carboxy signal at 582 (C-15) (FIGURE 4.8). Other two bond 
HMBC correlations from the two vinylic proton signals at 5 6.82 (1 H, d, J1314 = 15.8 Hz, 
H-14) and 5 6.51 (1 H, d, J 13,14 = 15.8 Hz, H-13) to the two carbon resonances at 5 82 
(C-15) and 5190 (C-12) respectively>(FIGURE 4.8), established the 1-keto-4-hydroxy-
4-methyl-pent-2-ene structure of the C-4 side chain in [102]: 
The 1-keto-4-methyl-pent-3-ene structure of the C-4 side chain in [103] was 
similarly determined from 2D NMR data. A prominent three bond correlation between 
H-3 and C 12 in the HMBC spectra of [102] and [103] further supported the position of 
the ketone functionality in the side chain in both these compounds and linked the side 
chain to the 1-acetoxy-dihydropyran ring at C-4 as expected. 
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TABLE 4.3 13C NMR (100 MHz, CDCI3) data for tsitsixenicin B [101], C [102] and D 
[103]. 
. . 
[101] [102] [103] 
1 92.0 d 93.4 d 93.3 d 
3 142.4 d 151.7 d ~~S1.2 d 
4 116.2 s 124.3 s 123.5 s 
, 
4a 37.0 d 28.2 d 28.6 d 
5 31.2 t 27.0 t 26.9 t 
6 39.2 t 37.5 t 37.8 t 
7 59.8 s 83.7 s 83.5 s 
8 62.3 d 131.2 d 131.4 d 
-
9 25.3 t 129.8 d 129.7 d 
10 31.2 t 30.7 t 30.8 t 
11 146.8 s 145.5 s 145.6 s .' 
._. 
11 a 49.3 d 48.1 d 48.0 d 
12 74.3 d 190.2 s 197.7 s 
13 31.3 t 125.6 d 38.6 t 
14 118.6 d 148.4 d 117.0d 
- -
. 
15 134.7 s 82.1 s 135.0 s 
16 18.1 q 24.2 q 25.8 q 
17 25.7 q 24.1 q 18.1 q 
18 17.2 q 28.5 q 28.5 q 
19 116.2 t 118.1 t 117.9 t 
COCH3 21.4 q 22.3 q 22.2 q 
21.0 q 20.9 q 20.9 q 
COCH3 170.2 s 169.2 s 169.3 s 
169.3 s 169.2 s 169.1 s 
A" assignments are supported by DEPT, COSY, HMQC and HMBC NMR experiments. 
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4.3.4 Stereochemistry of the tsitsixenicins A [100] - D [103]. 
1 8 
[100] [110] 
In tsitsixenicin A [100] an E configuration could be assigned to the /:).7 double 
bond based on the Me-18 chemical shift at 017.0149 (a Z configuration requires 0 22-
25). The slightly broadened H-11 a singlet at 0 1.96 in the 1H NMR spectrum of [100] 
indicated that the coupling to H-4a is very small (a dihedral angle of approximately 90~) 
and is in accordance with the trans-fused bicyclic ring system found in other naturally 
occurring xenicane diterpenes. Although an a stereochemistry for the proton at C-1 is 
prevalent in 1-acetoxy-xenicane compounds63,145,146,148-150,16o,163,164, NOEDS experiments 
tentatively suggested a ~ configuration for H-1 in tsitsixenicin A [100]. Irradiation of the 
H-11 a signal only caused significant enhancement (12%) of the H-1 signal, while 
irradiation of H-1 gave enhancement of H-11 a (5%) and no enhancement of the H-4a 
signal. An enhancement of the H-4a signal is expected in NOEDS experiments with 
xenicane compounds containing a H-1a relative stereochemistry164. A close look at the 
coupling constants measured between H-1 and H-11 a in analogous 1-acetoxy-xenicane 
compounds (TABLE 4.4) indicates a disparity between the coupling of J1,11a = 3.6 Hz 
in [100] and the average coupling of J111a = 2.0 Hz in these compounds supporting the 
proposed difference in stereochemistry. 
9-Deacetoxy-14, 15-deepoxyxeniculin [110] isolated from the Red Sea soft coral 
Xenia obscuronata149 is diastereomeric with [100]. Unfortunately no optical rotation was 
reported for [110] where the relative stereochemistries at C-1, C-4a and C-11 a were 
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TABLE 4.4 J1•11a coupling constants (Hz) in 1-acetoxy-xenicane compounds. 
REFERENCE 
145 
146 
149 
149 
148 
150 
160 
160 
163 
63 
63 
63 
164 
164 
AVERAGE 
RANGE 
J111a COUPLING . 
2 
2.6 
1.8 
2.2 
2 
2 
1.6 
1.6 
1.8 
1.9 
2.3 
2.3 
1.8 
2.1 
2.0 
1.6 - 2.6 
-. 
R 
OAc 
H 
H 
H (7,8-epoxide) 
OH 
H 
H 
H 
H 
OAc 
H 
H 
H 
H (7,8-epoxide) 
x 
H 
H 
H 
H 
H 
H 
i-I 
OH 
H 
OH 
H 
OH 
H 
H 
assigned after comparison of 13C chemical shifts with analogous compounds of known 
stereochemistry. However, the recent isolation of [110] from an A/cyanium species of 
soft coral collected from Aliwal Shoal in South Africa (see chapter five) lends support 
to the H-1 P configuration in [100] based on a comparison of NOEs, J1•11a coupling 
constants and optical rotations of [100] and [110] (TABLE 4.5). 
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TABLE 4.5 Comparison of J1,11acoupling, NOEs and [a]~ in [100] and [110] . 
-
[100] [110] 
"~ r 
J1,11a (Hz) 3.6 2.2 
NOEs 
Irradiation of : Enhancement of : Enhancement of : 
't""~ ~ 
H-1 H-11 a (5%) H-11 a (2%) 
-
H-11a H-1 (12%) H-1 (7%) 
H-4a no effect on H-1 H-1 (3%) 
[a]~ -63.8 0 +126.90 
The comparatively stronger enhancements of H-11 a and H-1 in [100] after 
irradiation of H-1 and H-11 a, respectively, not only suggests a close spatial 
arrangement but also a ~ orientation for both protons.- The enhancement of H-1 in [110] 
from the irradiation of H-4a and the J111a = 2.2 Hz coupling are in accordance with 1-
, -
acetoxy-xenicane compounds reported in the literature having an H-1 a configuration. 
Although the considerable difference in optical rotations lends credence to the 
assigned configuration at C-1, this does not provide unequivocal proof as the 
stereochemistry at C-12 in [100] and [110] remains unassigned. The C-1 13C chemical 
shift in [100] (0 92.3) differs marginally from that reported for [110] (0 92.0) arid the 
assignment of stereochemistry from 13C chemical shift comparisons must therefore be 
considered tenuous in these compounds. 
[111] R = a - OAe 
[112] R = P - OAe 
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Gentle refluxing of a methanolic solution of [100] gave compound [111] in almost 
quantitative yield. A similar compound, acalycigorgin D [112], isolated from the 
gorgonian Aca/ycigorgia species 164, was assumed to be an artifact arising from [110] 
via a SN2' syn reaction with the MeOH extraction solvent. The above observation 
supports this contention and it was fortuitous that only EtOAc was used to extract both 
colour variants of C. thyrsoidea. 
18 
[101] 
The observed NOEs in tsitixenicin B [101] between 8-H and the a-proton at C-
4a, between the C-18 methyl protons and the ~-proton at C-11 a, and the apparent lack 
of enhancement of H-8 with the irradiation of the C-18 methyl protons and vice versa, 
in a series of NOEDS experiments, are in accordance with observations reported for 
a 7(8)-E-epoxy configuration157. There seems to be a disparity in literature157,164 
concerning the stereochemistry of the 7(8)-oxirane ring in xenicane compounds and 
this is discussed in greater detail in section 5.3.4. The stereochemistry at C-12 in 
tsitsixenicin 8 remains unassigned. Previous attempts to define the stereochemistry of 
an acetoxy group at C-12 in xenicane compounds by chemical transformations and 
spectroscopy have proven unproductive157,160. Reactions with mild acid, mild base, 
NaBH4 or LiAIH4 have allied to decomposition of the parent compound. 
In tsitsixenicin C [102] an E stereochemistry could be assigned to the exocyclic 
olefin based on the J1314 = 16 Hz coupling constant for the vinylic protons in the side 
chain. Irradiation of the Me-18 protons in NOEDS experiments on [102] and [103] 
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induced significant enhancement of H-8 and marginal enhancement of H-11 a 
suggesting a tentative a-configuration for the acetoxy group at C-7. 
19 
[102] [103] 
The significant enhancement of the H-11 a signal on irradiation of H-1 in the 
NOEDS experiments on [101] (12%), [102] (14%) and [103] (9%) confirmed that the 
configuration at C-1 in these compounds was consistent with that proposed for 
tsitsixenicin A [100]. In addition, no enhancement of H-4a was observed on irradiation 
,--
of either H-1 or H-11 a in any of these three compounds. 
Structural elucidation of the xenicane diterpenes, particularly the 
stereochemistry, is difficult due to the inherent instability of the xenicane ring system 150 
as reflected by the degradation of a number of the pure compounds in air and in 
solution (particularly CHCI3)63,157,16°.-lt was observed that compounds [100] - [103] had 
all decomposed to some extent over several weeks storage at GOC. Previous 
reports157,160 suggest that [101] and [102] are oxidation products of [100] and [103], 
respectively. It is unclear, however, as to whether [101] and [102] exist as such in the 
soft coral or whether they are artifacts of the isolation procedures. 
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4.4 BIOLOGICAL ACTIVITY 
Inspired by the isolation of new anti-i~flammatory diterpenes from a South 
African soft coral60, tne pregnadiene steroids (97] - [99], the tsitsixenicins A'[100] - 0 
[103] and compound [111] were screened for anti-inflammatory activity based on their 
ability to inhibit superoxide production in neutrophils t. 
Neutrophils play an important role in the protection of the host from infections 
through the production of superoxide. This serves as a precursor for a series of lethal 
oxidants (H20 2, -OH and HOCI) which are responsible for attacking the infectious 
bacteria. However, in abnormal environments such as ischaemia, trauma or the 
activation of the auto-immune system, neutrophils can produce superoxide in 
uncontrollable and excessive amounts which causes serious tissue injury and 
inflammation. To prevent this injury either the production of superoxide needs to be 
inhibited or excess superoxide must be rapidly neutralised by superoxide scavengers. 
Previously, research in this area has largely focussed on superoxide scavengers and 
it appears that no drugs have been developed with inhibition of superoxide production 
as their primary pharmacological function 167. Thus, the screening of natural products 
for superoxide inhibition provides a significant opportunity for the discovery of new anti-
inflammatory drugs. 
The assay used to screen' the pregnadiene and tsitsixenicin compounds for 
potential anti-inflammatory effects involved stimulating the release of superoxide from 
rabbit and human cell neutrophils using the chemotactic factor formyl-methyl-Ieucyl-
phenylalanine (FMLP). FMLP causes a rapid increase in superoxide production over 
a five minute period and this is detected colourimetrically by the superoxide induced 
reduction of ferric cytochrome C to its ferrous form. By monitoring the change in 
absorbance of cytochrome C the ability of compounds to inhibit superoxide production 
can be assayed. The results of the assay are contained in FIGURE 4.9 and TABLE 4.6. 
t Assay courtesy of InfiaZyme Pharmaceuticals Limited, Vancouver, Canada. 
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Sample No. 
[97] 
~ [98] 
[99] 
[100] 
[101] 
[102] 
[103] 
[111] 
DMSO 
[97] [98] [99] [100] [1 01] [1 02] [103] [111] DMSO 
o ,Rabbit neutrophils 
II Human neutrophjls 
% Inhibition (rabbit) 
34.1 
29.9 
75.6 
100.0 
99.4 
66.5 
80.5 
100.0 
34.0 
% Inhibition (human) -
-104.7* 
. ~. 
-25.9* 
39.9 
34.2 
19.2 
33.6 
0 
* indicates stimulation of superoxide production. 
FIGURE 4.9 The effect of the pregnadiene steroids [97] - [99], the tsitsixenicins A 
[100] - D [103], and compound [111] on superoxide production in rabbit 
and human neutrophils at a concentration of 12.5 jJg mL-1. 
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TABLE 4.6 The effect of compounds [100], [101] and [111] on superoxide production 
in rabbit and human neutrophils at a concentration of 1.25 I..Ig mL-1. 
Sample No. % Inhibition (rabbit) % Inhibition (human) 
[100] - 68.4 
[101] 72.6 20.7 
-~ ~ 
[111] - 3.0 
-
DMSO 34.0 0 
Compounds [100], [101], [103] and [111] showed good inhibition (>80%) of 
superoxide production in rabbit neutrophils at a concentration of 12.5 I..Ig mL-1 with only 
[101] retaining a high level of activity on ten fold dilution. It is generally observed that 
human cell neutrophils are less active than rabbit cell neutrophils in this assay and the 
superoxide inhibition by compounds in the former is generally reduced. Accordingly, 
only [100] and [101] showed good to moderate inhibition of superoxide production in 
the human neutrophil bioassay at low concentration (1.25 I..Ig mL-1). Unfortunately, the 
chemical instability of these two compounds precluded their further development as 
anti-inflammatory agents. Interestingly, the pregnadiene steroids [97] and [98] 
stimulated superoxide production in rabbit neutrophils and this observation is attrfbuted 
to cytotoxicity in which cell lysis increases superoxide levels. 
Recent reports have included other interesting biological activities for xenicane 
diterpenes including the inhibition of fertilised ascidian eggs 164, ichthyotoxicity157, and 
cytotoxicity towards mouse leukaemia cell lines and several human carcinomata63• 
97 
CHAPTER FIVE 
NEW METABOLITES FROM TWO SOUTH-AFRICAN SOFT CORALS 
ALCYONIUM SPECIES A AND SPECIES B 
98 
5.1 INTRODUCTION 
A continuation of the search for bioacti~e compounds from South African soft 
corals84 led to the isolation of six metabolites, from two Alcyonium species. 'The soft 
coral genus Alcyonium has been described by Williams59 as a cosmopolitan genus of 
many species. The two soft corals in this study could only be identified to genus level 
and so have been designated Alcyonium species A and species 8. In acC'ordance with 
the I5.nowledge that alcyonaceans constitute an abundant source of polyhydroxysterols 
and terpenoids83,133, sections 5.2 and 5.3 of this chapter report on the isolation and 
structure determination of two new polyhydroxysterols from Alcyonium species A, and 
two new and two known xenicane diterpenes from Alcyonium species 8. 
Complex mixtures of monohydroxysterols such as cholesterol [113], 24-
methylcholesterol [114] and 24-methylenecholesterol [115] as well dihydroxysterols 
and polyhydroxysterols have frequently been reported from soft corals of the family 
Alcyoniidae. Examples of these reports include the genera Alcyonium~,68,169, 
Sinularia170-176 and Lobophytum177,178. It is the genus Alcyonium which is the focus of 
this chapter. 
[113] [114] 
[115] /:.24 
A chemical investigation of an Alcyonium species of soft coral by Kobayashi and 
co-workers168, collected in the Andaman and Nicobar Islands, resulted in the isolation 
of the polyhydroxysteroI3~,7~-dihydroxy-24-methylenecholesterol [116], and three new 
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polyhydroxysterol glycosides [117], [118] and [119]. Compound [116] had previously 
been isolated from a finger sponge Haliclona oculata 179. 
[116] [117] R = H 
[118] R = f3 - OH 
[119] R = a - OH 
A recent study of the soft coral A/cyonium patagonicum, collected from the South 
China Sea, yielded the new sterol 24-methylenecholest-4-ene-3~,6~-diol [120t6~,. The 
structure was determined by spectral analysis and compound [120] was found to be 
cytotoxic against the murine leukaemia cell line P-388. 
[120] [121] 
[122] ~24 
24 
The first part of sections 5.2 and 5.3 describe the isolation and structure 
determination of two new polyhydroxysterols, cholest-5-ene-3~, 7~, 19-triol 19-acetate 
[121] and cholest-5,24-diene-3~, 7~, 19-triol 19-acetate [122], from the soft coral 
A/cyanium species A collected in the Tsitsikamma Marine Reserve. 
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As discussed in chapter four, xenicane diterpenes were originally believed to 
exist exclusively in the soft coral family Xeniidae, but were subsequently isolated from 
several other sources. The latter part of sections 5.2 and 5.3 report on the isolation and 
structure determination of two known xeni.cane diterpenes, 9-deacetoxy-14,15-
deepoxyxeniculin [110] and zahavin A [16], and two new xenicane diterpenes, 7-
epoxyzahavin A [123] and xeniolide C [124], from the South African soft coral 
A/cyonium species B collected from the Aliwal Shoal off the Natal coast; 
[110] 
[123] 
[16] R = H 
[17] R = OH 
[124] 
9-Deacetoxy-14,15-deepoxyxeniculin [110] has previously been reported by 
Kashman et a/. from the soft coral Xenia obscuronata (Family: Xeniidae) collected in 
the Red Sea149. Recently, after completion of our chemical investigation of A/cyonium 
species B, a paper by Kashman and co-workers was published which detailed the 
isolation of zahavin A and B from a newly described soft coral A/cyonium aureum 
(Benayahu, 1995, Alcyoniidae) collected at Sodwana Bay in South Africa63. Sodwana 
Bay is approximately 500 km north of Aliwal Shoal. Spectroscopic similarities between 
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the metabolites of the soft coral A/cyonium species B and A. aureum indicated that 
A/cyonium species B also contained zahavin A [16]. Kashman reported that zahavin 
A [16] and B [17] were the first examples of the discovery of xenicane diterpenes in the 
genus A/cyanium (Family: Alcyoniidae). Elecause of the very recent taxonomic 
description of A. aureum and the relative proximity of the collection sites the possibility 
exists that A/cyonium species B and A. aureum are taxonomically the same soft coral. 
In addition to zahavin A, the new metabolite 7-epoxyzahavin A [123] w.asJsolated from 
the ~oft coral A/cyanium species B. 
[105] 
[126] (Z) _ ~ 4(12) 
[127] 7,8 - epoxide of[126] 
[125] R = H 
[128] R = Ac 
[129] 7, 8 - epoxide of[125] 
[130] 
Interestingly, the second new compound isolated from the soft coral A/cyanium 
species B has a basic xeniolide skeleton and has been named xeniolide C· [124]. 
Xeniolide type metabolites were not reported from A. aureum. The xeniolide skeleton 
was first described by Kashman and Groweiss147 with the isolation of xeniolide A [105] 
and B [125] from the Red Sea soft coral Xenia macrospicu/ata. This was followed by 
the characterisation of isoxeniolide A [126] and 7,8-oxido-isoxeniolide A [127] from the 
Papua-New Guinea soft coral Xenia navae-britanniae148 and xeniolide B 9-acetate 
[128], 7,8-epoxyxeniolide B [129] and xenialactol [130] from the Red Sea 50ft carals 
Xenia macraspicu/ata and X. abscuronata149• The difference between isoxeniolide A 
[126] and xeniolide A [105] lies in the geometry of the 6 4(12) double bond with an E-
configuration proposed for [105] as opposed to a Z-configuration for [126]. 
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Recently an investigation of the soft coral Xenia e/ongata has yielded the 
ichthyotoxic diterpenoid deoxyxeniolide B [131]157. While compound [131] was reported 
to be stable in the solid state, in solution (CHCI3, Me2CO, H20) it is oxidised to the 
oxidation products [132] and [133].< . 
[131] . [132] 1133] 
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5.2 COLLECTION, EXTRACTION AND ISOLATION 
, ~. 
FIGURE 5.1 Soft coral, A/cyanium species A, from the Tsitsikamma Marine Reserve. 
FIGURE 5.2 Soft coral, A/cyanium species B, collected off Aliwal Shoal, Umkomaas. 
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The slimy orange soft coral A/cyonium species A (FIGURE 5.1) was collected 
by SCUBA at a depth of -24 m in the Tsitsikamma Marine Reserve in May 1994. The 
soft coral was stored frozen until removal and f~eeze-drying. The EtOAc extract of the 
- -
freeze-dried soft coral (dry weight 203 g) was·subjected to silica gel chromatography 
followed by normal phase and reverse phase HPLC to yield the new polyhydroxysterols 
cholest-5-ene-3~,7~, 19-trioI19-acetate [121] and cholest-5,24-diene-3~, 7~, 19-trrol 19-
acetate [122] in 0.02 and 0.04% yield respectively. The chromatographk~procedure is 
shown in SCHEME 5.1. 
EtOAc extract 
(7.03 g) 
~ 
(1.75 g) 
'----,.---.11'" 
80% Hex I EtOAc 40% Hex I EtOAc 
(958 mg) (142 mg) 
EtOAc 
(119mg) 
I (b) 
(18.5 mg) (37.4 mg) 
I 
[121] 
11.9 mg 
0.02% 
(39.0 mg) 
I (c) 
I 
[122] 
21.5 mg 
0.04% 
SCHEME 5.1 Chromatographic procedure for the isolation of compounds [121] and 
[122]. (a) flash chromatography (silica, 230-400 mesh, 150 g, elution sequence: 80% 
hexane/EtOAc; 40% hexane/EtOAc; EtOAc). (b) HPLC (silica, 10 1..1, Whatman, 40% 
hexane/EtOAc, 4 mL min-1). (c) HPLC (C18, 101..1, Phenomenex, 7.5% H20/MeOH, 4 mL 
min-\ 
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The yellow-white soft coral A/cyonium species B (FIGURE 5.2) was collected by 
SCUBA from the Aliwal Shoal on the Natal coast jn June 1994. The frozen soft coral 
was freeze-dried (dry weight 210 g) and steeped in EtOAc. The crude EtOAc extract 
- -
showed slight inhioition of the Gram-positi\le bacteria Staphylococcus aUreus and 
Bacillus subtilis in the antimicrobial disc assay. Chromatography of two portions of the 
EtOAc extract was performed according to SCHEME 5.2 and this yielded the known 
compounds 9-deacetoxy-14,15-deepoxyxeniculin [110] and zaha\lirf,t( [16], and the 
new compounds 7 -epoxyzaha\lin A [123] and xeniolide C [124]. 
I 
(195 mg) 
I (b) 
~ 
(2.72 g) 
I (a) 
(640 mg) 
I 
[110] (210 mg) 
73.0mg 
0.09% 
cholesterol 
(c) 
~(d) 
[16] 
15.9 mg 
0.06% 
EtOAc extract 
(7.03 g) 
~ I 
(150 mg) chole 
I (e) 
I (f) 
[123] 
8.9mg 
0.05% 
sterol 
r 
(2.31 g) 
I (g) 
(572 mg) 
(h) 
(i) 
[110] 
111.6 mg 
0.17% 
1m 
[124] 
11.7 mg 
0.02% 
SCHEME 5.2 Chromatographic procedure for the isolation of compounds [110], [16], 
[123] and [124]. (a) flash chromatography (silica, 230-400 mesh, 150 g, elution 
sequence: 70% hexane/EtOAc; 50% hexane/EtOAc; EtOAc). (b) HPLC (silica, 10 IJ, 
Whatman, 90% hexane/EtOAc, 4 mL min-1). (c) HPLC (silica, 10 IJ, Whatman, 85% 
hexane/EtOAc, 4 mL min-1). (d) HPLC (C18, 10 IJ, Phenomenex, 30% H20/MeCN, 4 mL 
min-1). (e) HPLC (silica, 10 IJ, Whatman, 85% hexane/EtOAc, 4 mL min-1). (f) HPLC 
(C18, 10 IJ, Phenomenex, 20% H20/MeOH, 4 mL min-1). (g) repeat of (a). (h) 
recrystallisation and removal of cholesterol. (i) HPLC (silica, 10 IJ, Whatman, 85% 
hexane/EtOAc, 4 mL min-1). U) repeat of (i). 
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5.3 STRUCTURE DETERMINATION AND STEREOCHEMISTRY 
5.3.1 Structure determination of the hydroxysterols [121] and [122]. 
[121] 
[122] L'124 
24 
HREIMS data established the molecular formula of compound [121] as C29H4804 
(mlz 460.3541, L\mmu -11). The IR spectrum of [121] suggested the presence of 
hydroxyl (3380 cm-1) and acetoxy (1740 cm-1) functionalities. The 13C NMR spectrum 
of [121] (FIGURE 5.3) showed twenty nine clearly resolved resonances including a 
carbonyl (0 171), two oxymethine (0 73 and 71), an oxymethylene (0 64) and two v~nylic 
(0 138 and 130) signals. 
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FIGURE 5.3 13C NMR (100 MHz, CDCI3) spectrum of compound [121]. 
107 
, ~. 
. "'- -
·LI, 
i 
20 
,dLJill 
If"lr 
The molecular formula together with single carbonyl and olefinic moieties implied 
a tetra cyclic skeleton for [121]. The oxymethine signal at 0 71 and the two vinylic 
signals in the 13C NMR spectrum of [121], alqng with a multiplet at 0 3.56 in the 1H 
NMR spectrum of [121], typical of a 3-hYdroxysterol proton 173, suggested a 3:hydroxy-
5-cholestene steroid skeleton170.171.180 for compound [121]. The absence of the 
characteristic resonance for a steroidal C-19 methyl group in the 13C NMR spectrum, 
the presence of a coupled AB system between the oxymethylene protons at 0 4.48 (1 H, 
d, J = 11.9 Hz, H-19) and 0 3.98 (1 H, d, J= 11.9 Hz, H-19') in the COSY NMR 
spectrum, and the presence of two and three bond correlations from H-19 and H-19' to 
C-1, C-5, C-9, C-10 and the acetate carbonyl (FIGURE 5.4) in the HMBC NMR 
spectrum (FIGURE 5.5) of [121] placed the acetate group at C-19. 
5 7 
FIGURE 5.4 Selected two and three bond HMBC NMR correlations for compound 
[121]. 
A broad single proton doublet at 0 3.80 (1 H, br d, J = 7.8 Hz, H-7), strongly 
coupled in the COSY NMR spectrum of [121] with the /15 vinylic proton at 0 5.52 (1 H, 
br s, H-6), located the second hydroxyl at C-7. The proposed cholest-5-ene-3, 7, 19-triol 
19-acetate structure for [121] is consistent with the coupling correlations from COSY, 
relay COSY and double relay COSY NMR experiments presented in TABLE 5.1, and 
also with the 13C NMR data of [121] shown in TABLE 5.2. The stereochemistry of the 
C-3 and C-7 substituents is described in section 5.3.2. 
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FIGURE 5.5 HMBC NMR (400 MHz, CDCI3) spectrum of compound [121]. 
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TABLE 5.1 COSY, relay COSY and double relay COSY NMR (400 MHz, CDCI~) 
correlations in compound [121]. 
-
-
2 t' . 24 27 
18 20 
1 1 1 7 
.e 14 ._ ~ -i 10 3 7 
- HO 5~ OH 
6 
CHEMICAL COSY to 1H RELAY COSY to DOUBLE RELAY 
SHIFT (0) 1H COSY to 1H 
1ax 1.07 2 3 2,4 
1eq 2.03 2' 3,4,19,19' 
-
-, 
2ax 1.44 1,3 3,4 1ax,3,4 
2eq 1.87 
-
3 3.56 2,4 1,2,4,6,7 1 eq,2,4,6,OAc 
" 
4ax 2.27 3,4eq,6,7 2,3,4eq,6,7 1,2,3,4eq,6,7;8,OAc 
4eq 2.39 2,3,4ax 2,3,4ax,6,7 1,2,3,4ax,6,7,OAc 
6 5.52 4ax,7 3,4,7,8 3,4,7,8,9,19,19' 
7 3.80 4ax,6,8 3,4ax,6,8,9 4,6,8,9 
8 1.65 7 6,7,9 4ax,6,7 
. "'- -
9 1.03 7,8 6,7 
12 2.03 18 
18 0.70 12 
19/19' 3.98/4.48 1eq,OAc 1eq,6,OAc 
20 1.34 21 21 21 
21 0.91 20 20 20 
25 1.51 26,27 26,27 26,27 
26 0.85 25 25 25 
27 0.85 25 25 25 
OAc 2.05 19,19' 3,4,19,19' 
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TABLE 5.2 13C NMR (100 MHz, CDCI3) data for compounds [121], [122] and [135]. 
[121] [122] [135] 
- 1 .33.6 t - 33.6 t 33.2 t 
"~ r 
2 31.8 t 31.8 t 31.9 t 
3 71.2 d 71.1 d 71.1 d 
4 41.8 t 41.8 t 41.8 t 
_ _ A 
5 138.2 s 138.1 s 138.2 s 
- 6 129.5 d 129.5 d 130.7 d 
7 72.5 d 72.5 d 72.5 d 
8 42.0 d 42.0 d 42.3 d 
9 48.3 d 48.3 d 48.7 d 
10 39.6 s 39.6 s 43.2 s 
11 21.6 t 21.6 t 21.7 t 
" 
. 
12 39.8 t 39.8 t 39.9 t 
13 43.1 s 43.1 s 41.5 s 
14 56.6 d 56.6 d 56.9 d 
" 
15 26.1 t 26.1 t 26.1t " 
16 28.5 t 28.5 t 28.6 t 
17 55.5 d 55.4 d 55.5 d 
18 11.9 q 11.9 q 12.2 q 
19 64.3 t 64.3 t 62.6 t . "- - -
20 35.7 d 35.5 d 35.7 d 
21 18.8 q 18.7 q 18.8 q 
22 36.2 t 36.1 t 36.2 t 
23 23.8 t 24.7 t 23.9 t 
24 39.5 t 125.1 d 39.5 t 
25 28.0 d 131.0 s 28.0 d 
26 22.8 q 17.6 q 22.8 q 
27 22.5 q 25.7 q 22.6 q 
COCH3 170.7 s 170.7 s 
COCH3 21.1 q 21.1 q 
All assignments are supported by DEPT, COSY, HMQC and HMBC NMR experiments. 
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The molecular formula of compound [122], established as C29H4S04 (m/z 
458.3391, ~mmu -5) from HREIMS data, indicated a molecular structure with two 
hydrogen atoms less than the molecular stru~ture of [121]. The presence of m/z 251 
(M"-HOAc-2H20-side chain) and 209 (M+-HOAc-2H20-ring D fission) peaks in the EI 
mass spectra of both [122] and [121] implied that they differ only in the side chain at 
C-17. Thus, two additional olefinic signals at 0 131 and 125 in the 13C NMR spectrum 
of [122], absent from the 13C NMR spectrum of [121], suggested an urlsaturation in the 
side chain of [122]. Signals in the 1H NMR spectrum of [122] (FIGURE 5.6) at 01.59 
(3H, s, H-26) and 0 1.67 (3H, s, H-27), consistent with the presence of vinylic methyl 
groups, together with an olefinic triplet resonance at 0 5.08 (1 H, t, J = 7.1 Hz, H-24) 
broadened by long range coupling to H-26 and H-27, confirmed the presence of a C-24 
olefin. Three bond correlations between the C-26 and C-27 vinyl methyl group protons 
andt~e carbon atom at 0 125 (C-24) in the HMBC NMR spectrum of [122] placed this 
double bond in the ~24 position. Consequently the structure of [122] was established 
as cholest-5,24-diene-3,7,19-triol 19-acetate. The stereochemistry of the C-3 and C-7 
oxygen functionalities is discussed in section 5.3.2. 
26 
27 
24 
iii' i I 
ppo 5.0 
I • iii Iii i , \ ' , til' 
~.5 4.0 3.5 3.0 
FIGURE 5.6 1H NMR (400 MHz, CDCI3) spectrum of compound [122]. 
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5.3.2 Stereochemistry of the hydroxysterols [121] and [122]. 
The complexity (seven-line multiplet), the Wy. = 22 Hz and the chemical shift of 
the Carbinol methine signal resonating at is 3.'56 in the 1H NMR spectrum of [121] and 
[122] are consistent with those normally seen in a 3~-hydroxysteroid for a 3a-carbinol 
proton166.181. The 3a-orientation of this carbinol proton was confirmed from 
r~ ~ 
enhancements observed in the NOE difference spectra of [121]. These enhancements 
are summarised in TABLE 5.3. 
TABLE 5.3 Selected enhancements from the NOEDS (400 MHz, CDCI3) spectra of 
compound [121]. 
AcO 
H1 IRRADIATED H1ENHANCED ENHANCEMENT - - . 
2 eq 3 ax 8% 
3 ax 4 eq 8% 
4 eq 3 ax, 6 4%,12% 
6 4 eq, 7 ax 9%,7% 
7 ax 6 7% 
The large coupling observed between H-7 and H-8 (J = 7.8 Hz) in the 1H NMR 
spectra of compounds [121] and [122], consistent with a diaxial relationship173, 
established a 7~-OH configuration for the second hydroxy group in both these 
compounds. Support for the 7~-OH assignment was obtained by acetylating compound 
[121] to yield the triacetate [134]. The coupling observed between H-6 and H-7 (J = 2.1 
113 
Hz) in [134] was consistent with a dihedral angle of about 80° previously deduced from 
examination of molecular models of 7~-acetoxy-~5-steroids182-184 (the epimeric 70-
acetoxy isomers show larger coupling constant values of J = 5 Hz resulting from an H-
6tH:? bond angle of about 25°).< . 
[134] R = Ac 
[135] R = H 
Final confirmation of the structure and stereochemistry of [121] was achieved 
by reducing [121] with LiAIH4 to yield cholest-5-ene-3~,7~, 19-triol [135]. The melting 
point and 13C NMR data (TABLE 5.2) of this productcompared favourably with that of 
cholest-5-ene-3~, 7~, 19-triol previously isolated from the black coral Antipathes 
subpinnata 185. 
5.3.3 Structure determination of the xenicane diterpenes [110], [16], [123] and [124]. 
17 
19 
[110] [100] 
The molecular ion at m/z 402.2429 (ilmmu +13) in the HREIMS spectrum of 
compound [110] is compatible with the molecular formula C24H340 5. Interestingly, this 
molecular formula was found to be identical to that of tsitsixenicin A [100] isolated from 
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the soft coral Capnel/a fhyrsoidea84 (chapter four). This naturally led to a comparison 
of the NMR spectral data of [110] and [100] which were very similar. The 13C NMR 
spectrum of [110] also contained two acetate carbonyl (0 169 and 170) and eight 
olefinic (0 113, 117-, 119, 124, 135, 136, 137 and 151) resonances and implied a 
bicyclic xenicane diterpene skeleton. Analogous coupling sequences and correlations 
in the COSY and HMBC NMR experiments of [110], when compared to those in[100], 
suggested that these compounds were identical. However, a difference in optical 
rota~ion, [110] ([a]~1 +12r) and [100] ([a]~ -64°), and slight differences in the 13C and 
1H NMR chemical shifts between the two compounds (TABLE 5.4) suggested that they 
were stereoisomers. 
18 18 
[16] [123] 
HREIMS data established the molecular formula of compound [16] as C2sH360 7 
(mlz 460.2448, ~mmu -11). Three acetate carbonyl (0 169.9,169.8 and 169.7) and 
eight vinylic (0 113,114,117,125,136,137,143 and 151) resonances in the 13C NMR 
spectrum of [16] accounted for seven of the nine degrees of unsaturation implied by 
the molecular formula and again required a bicyclic diterpene skeleton. The 1H and 13C 
NMR data of compound [16] (TABLE 5.5), together with a two bond correlation from 
the enol ether proton at 0 6.38 (1 H, s, H-3) to a quarternary vinylic carbon at 0 117 (C-
4), and three bond correlations from the same enol ether proton to an acetylated hemi-
acetal carbon at 0 92 (C-1) and to a methine carbon at 0 38 (C-4a), implied that one 
of the rings in the bicyclic structure of [16] had the same 1-acetoxydihydropyran ring 
structure as found in compound [110]. 
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TABLE 5.4 Comparison of 1H and 13C NMR data for compounds [110] and [100]. 
[110] [100] 
-
13C 1H .t; , 13C 1H 
1 92.0 d 5.84 d (2.2) 92.3 d 5.75 d (3.6) 
3 136.5 d 6.37 s 142.6 d 6.52 d (1.9) 
- ~ 
4 116.9 s 116.1 s 
4a 37.8 d 2.00m 39.7 d 2.29m 
5,5' 30.0 t 1.87 m, 1.50 m 32.3 t 2.08 m, 1.22 m 
6,6' 40.2 t 2.22 m, 1.94 m 39.7 t 2.19 m, 2.07 m 
7 135.6 s 134.4 s 
8 124.4 d 5.26 br 0 (5.9) 124.3 d 5.37 dd (8.0, 9.5) 
9,~ 9' 25.2 t 2.45 m, 2.11 m 25.5 t 2.43 m, 2.07 m 
10,10' 35.5 t 2.26 m, 2.24 m 35.9 t 2.31 m, 2.07 m 
11 151.1 s 149.3 s 
-~~-
11a 49.5 d 1.96 m 50.1 d 1.96 br.s 
12 72.2 d 5.35 t (6.2) 74.7 d 5.25 t (7.6) 
13, 13' 33.4 t 2.33m 31.4 t 2.43 m, 2.31 m 
14 118.8 d 5.07 t (6.6) 118.9 d 4.97 t (6.9) 
15 134.5 s 135.6 s . -- - . 
16 18.0 q 1.60 br s 18.1 q 1.64 br 5 
17 25.8 q 1.68 br s 25.7 q 1.67 br s 
18 16.7 q 1.64 br s 17.0 q 1.67 br s 
19, 19' 113.2 t 4.87 br s, 4.83 br s 113.4 t 4.91 br s, 4.78 br s 
COCH3 21.2 q 2.03 s 21.5 q 2.07 s 
21.0 q 2.05 s 21.0 q 2.01 s 
COCH3 169.7 s 169.5 s 
170.0 s 170.2 s 
Spectra were recorded at 400 MHz for 1 Hand 100 MHz for 13C in CDCI3 with chemical 
shifts (5) quoted in ppm. Coupling constants in Hz are in parentheses. 
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TABLE 5.5 1H and 13C NMR data for compounds [16] and [123]. 
[16] [123] 
-
13C 1H ":. r 13C 1H' 
1 92.1 d 5.84 d (2.3) 91.6 d 5.93 d (3.1) 
3 137.1 d 6.38 s 137.5 d 6.40 s 
4 117.3 s 116.9 s - - ~ 
4a 37.6 d 1.98 m 37.1 d 2.06 m 
5,5' 30.2 t 1.90 m, 1.57 m 29.2 t 2.08 m, 1.67 m 
6,6' 40.2 t 2.23 m, 1.94 m 39.5 t 2.25 m, 1.08 m 
7 135.7 s 59.8 s 
8 124.5 d 5.32m 62.8 d 2.95 dd (3.7, 10.8) 
9,9' 25.2 t 2.45 m,2.12 m 24.7 t 2.28 m, 1.49 m 
10; 10' 35.5 t 2.27 m, 2.24 m 32.1 t 2.39m 
11 151.0 s 148.0 s 
11a 49.6 d 1.99 m 47.9 d 2.42 m 
12 68.9 d 5.34m 68.6 d 5.29 dd (4.I,8.2) 
13 38.6 t 1.94 m 38.9 t 1.90 m 
14 73.3 d 5.21 dd (4.1, 9.3) 73.1 d 5.19 dd (5.3, 8.2) 
15 143.0 s 142.8 s 
16,16' 112.7 t 4.97 br s, 4.89 br s 112.8 t 4.95 br s, 4.89 br s 
17 18.3 q 1.74 br s 18.3 q 1.72 br s -- - -
18 16.8 q 1.66 br s 16.9 q 1.30 br s 
19, 19' 113.5 t 4.89 br s, 4.83 br s 115.2 t 5.04 br s, 4.95 br s 
COCH3 21.0 q 2.05 s 21.0 q 2.07 s 
21.0 q 2.05 s 21.0 q 2.05 s 
21.0 q 2.03 s 21.0 q 2.03 s 
COCH3 167.7 s 169.5 s 
169.8 s 169.8 s 
170.0 s 170.0 s 
Spectra were recorded at 400 MHz for 1 Hand 100 MHz for 13C in CDCI3 with chemical 
shifts (5) quoted in ppm. Coupling constants in Hz are in parentheses. 
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The comparison between [16] and [110] was extended to the nine-membered 
ring. Contiguous coupling in the COSY NMR spectra of [16] was evident from the 
methine proton at 0 1.98 (1 H, m, H-4a) to protons at 0 1.90 and 1.57 (2H, m, H-5 and 
H-5') and to protons at 0 2.23 and 1.94 (2H, 1)\ H-6 and H-6') and also from an olefinic 
proton at 0 5.32 (1H, m, H-8) to the protons at 0 2.45 and 2.12 (2H, m, H-9 and H-9') 
and to protons at 0 2.27 and 2.24 (2H, m, H-10 and H-10'). Correlations in the HMBC 
NMR spectrum of [16] (FIGURE 5.7) were observed from the vinylic methyl protons at 
o 1_.66 (3H, br s, H-18) to carbons at 0 40 (C-6) and 125 (C-8) and from the exocyclic 
methylene protons at 0 4.89 and 4.83 (2H, br s, H-19 and H-19') to carbons at 0 36 (C-
10) and 50 (C-11 a). 
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FIGURE 5.7 HMBC NMR (400 MHz, CDCI3) spectrum of compound [16]. 
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The above 2-D NMR correlations, together with a comparison of the 13C NMR 
data of [16] and [110], unequivocally showed that [16] also contained a 2-
oxabicyclo[7.4.0]tridecane ring system with the same functional group distribution as 
established in [110]. The only difference between the two compounds, therefore, was 
in the composition of the side chain. Having accounted for the bicyclic ring system, 2-D 
NMR spectral analysis indicated the presence of a 1,3-diacetoxy-4-methyl-pent-4-ene 
side chain. This was shown to be positioned at C-4 by virtue of the two oorld correlation 
from the acetoxy methine proton at 55.34 (1 H, m, H-12) to the carbon at 5 117 (C-4) 
and the three bond correlations from the same proton to carbons at 5 137 (C-3) and 38 
(C-4a) (FIGURE 5.8) in the HMBC NMR spectrum of [16]. The assignment of a terminal 
olefin in the side chain was supported by three bond correlations from the methylene 
protons at 5 4.97 and 4.89 (2H, br s, H-16 and H-16') to the vinylic methyl carbon at 5 
18 (C.-17) and to the acetoxy carbon at 573 (C-14) (FIGURE 5.8). Irradiation of the H-
14 signal resulted in no change in the splitting pattern of the H-12 signal and vice-versa 
in a 1H-decoupling NMR experiment (400 MHz, CsOs) performed on compound [16} 
This observation indicated that the acetoxy carbons were not adjacent to each,.other 
and confirmed the -CH(OAc)CH2CH(OAc)- substructure of the side chain in ,[16]. 
FIGURE 5.8 Selected HMBC NMR correlations in compound [16]. 
Subsequent to the assignment of [16], Kashman et at. published the structure 
of zahavin AS3. Comparison of the NMR spectral data of [16] and zahavin A indicated 
that they were identical compounds. Although there is a difference in the optical 
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rotation measured for [16] ([a]~ +21.5°) and the published value for zahavin A ([a]~ 
+7.3°), this is possibly a consequence of the chemical instability of these compounds 
in CHCI3 (the solvent used for both rotation measurements) rather than any 
stereochemical difference. 
HREIMS data established the molecular formula of [123] as C26H360S (mlz 
476.2419, ilmmu +11). Comparison of this molecular formula with that ~f compound 
[16]Jndicated that the only difference was an additional oxygen atom in the molecular 
formula of [123]. Comparison of the 1H and 13C NMR data of [123] with that of [16] 
(TABLE 5.5) indicated that the vinylic proton resonance at 55.32 (1 H, m, H-B) and the 
olefinic carbon resonances at 5 125 (C-B) and 136 (C-7) in the 1H and 13C (FIGURE 
5.9) NMR spectra of [16], respectively, had been replaced by an oxymethine doublet 
of dou.blets at 5 2.95 (1 H, dd, J = 3.7, 10.B Hz, H-B) and two carboxy resonances at 5 
63 (C-B) and 60 (C-7) in the 1H and 13C (FIGURE 5.10) NMR spectra of [123], 
respectively. The above data established that a 7,B-epoxide functionality in compouno 
[123] had replaced the unsaturation at this position in [16]. 
[136] [131] 
It is unclear as to whether the 7,B-epoxide is itself a natural product or an 
oxidation artifact of the isolation procedure. There are conflicting reports on the ease 
of oxidation of the il7-double bond in xenicane diterpenes. Scheuer160 suggested that 
7,B-epoxidation of [136] occurred readily on exposure to air while Higuchi only obtained 
the 7,B-epoxide of [131] in thirteen per cent yield after stirring [131] in CHCI3 solution 
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for two weeks. The fact that the 7,8-epoxide signal at 0 2.95 (1 H, dd, J = 3.7,10.8 Hz, 
H-8) in the 1H NMR spectrum of [123] was evident in the initial 1H NMR spectrum of the 
crude EtOAc extract of the A/cyonium specie~ 8 soft coral suggests that compound 
[123] may itself be present in the soft coral. However, further work is needed to qualify 
this observation. 
8 
7 
FIGURE 5.9 13C NMR (100 MHz, CDCI3) spectrum of compound [16]. 
FIGURE 5.10 13C NMR (100 MHz, CDCI3) spectrum of compound [123]. 
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[124] [105] 
A molecular formula of C22H3004 (mlz 358.2158, ilmmu -15) was established 
from HREIMS data for compound [124]. The presence of two ester carbonyl 
functionalities and four double bonds in the 13C NMR spectrum of [124] accounted for 
six of.the eight degrees of unsaturation in the molecule. The remaining two degrees of 
unsaturation therefore required [124] to be bicyclic. Interestingly, certain similarities 
existed between the NMR spectra of [124] and [16]. The fact that the 1H NMR spectru.m 
of [124] had exocyclic methylene resonances at 5 4.95 and 4.84 (2H, s, H-19 ~nd H-
19'), a vinylic proton resonance at 55.41 (1 H, br t, J = 7.8 Hz, H-8) and avinylTc methyl 
resonance at 51.70 (3H, s, H-18) suggested that [124] had the same 9-membered ring 
as found in [16]. Further common resonances included an olefinic methylene 
resonance at 5 5.00 and 4.95 (2H, s, H-16 and H-16'), a vinylic methyl resonance at 5 
1.76 (3H, s, H-17) and an oxymethine resonance at 55.25 (1H, t, J = 6.4 Hz, H~14). 
These latter resonances implied that the same terminal portion existed in the six-carbon 
side chain of [124] as found in [16]. However, the absence of the H-1 and H-12 
oxymethine signals and the absence of the H-3 enol ether proton resonance indicated 
that [124] did not have the 1-acetoxydihydropyran ring structure of [16]. 
The HMQC NMR spectrum of [124] revealed the presence of two oxymethylene 
protons with multiplets centred at 5H 4.06 (1 H, dd, J = 5.8, 11.4 Hz, H-1) and 3.52 (1 H, 
t, J = 12.0 Hz, H-1') coupled to a 13C resonance at 5c 71. These data were corroborated 
by a DEPT NMR experiment. A COSY NMR spectrum of [124] (FIGURE 5.12) showed 
that these oxymethylene protons were strongly coupled to the methine proton at the C-
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11 a ring junction (0 2.12). The same oxymethylene protons showed a three bond 
correlation to the C-4a ring junction carbon atom. at 0 44 and to an ester carbonyl 
carbon at 0 171 (C-3) (FIGURE 5.11) in the HMBC NMR spectrum of [124]. 
FIGURE 5.11 Selected three bond correlations from the HMBC NMR spectrum of [124]. 
The COSY NMR spectrum of [124] revealed contiguous coupling from the 
oxymethine proton at 0 5.25 (H-14) to the methylene protons at 0 2.60 and 2.50 (2H, 
m, H-13 and H-13') and, finally, to an olefinic proton at 0 6.33 (1 H, t, J = 7.3 Hz,H-12) 
(FIGURE 5.12). The H-12 olefinic proton, in turn, exhibited three bond long range 
correlations to the C-3 ester carbonyl and the C-4a ring junction carbon atom (FIGURE 
5.11) in the HMBC spectrum of [124]. The above implied that a C-4/C-12 double bond 
was the site of attachment of the 6-carbon side chain. The 1H and 13C NMR data 
(TABLE 5.6) for the bicyclic ring system of [124] compared favourably with the 
corresponding data for the bicyclic ring system of xeniolide A [105] previously isolated 
from the soft coral Xenia macrospiculata147 and the structure of [124], xeniolide C, was 
thus established. 
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FIGURE 5.12 COSY NMR (400 MHz, CDCI3) spectrum of compound [124]. 
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TABLE 5.6 NMR spectral data for compound [124]. 
13C 1H COSY to HMBC to 
1 70.9 t 4.06 dd (5.8, 11.4) < "H-1', H-11a C3,C4a,C11a 
l' 70.9 t 3.52 t (12.0) H-1, H-11a C3, C4a, C11, C11a 
3 170.6 s 
:-~ -* 
4 136.8 s 
-
4a 43.8 d 2.88 dd (3.6, 10.8) H-5, H-11 a C3,C4,C5,C6 
5,5' 37.6 t 1.62 m, 1.45 m H-4a, H-6 C7 
6,6' 40.3 t 2.21 m, 2.17 m H-5 
7 135.3 s 
8 124.6 d 5.41 br t (7.8) H-9, H-9', H-18 C6,C18 
-
9,9' 24.8 t 2.47 m, 2.12 m H-8, H-10 
10,10' 34.6 t 2.32 m, 2.12 m H-9, H-9' C11, C11a 
11 152.3 s -~'. 
'.-
11a 49.4 d 2.12 m H-1, H-1', H-4a 
12 133.2 d 6.33 t (7.3) H-13, H-13' C3, C4a 
13, 13' 31.0 t 2.60 m, 2.50 m H-12, H-14 C4,C12,C14,C15 
14 75;5 d 5.25 t (6.4) H-13, H-13' C12, C13, C15,_C16 
15 142.0 s 
16,16' 113.5 t 5.00 s, 4.95 s H-17 C14, C15, C17 
17 18.5 q 1.76 s H-16 C14,C15,C16 
18 18.5 q 1.70 s H-8 C6,C7,C8 
19, 19' 113.1 t 4.95 s, 4.84 s C10, C11a 
COCH3 21.1 q 2.06 s COCH3 
COCH3 169.9 s 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in CDCI3 with chemical 
shifts (5) quoted in ppm. Coupling constants in Hz are in parentheses. 
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5.3.4 Stereochemistry of the xenicane diterpenes [110], [16], [123] and [124]. 
[110] [112] 
An E-configuration was assigned to the /).7 double bond in compound [110] 
based on the 5 16.7 chemical shift for the Me-18 group in the 1H NMR spectrum of 
[110f(rather than 5 22-25 for the Z-configuration)147.149. As with the xenicanes in the 
previous chapter, the slightly broadened H-11 a singlet in the 1H NMR spectrum of [11 OJ 
indicated a very small coupling to H-4a (a dihedral angle of approximately 90°) and. this 
,--
is consistent with the trans-fused bicyclic ring system found in other naturally occurring 
xenicane diterpenes. An a-configuration was assigned to the proton at C-1 based on 
the J1.11a = 2.2 Hz coupling and observed NOEs (see TABLE 4.5, section 4.3.4) which 
are in accordance with H-1a configured 1-acetoxyxenicane compounds found in the 
Iiterature63.145.146.148-150.160.163.164. Comparison of the spectral data of compound [110] with 
that of 9-deacetoxy-14, 15-deepoxyxeniculin isolated from the Red Sea soft coral Xenia 
obscuronata149 suggested that they were in fact the same compound. However, this 
comparison was not definitive as no optical rotation was reported for the latter 
compound and the C-12 stereochemistry in both compounds remains unassigned. 
Previous attempts to define the stereochemistry of an acetoxy group at C-12 in 
xenicane compounds by chemical transformations and spectroscopy have failed157.160. 
Unsuccessful attempts were made to convert [110] to acalycigorgin 0 [112] ([a]~ -51°) 
by refluxing in MeOH for several hours. Compound [112], in which the stereochemistry 
has been defined, was assumed to be an artifact arising via an SN2' syn reaction of 
[110] with MeOH during the extraction of the gorgonian Alcalycigorgia species 164. 
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1 8 18 
[16] [123] 
An E-configuration for the /).7 double bond in [16], and a trans bicyclic ring 
system and a-proton at C-1 in [16] and [123], were assigned using the same methods 
and reasoning as that applied to [110l The assignment of the configuration for the 
7(8)-epoxide in [123] revealed a disparity in the literature concerning the interpretation 
-
of NOEDS experiments. The observed enhancement of the a-proton at C-4a (19%) 
with the irradiation of H-8 and enhancement of the ~-proton at C-11a (5%) with t~e 
irradiation of the Me-18 protons in NOEDS experiments on [123] indicated an a-
orientated epoxide according to Shibata and co-workers164. Curiously, however, there 
was an apparent complete lack of enhancement of H-8 with the irradiation of the Me-18 
protons and vice versa, and this, according to Higuchi and co-workers 157, indicated a 
7(8)-E-epoxy configuration. In an a-orientated epoxide the H-8 and Me-18 protons 
would be close in space and would be expected to enhance upon their respective 
irradiation. The fact that there is an absence of any correlation between the H-8 and 
Me-18 protons in NOEDS experiments on [123], therefore, must take precedence and 
supports a 7(8)-E-epoxy assignment for [123] rather than an a-orientated epoxide. 
An attempt was made to assign the relative stereochemistries of the acetoxy 
groups at C-12 and C-14 in compound [16l The proposed strategy (SCHEME 5.3) 
involved the removal of the acetate groups followed by elution through an Amberlyst 
15 column in acetone to form the corresponding acetonide [138]186. This method relies 
on the fact that acetonides derived from syn 1,3-diols exist in a well defined chair 
conformation with the alkyl substituents in equatorial positions while acetonides derived 
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from anti 1,3-diols exist in a twist conformation in order to avoid the 1,3-diaxial 
interaction that would occur between the alkyl substituents in a chair conformation186. 
The 13C NMR chemical shifts of the acetonide methyl groups allow the conformation 
and-hence the relative stereochemistry of the diol to be distinguished. The reason for 
this is that the 13C NMR spectra of syn 1,3-diol acetonides display an axial methyl 
resonance at about 5 19 and an equatorial methyl resonance at about 5 3D, whereas 
the spectra of anti 1,3-diol acetonides show two methyl resonances at- about 5 25186. 
Pilot scale reactions of [16] with K2C03 in MeOH followed by NMR analysis suggested 
that, although the acetate groups had been removed, a mixture of products had 
resulted in which aldehyde and methoxy resonances were evident. Work up of the 
reaction followed by normal phase HPLC did not yield the desired saponified product 
[137]. 
MeOHI HP 
[16] [137] 
Amberlyst 15 column 
~ 
[138] 
SCHEME 5.3 Reaction sequence proposed for the preparation of an acetonide 
derivative of compound [16]. 
An interesting rearrangement compound [139] was, however, isolated in a pure 
state from the chromatography of the saponification reaction products. HREIMS data 
established the molecular formula of [139] as C2oH2602 (mlz 298.1939, .1mmu +6). The 
presence of a single aldehyde carbonyl resonance and ten olefinic resonances in the 
13C NMR spectrum of [139] accounted for six of the eight degrees of unsaturation 
implied by the molecular formula and this required [139] to be bicyclic. Comparison of 
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the 1H and 13C NMR chemical shifts of compound [139] with those of zahavin A [16] 
indicated that the nine-membered ring and its associated substituents in [16] was still 
present in compound [139]. The absence of resonances characteristic of an acetylated 
hemi-acetal functionality in [139] implied-thaLthe second ring in [139] did not-have the 
same 1-acetoxydihydropyran ring structure as in zahavin A. The comparison was also 
extended to the side chain. An olefinic methylene resonance at 5H 5.19 and 5.00 (2H, 
s, H-18 and H-18') and 5c 112, an olefinic methyl resonance at 5H 1.63{3H, s, H-19) 
anq 5c 19, and an oxymethine resonance at 5H 4.61 (1H, s, H-16) and 5c 77 indicated 
that the terminal portion of the six-membered side chain of [16] was still intact in [139]. 
Interestingly, an aldehyde functionality was present at 5c 193 in [139] which was not 
present in the natural product [16]. 
14 
19 18 
[139] [140] 
The COSY NMR spectrum of [139] (FIGURE 5.13) showed contiguous coupling 
from the methylene protons at 5 1.51 (2H, m, H-2) to the ring junction proton at 5 2.90 
(1 H, m, H-1) and to the other ring junction proton at 5 2.36 (1 H, m, H-9). The latter ring 
junction proton was coupled to a viriylic proton at 5 5.91 (1 H, d, J = 5.3 Hz, H-10) which 
showed long range coupling to a further vinylic proton at 5 6.65 (1 H, s, H-12) and then 
to the H-1 ring junction proton. These COSY couplings suggested the presence of an 
unsaturated six-membered ring system. The existence, in the HMBC spectrum, of three 
bond correlations from the H-12 olefinic proton to the C-1 ring junction carbon atom, the 
aldehyde carbonyl and the C-10 vinylic carbon, together with three bond correlations 
from the H-10 olefinic proton to the C-1 ring junction carbon atom, the C-16 carbinol 
carbon and to the C-12 vinylic carbon atom, confirmed the six-membered ring structure 
and placed the aldehyde functionality at C-13 (5141) and the side chain at C-11 (5 
130). This completed the structure determination of the rearrangement product [139]. 
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FIGURE 5.13 COSY NMR (400 MHz, CDCI3) spectrum of compound [139]. 
A literature survey revealed the recently reported isolation, by Kashman and co-
workers187, of xeniafaraunol A [140], along with the known xeniolide A and 8 xenicane 
diterpenes from the Red Sea soft coral Xenia faraunensis. Xeniafaraunol A was 
described as being a novel compound with an unprecedented diterpene skeleton. 
Coincidently, the rearrangement product [139] contains the same 
bicyclo[7.4.0]tridecane carbon skeleton as xeniafaraunol A [140]. A comparison of the 
1H and 13C NMR data of [139] and [140] is contained in TABLE 5.7. The fact that 
xeniolide diterpenes were isolated from the same soft coral that yielded [140] suggests 
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a biosynthetic link between xenicane diterpene compounds and compounds with this 
new skeleton. The following mechanism (SCHEME 5.4) is proposed for the formation 
of the rearrangement product [139] from zahavin A [16]. 
(- 3HOAc) 
[16] 
... 
[139] 
SCHEME 5.4 Mechanism proposed for the formation of the rearrangement product 
[139] which resulted from the saponification of zahavin A [16]. 
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TABLE 5.7 1H and 13C NMR data for compounds [139] and [140]. 
[139] [140] 
-
13C 1H ":. ~ 13C 1H 
1 37.7 d 2.90m 36.6 d 2.80m 
2,2' 34.4 t 1.51 m 36.3 t 1.65,1.20 m 
-- ~ 
3,3' 39.8 t 2.30,2.17 m 40.6 t 2.72,2.10 dt 
-
4 136.1 s 136.0 s 
5 125.0 d 5.49 t (8.3) 125.1 d 5.40 dd 
6,6' 25.3 t 2.45,2.17 m 28.5 t 2.30,1.88 m 
7,7' 35.8 t 2.30m 32.2 t 2.06,1.62 m 
8 156.3 s 146.9 s 
-
9 49.5 d 2.36m 61.0 d 1.87 t (9) 
10 134.3 d 5.91 d (5.3) 73.3 d 3.03 t (9) 
11 130.2 s 44.0 d 3.06m" 
, ~. 
12 139.8 d 6.65 s 150.1 d 5.90 s 
13 140.9 s 146.0 s 
14 16.9 q 1.69 s 18.4 q 1.53 s 
15, 15' 114.3 t 4.90,4.66 s 118.0 t 4.80 s 
..... - , 
16 77.2 d 4.61 s 125.6 d 4.90 d (7.5) 
17 145.1 s 135.6 s 
18,18' 111.6 t 5.19,5.00 s 18.5 q 1.60 s 
19 18.7 q 1.63 s 26.0 q 1.67 s 
20 193.6 d 9.43s 192.0 d 9.26 s 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in CDCI3 for [139] and 
at 500 MHz for 1H and 125 MHz for 13C in CsDs for [140]. Chemical shifts (0) are quoted 
in ppm. Coupling constants in Hz are in parentheses. 
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[124] [105] 
[126] (Z) - L'l4(12) 
Overlapping resonances in the 1 H NMR spectrum of [124] did not permit 
unambiguous assignment of the relative stereochemistry at the site of ring fusion in 
xeniolide C [124]. However, based on the comparible J1,11a coupling between [124] and 
xeniolide A [105r47 and isoxeniolide A [126r48 it was presumed that these compounds 
have the same ring junction configuration. As for the cOnfiguration of the double bonds; 
an E-configuration was assigned to the fj.7 double bond based on the 13C NMR chemical 
shift for the Me-18 functionality at (5 18.5 {in a Z-configuration Me-18 resonates at (5 22-
25)147.149. The fj,4(12) double bond was tentatively assigned an E-configuration based on 
NOEDS experiments. The enhancement of the H2-13 proton signals upon irradiation 
of H-4a and vice versa suggested the spatial closeness expected for an E-
- "'- - -
configuration. The stereochemistry of the acetoxy group at C-14 in [124] remains 
unassigned. 
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5.4 BIOLOGICAL ACTIVITY 
Although the polyoxygenated sterol [135] isolated from the black coral 
Antipathes subpinnata was reported to be Jethal toward the brine shrimp '(Artemia 
sa/ina)185, this activity could not be reproduced with the identical compound derived 
from the reduction of [121] with LiAIH4. In addition, neither the natural product [121] nor 
[122], both isolated from A/cyonium species A, showed any toxicity towSrds A. sa/ina 
when screened in the Microwell Cytotoxicity Assay188. 
In chapter four (section 4.4) the anti-inflammatory activity of the tsitsixenicins A 
[100] - 0 [103] was discussed. This activity was in the form of superoxide inhibition in 
rabbit and human neutrophils. Because of this positive activity, the xenicane diterpenes 
[110], .£16] and [123], isolated in this chapter, were also screened for anti-inflammatory 
activity. The assay used, similar to that described in the previous chapter, involved 
measuring the inhibition of release of superoxide from rabbit blood neutrophils upon 
stimulation with the chemotactic factor FMPL. It is evident from the results (TABLEi 5.8) 
that compounds [110], [16] and [123] all show significant inhibition of superoxide 
release which is indicative of anti-inflammatory actvity. 
TABLE 5.8 Effect of the xenicane diterpenes [110], [16] and [123] on superoxide 
production in rabbit neutrophils at a concentration of 20 lJg mL-1. 
Sample No. VMAX % DMSO (0.2%) control % Stirn I Inhibit 
Control 1.11 112.1 12.1 
sao 0.00 0.0 -100.0 
0.2% OMSO 0.99 100.0 0.0 
[110] 0.800 5.1 -91.9 
[16] 0.021 2.1 -97.9 
[123] 0.097 9.5 -90.2 
Incubated at RT for 10 min and 37°C for 5 min prior to stimulation with 1 lJM FMLP. 
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Compounds [110], [16] and [123] were also screened for antithrombotic activity. 
This was achieved by determining the extent to which the xenicane compounds 
prevented platelet aggregation caused by platelet activating factor (PAF). PAF is a 
loca1 mediator of thrombus formation whicla js involved, particularly in the arterial 
system, in the pathogenesis of atherosclerosis. Compounds that inhibit platelet 
aggregation and therefore prevent the formation of blood clots have direct implication 
in the treatment of thrombosis and associated cardiovascular diseases ta9. The effect 
of cqmpounds [110], [16] and [123] on PAF-induced aggregation of rabbit platelets was 
determined using two different concentrations of PAF (FIGURE 5.14). 
Although the results from the above two assayst clearly indicate that 
compounds [110], [16] and [123] have good anti-inflammatory and antithrombotic 
activit~, they must be interpreted with caution, and further studies at reduced 
concentration as well as cytotoxicity testing are necessary to assess more completely 
the anti-inflammatory and antithrombotic properties of these molecules. 
t Assays courtesy of InflaZyme Pharmaceuticals Limited, Vancouver, Canada. 
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% Inhibition of Response to 0.1 nM PAF 
% Inhibition of Response to 0.25 nM PAF 
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80 
60 
40 
2:j[:l1I~~1I~'I1I~~~~~1I~~1I~~~~~~~ 
(1 ) (2) (3) (4) (5) (6) 
LJ Compound [110] III . Compound [16] 00 -Compound [123] 
Cone. of compound [110] [16] [123] 
% Inhibition of Response to 0.1 nM PAF 
'.-
(1 ) 40 j.Jg mL-1 97.9 79.6 98.0 
(2) 4 j.Jg mL-1 100.0 100.0 100.0 
(3) 0.4 j.Jg mL-1 18.4 10.3 14.3 
% Inhibition of Response to 0.25 nM PAF 
(4) 40 j.Jg mL-1 93.5 89.1 100.0 
(5) 4 j.Jg mL-1 35.5 45.2 85.9 
(6) 0.4 j.Jg mL-1 
FIGURE 5.14 Effect of the xenicane diterpenes [110], [16] and [123] on PAF-induced 
aggregation of rabbit platelets. 
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CHAPTER SIX 
SESQUITERPENE HYDROQUINONES FROM THE SOUTH AFRICAN 
SOFT CORAL ALCYONIUM FA URI 
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6.1 INTRODUCTION 
The anti-inflammatory activity of the valdivones, isolated from the soft coral 
A/cyanium va/diviae60, and the xenicanediterpenes, isolated from the soft corals 
Capnel/a thyrsaidea84 and A/cyanium species B (see chapter five), has shown that 
South African soft corals are a good source of potential anti-inflammatory agents. A 
continuation of the search for new pharmaceuticals from South African .AJcyonacea led 
to !he chemical examination of the endemic southern African soft coral A/cyanium fa uri. 
This is one of the most common and conspicuous soft corals occurring in the rocky 
intertidal and shallow sublittoral zones along the South African coast line59. The colour 
of the A. fauri colonies is extremely variable. They are most often vivid purple but can 
be pink, white, golden yellow, orange, grey or brown59. The chemical investigation of 
the EtOAc extract of bright pink specimens of A. fauri resulted in the isolation of three 
new sequiterpene hydroquinones, rietone [141], 8'-acetoxyrietone [142] and 8'-
desoxyrietone [143r90• Rietone exhibited moderate activity in the Nel's in vitro anti-HJV 
bioassays. 
[141] R = OH 
[142] R = OAe 
[143] R=H 
OH 
COOMe 
Marine brown algae and sponges have yielded a variety of metabolites based 
on a mixed sesquiterpene and quinone or hydroquinone biosynthesis. Examples 
include structures in which the sesquiterpene unit exists in an acyclic, monocyclic, 
bicyclic or tricyclic form and also in which there are varied degrees of oxygenation and 
substitution around the aromatic ring. 
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[144] /':,.8 (1 3) 
[145] /':,.7 
OH 
[148] 
OH 
[151] 8-epimer 
OHC 
OH 
[146] 
HO~ 
~~ 
: 0 
[149] 
OH 
[147] 
[150] 
During the 1970's a number of sesquiterpene hydroquinones were isolated . 
. ~ - . 
Coupling of a hydroquinone functionality to an acyclic farnesyl moiety followed by 
cyclisation of the latter to give a rearranged drimane skeleton constitutes a plausible 
biosynthetic route to these sequiterpene hydroquinones. Examples include zonarol 
[144] and isozonarol [145] from the brown seaweed Dictyopteris zonarioides191 , the 
paniceins A, 8 1, 82 [146], 83 and C from the marine sponge Halichondria panicea192 , 
avarol [147] and its corresponding quinone, avarone, from the sponge Disidea avara 193, 
chromazonarol [148] and isochromazonarol from the brown seaweed Dictyopteris 
undulata194, ilimaquinone [149] from a marine sponge tentatively identified as 
Hippiospongia metachromia195, and aureol [150] and 8-epichromazonarol [151] from 
the marine sponge Smenospongia aurea196• 
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There was considerable renewed interest in these sesquiterpene hydroquinone 
compounds in the late 1980's with the discovery that avarol [147] and the quinone, 
avarone, inhibited replication of the human immunodeficiency virus (HIV) believed to 
beTesponsible for acquired immune deficiel1cy syndrome (AIDS)197. Further,studies of 
the inhibitory effects of avarol, avarone, ilimaquinone [149] and derivatives of these 
compounds on HIV type1 reverse transcriptase have identified their active sites of 
inhibition 198,199 and this could lead to the rational design of further potential anti-HIV 
drygs. 
NOMe 
HO~ 
"pi 
[152] 
OH 
[154] 
OH 
[153] 
OH 
[155] 
Recently, the number of sesquiterpene hydroquinones isolated from marine 
sponges and algae has grown steadily. An investigation of the marine sponge 
Strongylophora hartmani yielded strongylin A [152]200. This compound was active in in 
vitro assays against the P-388 tumour cell line and the influenza strain PR-8. A new 
sesquiterpene linked to a hydroquinone, fulvanin 2 [153], together with four known 
paniceins have been isolated from the Mediterranean sponge Reniera fulva201 • A further 
eight new compounds, six of them of the panicein class (as represented by [146]), and 
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two new cyclohexenones, renierin A [154] and B [155], together with seven related 
known compounds were isolated from the sponge Reniera mucosa202. In this report it 
was proposed that the cyclohexenones [154] and [155] might be biosynthetic 
intermediates between the hydroquinone-farnesyl precursors and the paniceins. 
COOMe MeO 
H o 
Br 
[156] [157] [158] 
Three new sesquiterpene hydroquinones peyssonol A [156] and B [157] and 
hyate"aquinone [158] have been isolated from the alga Peyssonnelia species ~,nd the 
sponge Hyatella intestinalis, respectively203. Certain of these compounds, not 'disclosed 
in the report, were found, in a prelimary test, to inhibit HIV reverse transcriptase. 
OMe 
OH 
[159] 
Capon and Bonny identified a new acyclic hydroquinone sesquiterpene [159], 
together with the corresponding quinone, from the southern Australian marine sponge 
Thorecta choanoideg204. It was reported that the 2,3,5-oxygenation pattern around the 
aromatic ring in [159] was rare. Although hydroquinone sesquiterpene compounds 
have been reported to inhibit both bacterial growth and HIV replication, neither [159] 
nor its quinone analogue demonstrated such activity. 
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De Rosa and co-workers205 screened twenty three hydroquinone and quinone 
derivatives for antimicrobial activity and brine shrimp and fish lethalities to establish 
relevant structure-activity relationships. From these data it was concluded that the 
optimum length of the side chain in the grolJP of terpenoid - hydroquinones/quinones 
assayed ranged from five to fifteen carbon atoms. 
12 
OH 
[160] Me12 = a 
[161] Me12=j3 
Na+ -0:38-
-[162] 
Crews ef a/. isolated cyclorenierins A [160] and 8 [161], which are slosely 
related to panicein A2 and renierin A, as an inseparable mixture from the marine 
sponge Haliclona species206• Recently a new disulphated sesquiterpene hydroquinone 
[162] has been isolated from a deep water collection of the marine sponge 
Siphonodicfyon coralliphagum207. This compound inhibited the binding of leukotriene 
84 to intact human neutrophils and as a consequence may have possible applications 
for the treatment of inflammatory and allergic diseases. 
From this introduction it is clearly seen that metabolites arising from mixed 
sesquiterpene and hydroquinone or quinone biogenesis are common in sponges and 
marine algae, particularly with a cyclisation of the sesquiterpene side chain. On the 
other hand, the isolation and structure determination of the sesquiterpene 
hydroquinones, described in section 6.2 and 6.3 of this chapter, is the first reported 
occurrence of these metabolites in a marine soft coral. In addition to containing the 
sesquiterpene side chain in the less common acyclic form, rietone and its analogues 
exhibit a novel oxygenation pattern in this side chain. 
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6.2 COLLECTION, EXTRACTION AND ISOLATION 
'---------------------------.......... 
FIGURE 6.1 The bright pink soft coral, A/cyonium fa uri, collected from Riet Point 
near Port Alfred. 
A sample of the bright pink colour variant of the soft coral A/cyonium faurl was 
collected in September 1994 using SCUBA at a depth of -15 m at Riet Point. This reef 
is located near Port Alfred on the warm temperate south east coast of South Africa. The 
EtOAc extract of the freeze-dried soft coral (dry weight 380 g) was concentrated to give 
a dark red oil (5.8 g). TLC and 1H NMR spectroscopy suggested that this extract 
consisted predominantly of one compound. Fractionation of the extract was performed 
according to SC HEM E 6.1 and resulted in the isolation of the new sesquiterpene 
hydroquinone rietone [141] in high yield along with the'related minor compounds 8'-
acetoxyrietone [142] and 8'-desoxyrietone [143]. 
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EtOAc extract 
(5.08 g) 
~ 
(1.50 g) 
(a) 
I 
[141] (32.0 mg) (48.5 mg) 
424.1 mg I (e) I (b) 1"'- ~ 
0.43% (9.8 mg) I I 
I (d) [141] [142] 15.8 mg 16.9 mg (8.1 mg) 0.02% 
~. (e) 
[143] 
.3.9mg 
0.003% 
SCHEME 6.1 Chromatographic procedure for the isolation of compounds [141] -[143]. 
(a) flash chromatography (silica, 230-400 mesh, 150 g, elution with 33% 
EtOAclhexane). (b) HPLC (silica, 10 J..I, Whatman, 35% EtOAC/hexane, 4 mL min-1). (c) 
HPLC (silica, 10 J..I, Whatman, 35% EtOAc/hexane, 4 mL min-\ (d) HPLC (silica, 10 J..I, 
Whatman, 33% EtOAC/hexane, 4 mL min-1). (e) HPLC (C18, 10 IJ, Phenomenex, 40% 
H20/MeCN, 4 mL min-1). 
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6.3 STRUCTURE DETERMINATION AND STEREOCHEMISTRY 
6.3.1 Structure determination of the sesquiterpene hydroquinones [141] - [143]. 
"< 
. . . 15 14 13 OH 
. • .. 10 S 2 
6H COOMe" 
OH 
[141] 
HREIMS established the molecular formula of rietone [141] as C24H320s (mlz 
416.2188, i1mmu -11). Rietone displayed UV (297,235 and 209 nm) and IR (1510, 
1620 and 1680 cm-1) absorptions consistent with a substituted aromatic ring and an aJ3-
unsaturated carbonyl moiety. Other IR absorptions at 3340 and 1730 cm-1 indicated 
additional hydroxyl and ester functionalities respectively. The twelve well resolv~d 
aromatic and vinylic resonances (0 116-161) together with the ester ang aJ3-
unsaturated carbonyl signals (0 173 and 198 respectively) in the 13C NMR spectrum of 
rietone [141] (FIGURE 6.2) accounted for eight of the nine degrees of unsaturation 
implied by the molecular formula and required [141] to be monocyclic. 
8' 
-1 I 
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FIGURE 6.2 13C NMR (100 MHz, CDCI3) spectrum of rietone [141]. 
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The HMQC NMR spectrum of rietone (FIGURE 6.4) exhibited correlations in 
accordance with four olefinic methyl groups (6H 1.43, 1.65, 1.91 and 2.21), one methoxy 
group (6H 3.68), two benzylic methylene grQups (6H 3.25 and 3.55), three vinylic 
protons (6H 5.28, 5.-59 and 6.12), one oxymethine proton (6 H 4.52) and two aromatic 
protons (6H 6.55 and 6.58). The 1H and 13C NMR chemical shifts for the aromatic ring 
component of [141] are consistent with the values reported for the 1,2,4,5-
tetrasubstituted parahydroquinone ring system, including the methyf ethanoate side 
chain, of peyssonol B [157], isolated by Kashman and co-workers from the Red Sea 
marine alga Peyssonnelia species203. 
r--------------- ---- ----., , 
, 
I 
I 
COOMe 
OH : I _______________________ .J 
[157] 
The position of the methyl ethanoate side chain relative to the phenolic hydroxyl 
groups and the unsaturated acyclic moiety in the aromatic substructure of rietone was 
unequivocally established from the two and three bond correlations (FIGURE 6.3) 
observed in the HMBC NMR spectrum of [141]. 
FIGURE 6.3 Selected two and three bond correlations observed in the HMBC NMR 
spectrum of [141]. 
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The above data established the hydroquinone moiety as the monocyclic portion 
of [141]. This left fifteen carbon and two oxygen atoms unaccounted for suggesting the 
presence of an acyclic oxygenated farnesyl side chain. The COSY NMR spectrum of 
rietone (FIGURE 6.5) revealed two prominent coupling sequences. The first sequence 
involved coupling from the benzylic methylene protons at 03.25 (2H, dd, J = 6.7,7.5 
Hz, H-1 ') to the vinylic proton at 0 5.28 (1 H, t, J = 7.1 Hz, H-2') and, by long range 
coupling, to the olefinic methyl protons at 0 1.65 (3H, s, H-13'). The se-c~nd sequence 
indicated a contiguous coupling from the methylene protons at 0 2.20 (2H, m, H-4'), to 
the adjacent methylene protons at 0 2.39 and 2.17 (2H, m, H-5'), then to the vinylic 
proton at 0 5.59 (1 H, dd, J = 7.9, 9.1 Hz, H-6') and finally, by long range coupling, to 
the olefinic methyl protons at 01.43 (3H, s, H-14'). These coupled systems, along with 
long range 1H_13C correlations, supported an oxygenated farnesyl side chain in which 
the Q)~ygen functionalities were confined to the terminal prenyl unit of this side chain. 
A sharp exchangeable doublet at 0 4:69 (1 H, d, J = 4.1 Hz, OH-8'), with nO 
correlating carbon atom in the HMQC NMR spectrum of [141], but strongly c~!Jpred to 
an oxymethine doublet at 0 4.52 (1 H, d, J = 4.1 Hz, H-8') in the COSY NMR spectrum 
(FIGURE 6.5) established the existence of a secondary alcohol. Prominent two bond 
correlations between the oxymethine proton and the carbon atoms at 0 132 (C-7') and 
0198 (C-9') in the HMBC NMR spectrum placed the secondary alcohol group at_C-8', 
between a terminal a~-unsaturated carbonyl functionality and the fj,s' double bond. This 
completed the assignment of rietone [141]. The NMR spectral data for rietone are 
presented in TABLE 6.1 and the stereochemical assignment of the 8'-OH functionality 
is discussed in section 6.3.2. 
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FIGURE 6.4 HMQC NMR (400 MHz, CDCI3) spectrum of [141]. 
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FIGURE 6.5 COSY NMR (400 MHz, CDCI3) spectrum of [141]. 
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TABLE 6.1 NMR spectral data for rietone [141]. 
13C 1H COSY to 1H HMBC to 13C 
1 127.65 ":. r 
2 146.95 
3 117.4 d 6.555 *1" 1,5, 1" 
4 118.65 r -
-
5 148.65 
6 116.4 d 6.585 *1' 2,4, l' 
l' 27.7 t 3.25 dd (6.7,7.5) *6, 2', *13' 1, 2, 6, 2', 3' 
2' 122.5 d 5.28 t (7.1) 1', *13' 1',4',13' 
3' 136.1 5 
4' 38.8 t ~ 2.20 m 5" 
-5' 25.5 t 2.39 m, 2.41 m 4',6' 4',6',7' 
6' 133.1 d 5.59 dd (7.9, 9.1) 5', *14' 
7' 132.65 
8' 83.0 d 4.52d(4.1) 8'-OH 6' 7' 9"> 14' 
- I !-_" -- , 
9' 198.4 5 
10' 118.5 d 6.125 *12', *15' 9', 12', 15' 
11 ' 160.85 
12' 21.4 q 2.21 5 *10' 10',11',15' 
. ~ - , 
13' 15.5 q 1.655 *1', *2' 2',3',4' 
14' 10.8 q 1.435 *6' 6',7',8' 
15' 28.0q 1.91 5 *10' 1 0', 11', 12' 
1" 35.8 t 3.555 *3 3,4,5,2" 
2" 173.4 5 
2-0H 5.225 
5-0H 7.51 5 4,5,6 
8'-OH 4.69 d (4.1) 8' 8',9' 
OMe 52.2 Q 3.685 2" 
* long-range COSY coupling. 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in CDCI3 with chemical 
shifts (5) in ppm. Coupling constants in Hz are in parentheses. 
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[141] R = OH 
[142] R = OAe 
[143] R=H 
OH 
COOMe 
The molecular formula of [142] was determined from HREIMS data as C2sH340 7 
(rn/z 458.2294, ilmmu -9) and differed from that of rietone [141] by the presence of a 
single acetate unit in [142]. This was corroborated by the acetate methyl singlet at 5 
2.11 _~nd the extra ester carbonyl resonance at 5 171 in the 1H and 13C NMR spectra 
of [142], respectively. The position of the acetate group at C-8' was confirmed firstly, 
by the downfield chemical shift of H-8' (55.40) in [142] relative to [141] (54.52), and 
secondly, by a correlation between H-8' and the acetate carbonyl in the HMBC.NMR 
- "-" 
spectrum of [142]. The stereochemical assignment of the 8'-acetoxy functionality in 
[142] is discussed in section 6.3.2. 
The molecular ion at m/z 400.2265 (6mmu +15) in the HREIMS spectrum of 
[143] is compatible with the molecular formula C24H320S' This molecular formula 
corresponds to the loss of a single oxygen atom from rietone [141]. The replacement 
of the C-8' oxymethine carbon resonance (FIGURE 6.2) with a deshielded methylene 
signal at 5 55 in the 13C NMR spectrum of [143] (FIGURE 6.6), coupled with the 
disappearance of optical activity, supported the loss of the chiral oxygen functional 
group in this compound. The 1H and 13C NMR data for 8'-acetoxyrietone [142] and 8'-
desoxyrietone [143] are presented in TABLE 6.2. 
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8' 
FIGURE 6.6 13C NMR (100 MHz, CDCI3) spectrum of 8'-desoxyrietone [143]. 
6.3.2 Stereochemistry of rietone [141] and 8'-acetoxyrietone [142]. 
'.-
Mosher's method for the determination of the absolute stereochemistry in 
secondary alcohols has found wide application in marine natural products208-212. This 
method requires the formation of diastereomers of the compound containing the chiral 
secondary alcohol, followed by 1 H NMR analysis of the diastereomers. In order to 
simplify the interpretation of the NMR data in the application of Mosher's method to 
rietone it was desirable to generate the mono-ester of rietone. This was achieved by 
first converting rietone to the corresponding quinone. Mild oxidation of rietone [141] 
with silver oxide213 followed by normal phase HPLC of the oxidation products gave 
unchanged [141] and the quinone [163] as a red oil in low yield (20%). 
[163] 
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TABLE 6.2 1H and 13C NMR data for compounds [142] and [143]. 
[142] [143] 
- 13C . 1H 13C 1H _ 
1 127.75 127.85 
2 147.55 147.65 
3 117.6 d 6.575 117.75 6.575 
_. ~ 
4 119.05 119.05 
-S 148.65 148.75 
6 117.9 d 6.655 118.1 d 6.685 
l' 28.5 t 3.27 d (7.2) 28.8 t 3.27 d (7.2) 
2' 122.4 d 5.28 t (7.3) 121.8d 5.28 t (7.2) 
3' 136.65 137.55 
4' 38.6 t 2.t4 m 39.1 t 2.12 m 
5' 25.8 t 2.22 m 26.0 t 2.18 m 
6' 133.3 d 5.62 t (6.5) 128.4 d 5.18 t (6.7) 
7' 129.35 129.95 
8' 84.1 d 5.405 54.8 t 3.045 -,,'.-
'--
9' 194.55 200.25 
10' 119.9 d 6.095 123.3 d 6.105 
11' 158.4 5 156.35 
12' 21.2 q 2.155 20.8 q 2.135 
13' 15.9 q 1.695 16.0 q 1.695 . -- - , 
14' 13.1 q 1 .. 625 16.9 q 1.565 
15' 28.0 q 1.885 27.8 q 1.875 
1" 36.5 t 3.585 36.7 t 3.585 
2" 173.75 173.85 
2-0H 4.925 4.785 
5-0H 7.135 7.195 
8'-OH 
OMe 52.4 q 3.705 52.5 q 3.71 5 
OAc 20.8 q 2.11 5 
170.65 
Spectra were recorded at 400 MHz for 1H and 100 MHz for 13C in CDCI3 with chemical 
shifts (6) quoted in ppm. Coupling constants in Hz are in parentheses. 
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The MTPA esters of the quinone [163] were prepared using the modified 
Mosher's method208,210, In this method the derivaUsing agent 2-methoxy-2-phenyl-2-
(trifluoromethyl)acetic acid (MTPA) was used to convert the quinone to its 
corresponding (S)- and (R)-MTPA esters, Interpretation of stereochemistry in Mosher's 
method relies on the fact that the most stable conformation of the ester in solution is 
when the Ca-proton and the ester carbonyl and trifluoromethyl groups of the MTPA 
ester lie in the same plane and cis to one another (FIGURE 6.7)208, - - ~ 
1-1 1-1 H (OMe) (Ph) • {,I;}MTPA 
,!,C ,!,B I A 
~ -c-c-c ~OMe • {S}-MTPA ~ '/ ", 
'. 0 . 
. ....-
/c" CF3 ~ MTPA plcrle 
~-C-C-C H 0 ~ Ioiewdowhtheplane I I \ (FIGURE 6.7) 
HxHvHz 
FIGURE 6.7 Representation of the MTPA plane of an MTPA ester with HA B C on the 
right hand side and Hx, y, z on the left side of the plane respecti~ely. 
In this conformation the 1H NMR signals HA,B,C of the (R)-MTPA ester will appear 
upfield relative to those of the (S)-MTPA ester due to the diamagnetic effect of the 
benzene ring208. The reverse is true for Hx, y,z, Therefore, when calculating .6.CSH ~~H(S) -
CSH(R») the protons on the right side of the MTPA plane should have positive values and 
those on the left should have negative values (FIGURE 6.8), By calculating the .6.CSH 
values it is thus possible to determine the stereochemistry of the chiral secondary 
alcohol. 
OvfTPA , 
~ -c-c-c'" .. ··c·· .... "c-c-c-~ 
I I I I I I I 
HxHvHz I ~HeM; 
H 
L\~<O 
FIGURE 6.8 A view down the plane of the MTPA ester (see FIGURE 6.7). 
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Application of the MTPA determination rule208 to the iloH values of the proton 
resonances in the diastereomeric MTPA-quinone esters (TABLE 6.3) established 
negative values on the right hand side .of the MTPA plane and positive valL!es on the 
-:, r 
left hand side as represented in FIGURE 6.9. This demonstrated an 8'(S)-configuration 
for the chiral centre in the ·quinone [163] and therefore also for the hydroquinone 
rietone [141]. 
-
TABLE 6.3 Calculation of the iloH values from the MTPA esters of [163]. 
12' 
15' 
10' 
14' 
6' 
5' 
13' 
2' 
l' 
0(5) 
1.8636 
2.1727 
6.1027 
1.4926 
5.6416 
2.0204 
1.5469 
5.1383 
3.0887 
o (R) 
1.8406 
2.1531 
6.0560 
1.5579 
5.7120 
2.0697 
1.5687 
5.1632 
3.1005 
Chemical shifts (0) quoted in ppm. 
. 
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FIGURE 6.9 Determination of the absolute configuration at C-8' in the MTPA ester of 
[163] (booH values represented in boxes in ppm). 
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The shielded chemical shifts of the C-13' and C-14' olefinic methyl groups at 0 
15 and 0 11, respectively, in the 13C NMR spectrum of rietone [141] defined an E-
geo_metry around the two exocyclic, asymmetrically substituted double bonds (a Z-
configuration requires Oc 22_25)214. 
I I I 15 14 13 OAe r - ~ 
I I 
" 10 
-
6 2 
OAe COOMe 
OAe 
[164] 
- . Acetylation of 8'-acetoxyrietone [142] with A~O in pyridine gave the triacetate 
[164] which was identical ([0]61, IR, 1H NMR) to the acetylation product of rietone [141] 
obtained under the same conditions. These data, therefore, established an 8'( S) 
stereochemistry at C-8' in [142] (based on the 8'(S) stereochemistry deter'T'In~d for 
rietone [141] using Mosher's method) and an E-geometry at the /12' and ~fl olefins. 
6.4 BIOLOGICAL ACTIVITY 
The anti-HIV reverse transcriptase activity reported for several sesquiterpene 
hydroquinone compounds197-199,203 prompted an investigation of the anti-HIV activity of 
rietone [141]. With almost two million people worldwide having already progressed to 
full-blown AIDS and with approximately thirteen million people infected with HIV, the 
magnitude of the AIDS problem continues to grow215. Tremendous resources have 
focussed on the study of the etiological agent, the retrovirus HIV. The target that has 
been most actively pursued for the chemotherapeutic treatment of HIV is the enzyme 
reverse transcriptase 198,215. 
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Rietone was screened in the NCI's Anti-HIV Drug Testing Systemt which, rather 
than specifically targeting reverse transcriptase, is designed to detect agents acting at 
any_stage of the virus reproductive cycle216,217. Tne assay procedure involves the killing 
of T4 lymphocytes by HIV. Compounds that irilsract with the virions, cells or virus gene-
products to interfere with the HIV activity will protect the lymphocyte cells from 
cytolysis. The assay uses a tetrazolium reagent that is metabolically reduced by viable 
cells to yield a soluble, coloured formazan product measurable by:*conventional 
colourimetric techniques. In other words, any drug-induced suppression of the HIV 
cytopathic effects is detected by the generation of the soluble formazan in the surviving 
cells216• 
Rietone was tested in several assay protocols. A repre~entative example of the 
resu~ts of one of these tests is contained in FIGURE 6.10. The solid line depicts the 
percentage of surviving HIV-infected cells treated with rietone (at the indicated 
concentration) relative to uninfected, untreat.ed controls, i.e. the line expresses the.in 
vitro anti-HIV activity of rietone. The dashed line depicts the percentage of sUA'iving 
' .. 
uninfected cells treated with rietone relative to the same uninfected, untreated controls, 
i.e. the line expresses the in vitro growth inhibitory properties of rietone. 
From FIGURE 6.10 it is evident that rietone offers a maximum protection of 67.5 
per cent against HIV in the assay at a concentration of 6.33 x 10-6 M. However, at 
higher concentrations rietone causes cytolysis. The 50% effective concentration (ECso) 
against H IV cytopathic effects was at a concentration of 1.23 x 10-6 M, the 50% 
inhibitory concentration (lCso) for cell growth was at a concentration of 9.32 x 10-6 M 
and, therefore, the Therapeutic Index of rietone (TI = ICso I ECso) was calculated to be 
7.55. From these results it was concluded that rietone exhibited moderate anti-HIV 
activity, however, its cytotoxicity mitigated against the further development of rietone 
as an anti-H IV agent. 
t Assays courtesy of Dr D. Newman, National Cancer Institute. 
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Conclusion 2.00 X 10.6 /i .. :.··.·66.45 76.18 100.83 
6.33 X 10.6 ....• :/67.46 : .... , 76.90 75.28 
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FIGURE 6.10 Selected test results from the anti-HIV screening of rietone by the NCI. 
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CHAPTER SEVEN 
EXPERIMENTAL 
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7.1 EXPERIMENTAL: GENERAL 
All solvents were redistilled before use: When necessary solvents w~re dried 
according to standard procedures. Normal phase TLC was performed on DC-Alufolien 
Kieselgel 60F254 plates and reverse phase TLC was performed on DC-Fertigplatten RP-
18F254S and RP-8F254S plates. The plates were viewed under 254 nm wavelength UV 
r - ~ 
light and were developed by spraying with 10% H2S04 in MeOH followed by heating for 
several minutes. Flash column chromatography was performed using Kieselgel 60 (230 
- 400 mesh) silica. 
Analytical grade solvents were used for HPLC. The HPLC system used in the 
fractionation of the organic ext racts_ included a Spectra-Physics IsoChrom LC pump 
equipped with a Rheodyne injector, a Waters R401-differential refractometer and a 
Rikadenki chart recorder. In normal phase separations a Whatman Magnum 9 Partisil 
column was used and in reverse phase separations a Phenomenex Selectosil C18 
column was used. Chapter three involved the addtional use of a Spectra-Physics 
SpectraSERIES P100 pump, a SpectraSERIES UV100 detector and Phenomenex 
Selectosil C8 and CN columns. 
Melting points were determined on a Gallenkamp melting point apparatus. 
Optical rotations were measured on a Perkin-Elmer 141 polarimeter. IR spectra were 
recorded on a Perkin-Elmer 180 Grating infrared spectrophotometer with the exception 
of spectra in chapters four and six which were recorded on a Perkin-Elmer series 7 
FTIR spectrophotometer. UV spectra in chapter three were obtained in MeOH on a 
GBC UVNIS 916 spectrophotometer and UV spectra in chapters one and six were 
obtained in MeOH on a Shimadzu UVNIS UV160A spectrophotometer. 
The 1H (400 MHz) and 13C (100 MHz) NMR experiments, in addition to the 2-D 
and NOEDS experiments, were recorded on a Bruker AMX400 spectrometer. 1 Hand 
13C NMR chemical shifts are reported in 0 units (ppm) and are referenced to residual 
protonated solvent. 
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Low-resolution mass spectra (ElMS) were recorded on a Hewlett-Packard 5988A 
spectrometer. All high-resolution spectra (HREIMS) were obtained by Dr P. Boshoff of 
the Mass Spectrometry Unit at the Cape Technikon, Cape Town, with the exception of 
spectra in chapter six which were obtained t;y~Professor Ferreira at the University of 
Orange Freestate, Bloemfontein. In chapter three the HRFABMS data were obtained 
by Dr M. Hemling of SmithKline Beecham Pharmaceuticals, US. 
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7.2 EXPERIMENTAL: CHAPTER ONE 
COLLECTION AND IDENTIFICATION - The grey-brown sponge Ircinia species (dry 
weight 252 g) was collected using SCUBA (-20 m) in the Tsitsikamma Marine'Reserve 
in March 1992. The sponge was identified by M. K. Harper of Scripps Institute of 
Oceanography, California. A total of 593 Siphonaria concinna marine molluscs were 
collected by hand from Old Woman's River mouth near Port Alfred in O-ecember 1992. 
The- animals were identified by Professor A. Hodgson of the Zoology Department at 
Rhodes University, Grahamstown. Voucher specimens of the sponge (No. 92-011) and 
the molluscs (No. 92-005) are housed at Rhodes University. 
EXTRACTION AND ISOLATION - The frozen Ircinia sponge was freeze-dried and 
extracted with hexane, EtOAc and MeOH respectively. The crude EtOAc extract 
exhibited moderate antimicrobial activity against Bacillus subtilis, Staphylococcus 
aureus and Escherichia coli bacteria. The EtOAc extract was fractionated by flash 
chromatography on silica gel using a hexane/EtOAc solvent gradient. The fraction 
which showed the strongest antimicrobial activity was further purified by normal phase 
HPLC (50% EtOAc/hexane) to yield variabilin [35] (47.2 mg, 0.26%). The Siphonaria 
concinna marine molluscs were steeped in acetone for seven weeks after which the 
combined aqueous/acetone extract was partitioned between EtOAc and H20. The 
..... - . 
EtOAc layer was concentrated and fractionated by flash chromatography using a 
hexane/EtOAc solvent gradient. The fraction eluted with pure EtOAc crystallised on 
standing. This crystalline fraction showed strong antimicrobial activity against 
Staphylococcus aureus. Recrystallisation with EtOAc gave pectinatone [36] (88.6 mg). 
Variabilin [35] - stable, yellow oil; [a]~ -29 0 (c 0.83, CHCI3); IR (film) 3140, 2925, 
1725,1630,1305,1060,750 cm-1; UV (MeOH)Amax 204.8 (€ 20100),250.8 (€ 15700), 
308.0 (€ 8 700); 1H NMR (CDCI3) 5 7.32 (1 H, s, H-1), 7.19 (1 H, s, H-4), 6.26 (1 H, s, H-
2),5.31 (1 H, d, J = 10.1 Hz, H-20), 5.15 (1 H, t, J = 7.0 Hz, H-7), 5.07 (1 H, t, J = 6.8 Hz, 
H-12), 2.77 (1 H, m, H-18), 2.22 (2H, q, J = 7.5 Hz, H-6), 2.04 (2H, m, H-11), 1.97 (2H, 
t, J = 7.7 Hz, H-10), 1.93 (2H, t, J = 7.6 Hz, H-15), 1.81 (3H, s, Me-25), 1.57 (3H, s, Me-
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9),1.54 (3H, 5, Me-14), 1.34 (2H, m, H-16), 1.28 (2H, m, H-17), 1.05 (3H, d, J = 6.7 Hz, 
Me-19); 13C NMR (CDCI3) 6172.0 (5),162.0 (5),142.7 (5),142.5 (d), 138.8 (d), 135.8 
(5),134.8 (5),125.0 (5),124.4 (d), 123.7 (d), 116:2 (d), 111.1 (d), 99.5 (5),39.7 (t), 39.5 
-
(t), 36.6 (t), 30.9 (d), 28.4 (t), 26.6 (t), 25.7 (t)" 25.0 (t), 20.6 (q), 16.0 (q), 15.8 (q), 6.1 
(q); ElMS (70 eV) mlz (int. %) No M+, 175 (2), 149 (6),135 (8),109 (9),95 (20),83 (35), 
81 (100), 69 (56), 55 (46), 44 (57); HREIMS m/z 398.2440 (calcd for C2sH3404' 
398.2457). 
Pectinatone [36] - white crystals; [a]~ +59 0 (c 1.15, CHCI3), IR (KBr) 3090, 2940, 
2910,2850,1655,1620,1540,1440,1370,1210,1110, 1070, 1020,960,740 cm-1; 1H 
NMR (CDCI3) 6 5.36 (1 H, dq, J = 9.9 Hz), 2.63 (1 H, m), 2.01 (6H, 5), 1.89 (3H, d, J = 
1.3 Hz), 1.46 (2H, m), 1.31 (4H, m), 1.24 (4H, m), 1.51 (2H, m), 1.05 (2H, m), 0.97 (3H, 
d, J = 6.6 Hz), 0.93 (2H, m), 0.85 (3H, t, J = 7.1 Hz), 0,83 (3H, d, J = 6.5 Hz), 0.79 (3H, 
d, J = 6.6 Hz); 13C NMR (CDCI3) 6165.9 (5),165.4 (5),159.3 (5),142.9 (d), 126.2 (5), 
106.4 (5),98.7 (5),45.8 (t), 44.7 (t), 39.3 (t), 30.5 (d), 29.7 (d), 28.3 (d), 21.2 (q), 20.2 
(q), 20.1 (q), 20.0 (t), 14.8 (q), 14.4 (q), 11.5 (q), 8.6 (q); ElMS (70 eV) m/z (int. o/~) 334 
- "-" (M+, 5), 278 (2), 221 (4), 181 (72), 168 (100), 125 (6), 83 (49), 69 (22), 43 (37); 
HREIMS m/z 334.2503 (calcd for C21 H340 3, 334.2508). 
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7.3 EXPERIMENTAL: CHAPTER TWO 
COLLECTION AND IDENTIFICATION - The colonial ascidian Pseudodistoma 
species was collected using SCUBA (-20 to -30'm) in the Tsitsikamma Marine'Reserve 
in May 1993. A voucher specimen (No. 93-002) resides at Rhodes University. The 
animal was identified by Dr P. Coetzee of the Zoology Department, University of Port 
Elizabeth, South Africa. 
EXTRACTION AND ISOLATION - The freshly collected ascidian was immediately 
frozen and stored for approximately one month. Upon removal it was freeze-dried and 
extracted with hexane, EtOAc and MeOH respectively. The crude EtOAc extract proved 
to be most active in the antimicrobial disc assay. Fractionation of this extract was 
conducted according to SCHEME 2.1 (section 2.2) to yield four new amino alcohols as 
their acetyl derivatives [47] (33.0 mg), [48] (10.7 mg), [49] (17.3 mg) and [50] (21.1 
mg). 
Preparation of Acetyl Derivatives - a mixture of amino alcohols (267 mg) was 
treated with A~O (5 mL) in pyridine and left overnight at RT. After evaporation of the 
solvents the mixture was separated by HPLC (SCHEME 2.1). 
2s*-Acetamido-3S*-acetoxy-5E,13~tetradecadiene [47] - stable, colourless oil; [a]~ 
-20 0 (cO.83, CHCI3); IR (film) 3290,2924,2850,1738,1647,1545,1368,1229,1018, 
950 cm-1; 1H NMR (CDCI3) 5 5.79 (1 H, dq, H-13), 5.50 (1 H, br s, NH), 5.48 (1 H, dt, Js,e 
= 15.3 Hz, Je,7 = 6.9 Hz, H-6), 5.30 (1 H, dt, J4,s = 6.8 Hz, JS,6 = 15.3 Hz, H-5), 4.94 (2H, 
dd, H-14), 4.82 (1 H, m, H-3), 4.20 (1 H, m, H-2), 2.22 (2H, m, H-4), 2.06 (3H, 5, OAc), 
2.01 (2H, m, H-12), 1.98 (3H, 5, OAc), 1.95 (2H, m, H-7), 1.36 - 1.25 (8H, m, H2~8 to H2-
11), 1.09 (3H, d, J = 6.8 Hz, H-1); 13C NMR (CDCI3) see TABLE 2.1 (section 2.3) ; ElMS 
(70 eV) m/z (int. %) 309 (M+, 2), 249 (32),206 (19),149 (13),98 (99),86 (100),83 (70); 
HREIMS m/z 309.2292 (calcd for C1sH31N03, 309.2304). 
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2S*-Acetamido-3S*-acetoxy-5E-tetradecene [48] - stable, colourless oil; [a]~ +140 
(cO.68, CHCI3); IR (film) 3290,2920,2850,1738,1645,1539,1366,1229,1016,949 em-1; 
1H NMR (CDCI3) 65.50 (1 H, br 5, NH), 5.47 (1~, dt, J5 ,6 = 15.1 Hz, J6,7 = 6.7 Hz, H-6), 
5.30 (1 H, dt, J4,5 = T.5 Hz, J5,6 = 15.0 Hz, H-<5), 4.82 (1 H, m, H-3), 4.21 (1 H; m, H-2), 
2.22 (2H, m, H-4), 2.06 (3H, 5, OAe), 2.01 (2H, m, H-7), 1.98 (3H, 5, OAe) , 1.30 - 1.23 
(12H, m, H2-8 to H2-13), 1.09 (3H, d, J = 6.8 Hz, H-1), 0.87 (3H, t, J = 6.7 Hz, H-14); 13C 
NMR (CDCI3) see TABLE 2.1 (section 2.3); ElMS (70 eV) m/z (int. %)r31c1 (M+, 2), 251 
(2Q.), 192 (20), 149 (71), 99 (65), 98 (61), 86 (100), 43 (55); HREIMS m/z 311.2478 
(ealed for C1sH33N03' 311.2460). 
1-Acetamido-2-acetoxy-4E,12-tridecadiene [49] - stable, colourless oil; [a]~ +140 
(cO.97, CHCI3); IR (film) 3290,2921,2848,1738,1652,1548, 1425, 1366, 1229, 1039, 
948Qm-1; 1H NMR (CDCI3) 6 5.79 (1 H, dq, H-12), 5.79 (1 H, br 5, NH), 5.48 (1 H, dt, J4,5 
= 15.3 Hz, J5,6=6.9 Hz, H-5), 5.31 (1H, dt, J3,4 = 7.1 Hz, J4,5 = 15.3 Hz, H-4), 4.95 (2H, 
m, H-13), 4.90 (1 H, m, H-2), 3.40 (2H, m, H-1), 2.25 (2H, t, J = 6.8 Hz, H-3), 2.05 (3J-i, 
5, OAe) , 2.02 (2H, m, H-11), 1.98 (2H, m, H-6), 1.96 (3H, 5, OAe) , 1.38 - 1.26 (~H, m, 
H2-7 to H2-10); 13C NMR (CDCI3) see TABLE 2.2 (section 2.3); ElMS (10 eV)m/z (int. 
%) 295 (M+, 2), 279 (10), 235 (74), 176 (19), 149 (100), 111 (41), 102 (46), 96 (46), 82 
(58),80 (67), 43 (62); HREIMS m/z 295.2156 (ealed for C17H29N03, 295.2147). 
1-Acetamido-2-acetoxy-4E-tridecene [50] - stable, colourless oil; [am +100 (c -0:75, 
CHCI3); IR (film) 3290, 2925, 2851,1740,1655,1550,1425,1368,1231,1041,948 
em-1; 1H NMR (CDCI3) 6 5.69 (1 H, br 5, NH), 5.50 (1 H, dt, J4,5 = 15.2 Hz, J5 ,6 = 8.2 Hz, 
H-5), 5.31 (1 H, dt, J3,4 = 7.1 Hz, J4,5 = 15.2 Hz, H-4), 4.91 (1 H, m, H-2), 3.41 (2H, m, H-
1),2.26 (2H, t, J = 6.7 Hz, H-3), 2.05 (3H, 5, OAe) , 1.98 (2H, m, H-6), 1.96 (3H, 5, OAe) , 
1.31 -1.25 (12H, m, H2-7 to H2-12), 0.87 (3H, t, J = 6.6 Hz, H-13); 13C NMR (CDCI3) see 
TABLE 2.2 (section 2.3); ElMS (70 eV) m/z (int. %) 297 (M+, 1), 237 (100), 178 (28), 
149 (23), 124 (18), 82 (34), 80 (45), 43 (25); HREIMS m/z 297.2305 (ealed for 
C17H31 N03, 297.2304). 
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Preparation of Oxazolidinones - a mixture of the amino alcohols (140 mg) was 
reacted with 1, 1-carbonyl-di-imidazole (330 mg) in refluxing CsHs for 6 h. The solution 
was washed with H20, dried over anhyd. Na2S04r concentrated under reduced pressure 
. -
and chromatographed by normal phase HPLC~50% EtOAC/hexane) and reverse phase 
HPLC (20% H20/MeOH) to afford pure [57] (4.1 mg) and [58] (2.5 mg). 
Oxazolidinone [57] - oil; [a]~l -320 (c 0.41, CHCI3); IR (film) 3280, 2917,~2848, 1749, 
1385,1232,1015,949 cm-1; lH NMR (CDCI3) 0 5.79 (1H, dq, H-13), 5.58 (1H, dt, Js,s 
. = 15.3 Hz, JS,7 = 6.7 Hz, H-6), 5.36 (1 H, dt, J4,s = 7.0 Hz, Js,s = 15.2 Hz, H-5), 5.15 (1 H, 
br s, NH), 4.94 (2H, dd, H-14), 4.11 (1H, q, J = 6.2 Hz, H-2), 3.60 (1H, m, H-3, 
transformed into a doublet with J = 6.1 Hz by spin decoupling at 0 1.25), 2.40 (2H, m, 
H-4), 2.01 (4H, m, H2-7 and H2-12), 1.29 (8H, m, H2-8 to H2-11), 1.25 (3H, d, J = 6.2 Hz, 
Me-1j;. 13C NMR (CDCI3) 0158.7 (s, CO), 139.1 (d, C ... 13), 135.7 (d, C-6), 122.5 (d, C-
5), 114.2 (t, C-14), 83.4 (d, C-3), 52.5 (d, C-2), 37.0 (t, C-4), 33.7 (t, C-12), 32.5 (t, C-7), 
29.2/29.0/28.9/28.8 (t, C-8 to C-11), 20.8 (q, Me-1); ElMS (70 eV) m/z (int. %) 251 
(M+, 1), 190 (6), 149 (18), 112 (31), 100 (52), 99 (33), 88 (100), 56 (50); HRE~.MS m/z 
251.1890 (calcd for ClsH1SN02' 251.1885). 
Oxazolidinone [58] -oil; [a]~l -260 (cO.25, CHCI3); IR (film) 3280,2917,2848,1749, 
1385,1232,1015,949 cm-1; lH NMR (CDCI3) 0 5.58 (1H, dt, Jss = 15.2 Hz, JS7 = 6.6 
, '. '- - -
Hz, H-6), 5.35 (1 H, dt, J4,s = 7.0 Hz, Js,s = 15.3 Hz, H-5), 4.99 (1 H, br s, NH), 4.11 (1 H, 
q, J = 6.1 Hz, H-2), 3.60 (1 H, m, transformed into a doublet withJ = 6.1 Hz by spin 
decoupling at 0 1.24),2.40 (2H, m, H-14), 2.04 (2H, m, H-7), 1.40 (12H, m, H2-8 to H2-
13),1.24 (3H, d, J = 6.2 Hz, Me-1), 0.97 (3H, t, J = 7.5 Hz, Me-14); 13C NMR (CDCI3 ) 
0158.6 (s, CO), 135.4 (d, C-6), 122.9 (d, C-5), 83.4 (d, C-3), 52.5 (d, C-2), 37.0 (t, C-
4), 32.2 (t, C-7), 29.2/29.2/29.2/26.7 125.5/20.5 (t, C-8 to C-13), 20.8 (q, Me-1), 
14.3 (q, Me-14); ElMS (70 eV) m/z (int. %) 253 (M+, 1), 149 (57),99 (89),88 (100), 81 
(74), 57 (96), 55 (79),43 (63). 
Preparation of Hydrogenated Derivatives - a solution of [47] (9.8 mg) in EtOH (6 
mL) containing Adams catalyst (10 mg) was stirred under an atmosphere of hydrogen 
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for 3.5 h. The catalyst was removed by filtration and the solvent evaporated to give the 
tetrahydroaeetate [59] (12.2 mg). By the same procedure [59] (8.2 mg) was obtained 
from [48] (6.5 mg). 
Hydrogenated Derivative [59] - oil; [a]~ _8 0 (c 1.06, CHCI3); IR (film) 3290, 2920, 
2850,1732,1654, 1550, 1458, 1366, 1233 cm-1; 1H NMR (CDCI3) ~ 5.73 (1 H, br 5, NH), 
4.89 (1 H, m, H-12), 3.40 (2H, m, H-1), 2.06 (3H, 5, OAe), 1.96 (3H, sOAe), 1.53 (2H, 
m, H-3), 1.24 (18H, m, H2-4 to H2-12), 0.87 (3H, t, J = 6.7 Hz, H-13); 13C NMR (CDCI3) 
0171.3 (5, OAe), 170.1 (5, OAe), 73.6 (d, C-2), 43.2 (t, C-1), 31.9/29.6/29.6/29.5 
129.4 1 29.3/29.3/29.3/25.2/22.7 (t, C-3 to C-12), 23.2 (q, OAe), 21.2 (q, OAe), 
14.1 (q, C-13); ElMS (70 eV) m/z (int. %) No M+, 149 (5),115 (38),73 (100),72 (17), 
60 (19), 43 (26). 
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7.4 EXPERIMENTAL: CHAPTER THREE 
COLLECTION AND IDENTIFICATION - The black nodular Latrunculid sponge was 
collected using SCUBA (-20 m) in the Tsitsikar'nma Marine Reserve in May 1993 and 
May 1995. A voucher specimen (No. 94-006) is housed at Rhodes University. The 
animal is presently being identified by Dr M. Kelly-Borges of The Natural History 
Museum, London. 
EXTRACTION AND ISOLATION - The freshly collected sponge was stored frozen. 
Upon removal it was freeze-dried and extracted with a 1: 1 MeOH/CHCI3. Fractionation 
of this extract was conducted according to SCHEME 3.2 and SCHEME 3.3 (section 3.2) 
to yield four new alkaloids, tsitsikammamine A [90] (7.9 mg), B [91] (8.9 mg), C [92] 
(63.2 mg) and D [93] (5.7 mg). 
Tsitsikammamine A [90] - characterised as its TFA salt; brown solid; intense 
pigmentation precluded measurement of [a]~; IR (film) 3150, 1670, 1620,_ 1579,1'540, 
1430,1370,1200,1130,1050, 780cm-1; UV(MeOH) Amax 242.9 (e 11700), 317.1 (e 
6500),377.3 (e 2 500); 1H NMR (DMSO-ds) and 13C NMR (DMSO-ds) see TABLE 3.1 
(section 3.3); 1H NMR (CD30D) (5 7.38 (2H, d, J = 8.3 Hz, H-18 and H-20), 6.99 (1 H, 
s, H-13), 6.95 (1H, s, H-2), 6.92 (2H, d, J = 8.4 Hz, H-17 and H-21), 3.90 (2H, t, J :=T8 
Hz, H-5), 3.03 (2H, t, J = 7.8 Hz, H-4); 13C NMR (CD30D) (5167.8 (s, C-10), 159.9 (s, 
C-19), 159.6 (s, C-7), 136.7 (s, C-11), 130.4 (d, C-18), 130.4 (d, C-20), 130.2 (s, C-9), 
129.5 (s, C-16), 125.9 (d, C-13), 124.5 (s, C-14), 123.9 (d, C-2), 122.0 (s, C-8), 120.7 
(s, C-3), 117.8 (d, C-17), 117.8 (d, C-21),115.0 (s, C-15), 46.1 (t, C-5), 19.2 (t, C-4); 
HRFABMS m/z 304.1087 (M+Ht (calcd for C1sH14N302' 304.1086). 
Tsitsikammamine 8 [91] - characterised as its TFA salt; brown solid; intense 
pigmentation precluded measurement of [a]~; UV (MeOH) Amax 242.9 (e 7 900), 317.1 
(e 3 900), 374.7 (e 1 900); 1 H NMR (DMSO-ds) and 13C NMR (DMSO-ds) see TABLE 
3.2 (section 3.3); HRFABMS m/z 318.1252 (M+Ht (calcd for C19H1sN302' 318.1243). 
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Tsitsikammamine C [92] - characterised as its TFA salt; brown solid; intense 
pigmentation precluded measurement of [a]~; IR (film) 1690, 1670, 1590, 1550, 1540, 
1430,1410,1320,1200,1170,1130 cm-1; UV (ryJeOH) "max 204.5 (8 13600),254.4 (8 
202(0), 382.4 (8 7600); 1H NMR (OMSO-ds) and 13C NMR (OMSO-ds) see TABLE 3.3 
(section 3.3); 1H NMR (C0300) 5 7.70 (2H, 5, H-1 and H-5), 3.81 (2H, t, J = 7.4 Hz, H-
17),3.72 (2H, t, J = 5.4 Hz, H-8), 2.78 (2H, t, J = 7.4 Hz, H-16), 2.10 (2H, t, J = 5.5 Hz, 
H-7); 13C NMR (C0300) 5172.8 (5, C-3), 165.4 (5, C-11), 155.2 (5, C-r9),~153.6 (5, C-
10),-152.6 (d, C-1), 152.6 (d, C-5), 126.1 (5, C-21), 125.4 (5, C-12), 124.4 (5, C-2), 
124.4 (5, C-4), 121.3 (5, C-15), 112.9 (5, C-14), 93.3 (5, C-20), 46.1 (5, C-6), 45.1 (t, C-
17),39.7 (t, C-8), 35.2 (t, C-7), 19.1 (t, C-16); HRFABMS m/z539.8544 (M+Ht (calcd 
for C1sH13N30/9Br3, 539.8558). 
Tsitsi~ammamine 0 [93] - characterised as its TFA salt; brown solid; intense 
pigmentation precluded measurement of [a]~ ;UV (MeOH) "max 249.3 (8 11 900),381.8 
(85400); 1H NMR (OMSO-ds) and 13C NMR (OMSO~ds) see TABLE 3.4 (section 3.3); 
HRFABMS m/z 541.8710 (M+Ht (calcd for C1sH1SN30/9Br3, 541.8714) .. 
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7.S EXPERIMENTAL: CHAPTER FOUR 
COLLECTION AND IDENTIFICATION - Yellow and grey colour variants of the soft 
coral Capnel/a thyrs-oidea were collected u~ing SCUBA (-30 m) in the Tsitsikamma 
Marine Reserve in May 1993 and May 1994. Voucher specimens of the yellow (No. 94-
003) and grey (No 94-004) soft corals reside at Rhodes University. The animals were 
identified by Dr G. Williams of the California Academy of Sciences. 
EXTRACTION AND ISOLATION - Portions of the EtOAc extracts of the freeze-dried 
yellow and grey colour variants were fractionated according to SCHEME 4.1 and 
SCHEME 4.2 (section 4.2) respectively. The yellow colour variant yielded 5a-pregna-
1,20-dien-3-one [97] (80.2 mg) together with the diterpene,tsitsixenicin A [100] (23.3 
mg),_while the grey colour variant gave 16~-hydroxy-5a-pregna-1,20-dien-3-one 16-
acetate [98] (7.5 mg), 3a,16~-cJihydroxy-5a-pregna-1,20-diene 3, 16-diacetate [99] (4.8 
mg) and tsitsixenicins A [100] (67.8 mg), B [101] (5.6 mg), C [102] (5.9 mg) and D 
[103] (8.3 mg). 
Sa-Pregna-1,20-clien-3-one [97] - white needles; mp 125-126 °C; [a]~ +45 0 (c 1.11, 
CHCI3); IR (CHCI3) 2943,2873, 1674, 1448, 1274, 1213,918 cm-1; 1H NMR (CDCI3) (5 
7.13 (1H, d, J1.2= 10.2 Hz, H-1), 5.83 (1H, d, J1.2= 10.0 Hz, H-2), 5.74 (1H, td, J = :16.5, 
10.8,8.8 Hz, H-20), 4.95 (2H, m, H-21), 2.35 (1H, dd, J = 17.7,14.1 Hz, H-4), 2.20 (1 H, 
dd, J = 17.7, 3.6 Hz, H-4), 1.95 (1H, m, H-17), 1.66 (1H, m, H-16), 1.55 (1H, m, H-6), 
1.45 (1H, m, H-8), 1.42 (2H, m, H-11), 1.42 (1H, m, H-15), 1.18 (1H, m, H-16), 1.08 (1H, 
m, H-14), 1.07 (1 H, m, H-12), 1.00 (3H, s, H-19), 0.99 (1 H, m, H-7), 0.97 (1 H, m, H-9), 
0.61 (3H, s, H-18); 13C NMR (CDCI3) see TABLE 4.1 (section 4.3); ElMS (70 eV) m/z 
(int. %) 298 (M+, 11),283 (29),134 (36),122 (100),121 (41),95 (42),79 (52),67 (35); 
HREIMS m/z 298.2313 (calcd for C21H300, 298.2296). 
16~-Hydroxy-Sa-pregna-1,20-clien-3-one 16-acetate [98] - colourless oil; [a]~ +91 0 
(c 0.58, CHCI3); IR (CHCI3) 2939, 1729, 1669, 1609, 1256 cm-1; 1H NMR (CDCI3) (5 7.12 
(1H, d, J1,2 = 10.2 Hz, H-1), 5.85 (1H, d, J 1,2= 10.2 Hz, H-2), 5.77 (1H, td, J = 17.1, 
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10.5,8.9 Hz, H-20), 5.11 (1H, m, H-16), 5.08 (2H, m, H-21), 2.36 (1H, dd, J = 17.6,14.1 
Hz, H-4), 2.21 (2H, dd, J = 17.7,4.0 Hz, H-4), 2.12 (1H, dd, J17,20 = 7.7 Hz, J16,17 = 4.1 
Hz, H-17), 2.02 (3H, 5, OAc), 1.95 (1H, m, H-5), 1 .. 85 (1H, m, H-11), 1.77 (1H, m, H-15), 
1.74 (1H, m, H-12), 1.67 (1H, m, H-7), 1.56 (1H,·m, H-11), 1.47 (1H, m, H-8), 1.45 (1H, 
m, H-6), 1.42 (1H, m, H-15), 1.41 (1H, m, H-6), 1.38 (1H, m, H-14), 1.20 (1H, m, H-12), 
1.02 (1 H, m, H-9), 1.01 (3H, 5, H-19), 0.98 (1 H, m, H-7), 0.69 (3H, s, H-18); 13C NMR 
(CDCI3) see TABLE 4.1 (section 4.3); ElMS (70 eV) m/z (int. %) No M"'; 296 (41), 122 
(73)~ 121 (45), 107, (45), 94 (73), 79 (76),43 (100); HREIMS m/z 356.2338 (calcd for 
C23H3203, 356.2351). 
3a,16J3-Dihydroxy-5a-pregna-1,20-diene 3,16-diacetate [99] - colourless oil; [aW 
+133 0 (cO.53, CHCI3); IR (CHCI3) 3029,2934,1726,1482,1378,1257,1039 cm-1; 1H 
NMR (CDCI3) 5 6.18 (1 H, d, 10.0 Hz, H-1 ),.5.76 (1 H, td, J =17.1, 10.4,8.9 Hz, H-20), 
5.60 (1 H, ddd, J1,2 = 10.0 Hz, J2,3 = 5.5 Hz, J2,4 = 1.2 Hz, H-2), 5.15 (1 H, m, H-3), 5.08 
(1H, m, H-16), 5.04 (2H, m, H-21), 2.13 (1H, t, J = 7.7 Hz, H-17), 2.04 (3H, 5, OAc), 
2.02 (3H, s, OAc) , 1.85 (1H, m, H-11), 1.81 (1H, m, H-4), 1.76 (1H, m, H-15), 1.71.-(1H, 
'.' 
m, H-12), 1.68 (1H, m, H-7), 1.58 (1H, m, H-11), 1.58 (1H, m, H-5), 1.53 (1H, m, H-4), 
1.40 (1H, m, H-8), 1.37 (1H, m, H-15), 1.37 (1H, m, H-14), 1.37 (2H, m, H-6), 1.14 (1H, 
m, H-12), 1.02 (1 H, m, H-7), 0.99 (1 H, m, H-9), 0.81 (3H, 5, H-19), 0.66 (3H, 5, H-18); 
13C NMR (CDCI3) see TABLE 4.1 (section 4.3); ElMS (70 eV) m/z (int. %) No M+, 120 
. ~ - . 
(43), 105 (76), 95 (36), 94 (54), 91 (72),.43 (100); HREIMS m/z 400.2609 (calcd for 
C2sH3604' 400.2613). 
Saponification of 16J3-hydroxy-5a-pregna-1,20-dien-3-one 16-acetate [98] - a 
solution of [98] (3.4 mg) in EtOH (1 mL) was refluxed at 80 °C for 1 h with ethanolic 
KOH (0.24 mmol). H20 was added and the EtOH removed under reduced pressure. 
The aqueous solution was acidified, extracted with ether, dried over anhyd. Na2S04, 
filtered and concentrated to yield [107] (3.0 mg). 
16J3-Hydroxy-5a-pregna-1,20-dien-3-one [107] - yellow oil; [a]~ +120 (c 0.24, 
CHCI3); 1H NMR(CDCI3) 5 7.13 (1H, d, J = 10.2 Hz, H-1), 5.85 (1H, d, J = 10.7 Hz, H-
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2),5.81 (1 H, m, H-20), 5.14 (2H, m, H-21), 4.22 (1 H, m, H-16), 2.36 (1 H, dd, J = 17.6, 
14.1 Hz, H-4), 2.22 (1 H, dd, J = 18.3, 4.2 Hz, H-4), 1.92 (1 H, m, H-5), 1.00 (3H, 5, H-
19),0.68 (3H, 5, H-18); 13C NMR (CDCI3) 5 200 .. 1 (5, C-3), 158.2 (d, C-1), 136.8 (d, C-
20),-127.5 (d, C-2), 117.2 (t, C-21), 76.5 (d, 0-16),66.2 (d, C-17), 53.2 (d, C-'14), 50.3 
(d, C-9), 44.9 (5, C-13), 44.4 (d, C-5), 41.0 (t, C-4), 39.9 (5, C-10), 37.3 (5, C-12), 35.6 
(d, C-8), 35.3 (t, C-11), 31.3 (t, C-7), 27.6 (t, C-6), 20.4 (t, C-15), 14.4 (q, C-18), 13.1 
(q, C-19). 
Reduction of 3a,16~-dihydroxy-5a-pregna-1,20-diene 3,16-diacetate [99] - LiAIH4 
(8 mg) was added to a stirred solution of [99] (3.5 mg) in dry ether (2 mL). The solution 
was cooled in ice and 5% NaOH (2 mL) was added. The basic solution was extracted 
with ether, dried over anhyd. Na2S04, filtered and concentrated to give [108] (3.1 mg). 
5a-pregna-1,20-dien-3a, 16~-diol [108] - white solid; [a]~ -63 0 (c 0.20, CHCI3); 1H 
NMR (CDCI3) 5 6.06 (1 H, d, J = 10.0 Hz, H-1), 5.81 (1 H, m, H-20), 5.65 (1 H, m, H-2), 
5.12 (2H, m, H-21), 4.22 (1H, td, J = 8.8,2.1 Hz, H-16), 4.08 (1H, td, J = 4.5 Hz,H-3); 
13C NMR (CDCI3) 5140.3 (d, C-1), 136.9 (d, C-20), 126.2 (d, C-2), 116.9 (t, C-21), 76.6 
(d, C-16), 66.3 (d, C-17), 64.4 (d, C-3), 53.4 (d, C-14), 51.3 (d, C-9), 45.0 (5, C-13), 
39.0 (5, C-5), 38.3 (5, C-10), 35.7 (t, C-12), 35.4 (d, C-8), 34.8 (t, C-11), 31.9 (t, C-4), 
29.7 (t, C-7), 27.9 (t, C-6), 20.3 (t, C-15), 14.4 (q, C-18), 13.9 (q, C-19). 
Tsitsixenicin A [100] - yellow oil; [a]~ -64 0 (c 0.9, CHCI3); IR (CHCI3) 3090, 3038, 
1960,1821,1735,1482, 1230, 1039 cm-1; 1H NMR (CDCI3) and 13C NMR (CDCI3) see 
TABLE 4.2 (section 4.3); ElMS (70 eV) m/z (int. %) No M+, 231 (11), 83 (38), 69 (19), 
55 (17), 43 (100); HREIMS m/z 402.2398 (calcd for C24H340S' 402.2406). 
Tsitsixenicin B [101] - colourless oil; [a]~ -38 0 (c 0.49, CHCI3); IR (CHCI3) 2960, 
2934,2864,1726,1239,1074 cm-1; 1H NMR (CDCI3) 5 6.51 (1H, d, J = 1.3 Hz, H-3), 
5.87 (1h, d, J = 3.3 Hz, H-1), 5.24 (1 H, t, J = 7.6 Hz, H-12), 5.06 (1 H, br 5, H-19), 4.95 
(1H, m, H-14), 4.93 (1H, br 5, H-19'), 2.98 (1H, dd, J = 3.2,10.8 Hz, H-8), 2.43 (1H, m, 
H-11 a), 2.41 (1 H, m, H-5), 2.41 (1 H, m, H-13), 2.38 (1 H, m, H-4a), 2.23 (1 H, m, H-5'), 
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2.23 (1 H, m, H-13'), 2.22 (1 H, m, H-9), 2.19 (1 H, m, H-6), 2.08 (3H, s, OAc), 2.00 (3H, 
s, OAc) , 1.67 (3H, s, H-17), 1.61 (3H, s, H-16), 1.43 (1 H, m, H-9'), 1.35 (2H, m, H-10), 
1.31 (3H, s, H-18), 1.19 (1 H, m, H-6,);13C NMR. (CDCI3) see TABLE 4.3 (section 4.3); 
ElMS (70 eV) m/z (int. %) No M+, 167 (31<),·149 (100), 83 (25), 71 (22),' 43 (75); 
HREIMS m/z418.2378 (calcd for C24H340S' 418.2355). 
Tsitsixenicin C [102] - colourless oil; [a]~ -139 0 (c 0.60, CHCI3); IR (CHCI3) 3620, 
3029,2934,1735,1613,1221,1013 cm-1; 1H NMR (CDCI3) 0 7.25 (1H, d, J = 2.0 Hz, 
H-3), 6.82 (1H, d, J 13,14= 15.8 Hz, H-14), 6.51 (1H, d, J13,14 = 15.8 Hz, H-13), 6.14 (1H, 
d, J = 2.3 Hz, H-1), 5,59 (1 H, m, H-9), 5.40 (1 H, d, Ja,9 = 11.9 Hz, H-8), 5.14 (2H, d, J 
= 7.0 Hz, H-19), 3.44 (1H, m, H-4a), 3.17 (1H, m, H-10), 2.89 (1H, m, H-6), 2.63 (1H, 
m, H-10'), 2.63 (1H, m, H-11a), 2.06 (3H, s, OAc) , 2.04 (3H, s, OAc), 1.73 (1 H, m, H-5), 
1.61 J~H, s, H-18), 1.57 (1H, m, H-5'), 1.46 (1H, m, H-6'), 1.40 (3H, s, H-16), 1.39 (3H, 
s, H-17); 13C NMR (CDCI3) see TABLE 4.3 (section 4.3); ElMS (70 eV) m/z (int. %) No 
M+, 91 (13),85 (24),83, (32),69 (15), 55 (14), 43 (100); HREIMS m/z 432.1961 (calcd 
for C24H3207' 432.1948). 
Tsitsixenicin D [103] - colourless oil; [a]~ -126 0 (c 0.81, CHCI3); IR (CHCI3) 3029, 
2934,1735,1613,1230,1013 cm-1; 1H NMR (CDCI3) 0 7.26 (1H, d, J = 2.0 Hz, H-3), 
6.12 (1 H, d, J = 2.3 Hz, H-1), 5.57 (1 H, m, H-9), 5.41 (1 H, d, Ja,9 = 11.8 Hz, H-8), 5.30 
(1H, t, J = 7.0 Hz, H-14), 5.12 (2H, d, J = 8.3 Hz, H-19), 3.32 (1H, m, H-4a), 3.25 (2H, 
t, J = 5.6 Hz, H-13), 3.16 (1 H, m, H-10), 2.84 (1 H, br t, J = 12.2 Hz, H-6), 2.65 (1 H, m, 
H-10'), 2.60 (1 H, d, J = 12.3 Hz, H-11a), 2.04 (3H, s, OAc) , 2.04 (3H, s, OAc), 1.74 (3H, 
d, J = 1.0 Hz, H-16), 1.69 (1 H, m, H-5), 1.64 (3H, s, H-17), 1.59 (3H, s, H-18), 1.55 (1 H, 
m, H-5'), 1.43 (1 H, m, H-6'); 13C NMR (CDCI3) see TABLE 4.3 (section 4.3); ElMS (70 
eV) mlz (int. %) No M+, 245 (19),135 (14),85 (22),83 (27), 69 (22), 55, (14),43 (100); 
HREIMS m/z 416.2174 (calcd for C24H320S' 416.2199). 
Methylation of tsitsixenicin A [100] - a solution of tsitsixenicin A (33 mg) in MeOH 
(4 mL) was refluxed for 90 min, concentrated, and purified by normal phase HPLC (7% 
EtOAc/hexane) to give compound [111] (17 mg). 
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Methylation product [111] - colourless oil; [a]~ -95 0 (c 0.15, CHCI3); 1H NMR 
(CDCI3) (5 5.78 (1 H, d, J = 2.3 Hz, H-1), 5.41 (1 H, dd, J = 11.2, 3.6 Hz, H-8), 5.39 (1 H, 
t, J = 7.3 Hz, H-12), 5.15 (1H, t, J = 7.0 Hz, H-14) .. 5.06 (1H, s, H-3), 3.37 (3H, s, OMe), 
1.96-(3H, s, OAe); 13C NMR (CDCI3) (5 170.0 (s), 135.2 (s), 132.7 (s), 125.4 (d), 121.5 
(d), 113.9 (t), 1 03.4 (d), 90.2 (d), 54.8 (q), 40.4 (t), 27.0 (t), 25.6 (t), 25.6 (q), 21.3 (q), 
17.4 (q). 
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7.6 EXPERIMENTAL: CHAPTER FIVE 
COLLECTION AND IDENTIFICATION - The orange soft coral A/cyonium species A 
was collected using SCUBA (-24 m) in the Tsitsikamma Marine Reserve in M'ay 1994. 
The yellow-white soft coral A/cyonium species B was collected using SCUBA (-20 m) 
from Aliwal Shoal in June 1994. Voucher specimens for species A (No. 94-001) and for 
species B (No. SAF94-013) are housed at Rhodes University. 
EXTRACTION AND ISOLATION - A portion of the EtOAc extract of the freeze-dried 
species A soft coral was fractionated according to SCHEME 5.1 (section 5.2). The 
fractionation yielded the new polyhydroxysterols, cholest-5-ene-3~,7~, 19-triol 19-
acetate [121] (11.9 mg) and cholest-5,24-diene-3~,7~, 19-trio119-acetate [122] (21.5 
mg). Two separate portions of the EtOAc extract of the freeze-dried species B soft coral 
were fractionated according to SCHEME 5.2 (section 5.2). The fractionation yielded the 
xenicane compounds 9-deacetoxy-14, 15-deepoxyxeniculin [110] (184.6 mg), zahavin 
A [16] (15.9 mg), 7-epoxyzahavin A [123] (8.9 mg) and xeniolide C [124] (1 ~Jmg). 
Cholest-5-ene-3~,7~,19-trioI19-acetate [121] - colourless oil; [a]~ -24 0 (c 0.47, 
CHCI3); IR (film) 3380,2940,2880,1740,1230, 1040 cm-1; 1H NMR (CDCI3) 5 5.52 (1 H, 
brs, H-6), 4.48 (1H, d, Jgem = 11.9 Hz, H-19), 3.98 (1H, d, Jgem = 11.9 Hz, H-19')r ;3.80 
(1 H, d, J7,8 = 7.8 Hz, H-7), 3.56 (1 H, m, H-3), 2.39 (1 H, m, H-4eq), 2.27 (1 H, m, H-4ax), 
2.05 (3H, s, OAc) , 1.65 (1 H, m, H-8), 0.85 (3H, d, J2526 = 6.6 Hz, H-26), 0.91 (3H, d, 
J21 ,20 = 6.5 Hz, H-21), 0.85 (3H, d, J25,27 = 6.6 Hz, H-27), 0.70 (3H, s, H-18); 13C NMR 
(CDCI3) see TABLE 5.2 (section 5.3) m/z (int. %) No M+, 442 (24), 400 (22),382 (19), 
174 (36),161 (66), 143 (49),105 (50),91 (52),43 (100); HREIMS m/z460.3541 (calcd 
for C2sH4804' 460.3552). 
Cholest-5,24-diene-3~,7~,19-triol 19-acetate [122] - colourless oil; [a]~ -25 0 (c 
0.58, CHCI3); IR (film) 3380,2940,2880, 1740, 1230, 1040 cm-1; 1H NMR (CDCI3) 5 
5.52 (1 H, br s, H-6), 5.08 (1 H, t, J23,24 = 7.1 Hz, H-24), 4.48 (1 H, d, Jgem = 11.9 Hz, H-
19),3.98 (1H, d, Jgem= 11.9 Hz, H-19'), 3.80 (1H, d, J7,8 = 7.8 Hz, H-7), 3.57 (1H, m, H-
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3), 2.39 (1 H, m, H-4eq), 2.27 (1 H, m, H-4ax), 2.06 (3H, s, OAc), 2.02 (2H, m, H-23), 
1.67 (3H, s, H-27), 1.59 (3H, s, H-26), 0.93 (3H, d, J21 ,20 = 6.5 Hz, H-21), 0.70 (3H, s, 
H-18); 13C NMR (CDCI3) see TABLE 5.2 (section 5.3);EIMS (70 eV) m/z (int. %) No M+, 
440 {13), 349 (13),197 (16),161 (38), 143 (~~), 141 (52),91 (42),69 (100),A3 (45); 
HREIMS m/z 458.3391 (calcd for C29H4S04' 458.3396). 
Acetylation of cholest-5-ene-3J3,7J3,19-triol 19-acetate [121]- A~Q (1 mL) was 
add~d to a solution of [121] (7.1 mg) in pyridine (1 mL) and the reaction was left 
overnight. EtOH (1.5 mL) was added to quench the excess A~O and the solution was 
concentrated in vacuo. The product was dissolved in EtOAc, filtered through a celite 
column and concentrated under reduced pressure to yield [134] (8.5 mg). 
Cholest-5-ene-3J3,7J3,19-trioI3J3,7J3,19-triacetate [134] - colourless oil; [a]~ +180 (c 
0.70, CHCI3); 1H NMR (CDCI3) 5 5.47 (1 H, d, JS,7 = 2.1 Hz, H-6), 4.99 (1 H, d, J7,8 = 8.4 
Hz, H-7), 4.61 (1 H, m, H-3), 4.59 (1 H, d, Jgem = 11.9 Hz, H-19), 3.94 (1 H, d, J gem = 11.~ 
Hz, H-19'), 2.38 (2H, br d, J34 = 7.9 Hz, H-4), 2.08 (3H, s, OAc), 2.01 (3H, s, OAc), 2.00 , - .... 
(3H, s, OAc) , 0.90 (3H, d, J21 ,20 = 6.5 Hz, H-21), 0.85 (3H, d, J2S,25 = 6.6 Hz, H .. 26) , 0.85 
(3H, d, J27,25 = 6.6 Hz, H-27), 0.70 (3H, s, H-18); 13C NMR (CDCI3) 5 171.0 (s, OAc), 
170.6 (s, OAc) , 170.3 (s, OAc) , 139.0 (s, C-5), 126.4 (d, C-6), 74.5 (d, C-7), 72.7 (d, C-
3),64.0 (t, C-19), 56.2 (d, C-14), 55.4 (d, C-17), 48.2 (d, C-9), 43.0 (s, C-13), 39.8 (t, 
C-12), 39.6 (s, C-10), 39.5 (t, C-24), 37.6 (t, C-4), 37.6 (d, C-8), 36.1 (t, C-22), 35:7 (d, 
C-20), 33.2 (t, C-1), 28.3 (t, C-16), 28.0 (d, C-25), 27.8 (t, C-2), 24.9 (t, C-15), 23.8 (t, 
C-23), 22.8 (q, C-26), 22.5 (q, C-27), 21.6 (t, C-11), 21.6 (q, OAc), 21.3 (q, OAc), 21.0 
(q, OAc), 18.7 (q, C-21), 11.8 (q, C-18); ElMS (70 eV) mlz (int. %) No M+, 424 (33), 382 
(32), 157 (43), 156 (48),145 (38), 143 (100), 141( (70), 43 (94). 
Reduction of cholest-5-ene-3J3, 7J3, 19-triol 19-acetate [121] - the fractionation 
procedure in SCHEME 5.1 (section 5.2) was repeated in order to isolate further [121] 
for this reduction. LiAIH4 was added to a stirred solution of [121] (19.2 mg) in dry ether 
(6 mL). After 20 min 5% m/v KOH (8 mL) was added to terminate the reaction. The 
basic solution was extracted with ether which was then dried over anhyd. Na2S04, 
176 
filtered and concentrated under reduced pressure to yield [135] (10.4 mg). 
Cholest-5-ene-3J3,7J3,19-triol [135] -white solid; mp 160 - 162 °C; [a]~ +35 0 (c 0.17, 
CHCI3); 1H NMR (CDCI3) 6 5.65 (1 H, br s; H-6), 3.83 (1 H, d; Jgem = 11.6 Hz, H-19), 3.62 
(1 H, d, Jgem = 11.6 Hz, H-19'), 0.91 (3H, d, J21 ,20 = 6.5 Hz, H-21), 0.86 (3H, d, J26,25 = 6.6 
Hz, H-26), 0.86 (3H, d, J27,25 = 6.6 Hz, H-27), 0.74 (3H, s, H-18); 13C NMR (CDCI3) see 
TABLE 5.2 (section 5.3). 
9-Deacetoxy-14,15-deepoxyxeniculin [110] - colourless oil; [a]~ = +126.9° (c 0.86, 
CHCI3); IR (film) 2970,2930,2860, 1735, 1670, 1445, 1370, 1230, 1155, 1015, 1015 
cm-1; 1H NMR (CDCI3) and 13C NMR (CDCI3) see TABLE 5.4 (section 5.3); ElMS (70 eV) 
m/z (int. %) No M+, 359 (2),349 (21),342 (4),333 (13),291 (14),231 (25), 149 (25), 
91 (37), 69 (38), 43 (100); HREIMS m/z 402.2419 (calcd for C24H3405' 402.2406). 
Zahavin A [16] - colourless oil; [a]~ +21.5° (c 0.77, CHCI3); IR (film) 2960, 2920, 
2850,1735,1365,1230,1155,1010 cm-1; 1H NMR (CDCI3) and 13C NMR (CDCI3) see 
TABLE 5.5 (section 5.3); ElMS (70 eV) m/z (int. %) No M+, 417 (1), 297 (4), ,243 (9), 
149 (30), 105 (23), 91 (20), 83 (23), 69 (16), 43 (100); HREIMS m/z 460.2448 (calcd 
for C26H3607' 460.2459). 
7-Epoxyzahavin A [123] - colourless oil; [a]~1 +121.r (c 0.34, CHCI3); IR (film) 2970, 
2940,2870,1740,1440,1372,1235,1162,1020,915 cm-1; 1H NMR (CDCI3) and 13C 
NMR (CDCI3) see TABLE 5.5 (section 5.3); ElMS (70 eV) m/z (int. %) No M+, 417 (1), 
356 (5),297 (6), 243 (15), 149 (23), 145 (23), 105 (23),91 (27),81 (25),69 (17), 43 
(100); HREIMS m/z 476.2419 (calcd for C26H360S' 476.2408). 
Xeniolide C [124] - colourless oil; [a]~ +96.4° (c 1.17, CHCI3); IR (film) 2970,2925, 
2870,1735,1645,1438,1365,1225,1025 cm-1; 1H NMR (CDCI3) and 13C NMR (CDCI3) 
see TABLE 5.6 (section 5.3); ElMS (70 eV) m/z (int. %) No M+, 298 (9), 246 (60), 203 
(20), 145 (37), 105 (48),91 (82),79 (57),43 (100); HRIEMS m/z 358.2158 (calcd for 
C22H3004' 358.2143). 
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Attempted saponification of zahavin A [16] - dry K2C03 (56.0 mg) was dissolved 
in H20 (0.5 mL) and added to a stirred solution of [1~] (18.0 mg) in MeOH (6 mL). The 
reaction was monitored by reverse phase TLC. After 16 h, H20 (4.5 mL) was added and 
the MeOH was removed under reduced pressure. The aqueous layer was extracted 
with EtOAc which was then dried over anhyd. Na2S04 and concentrated in vacuo. TLC 
and 1 H NMR spectroscopy suggested the presence of numerous rearrangment 
products. These products could not separated and purified by normal phase HPLC, with 
the exception of the rearrangement compound [139] (1.3 mg) (80% hexlEtOAc). 
Rearrangment compound [139] - colourless oil; [0]61 -76.4 0 (c 0.16, CHCI3); 1H NMR 
(CDCI3) (5 9.43 (1 H, 5, H-20), 6.65 (1 H, 5, H-12), 5.91 (1 H, d, J = 5.3 Hz, H-10), 5.49 
(1H, t, J = 8.3 Hz, H-5), 5.19 (1H, 5, H-18), 5.00 (1H, 5, H-18'), 4.90 (1H, 5, H-15), 4.66 
(1 H, 5) H-15'), 4.61 (1 H, 5, H-16), 2.90 (1 H, m, H-1), 2:45 (1 H, m, H-6), 2.36 (1 H, m, H-
9), 2.30 (1 H, m, H-3), 2.30 (2H, m, H-7), 2.17 (1 H, m, H-3'), 2.17 (1 H, m, H-6'), 1.69 
(3H, 5, H-14), 1.63 (3H, 5, H-19), 1.51 (2H, m, H-2); 13C NMR (CDCI3) (5 193.6 (d), 
156.3 (5),145.1 (5),140.9 (5),139.8 (d), 136.1 (5),134.3 (d), 130.2 (5),125.0 (d),j 14.3 
(t), 111.6 (t), 77.2 (d), 49.5 (d), 39.8 (t), 37.7 (d), 35.8 (t), 34.4 (t), 25.3 (t), 18.7 (q), 16.9 
(q); HREIMS m/z 298.1939 (calcd for C2oH3602' 298.1933). 
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7.7 EXPERIMENTAL: CHAPTER SIX 
COLLECTION AND IDENTIFICATION - A bright pink colour variant of the soft coral 
A/cyanium tauri was -collected using SCUBA' (;'15 m) at Riet Point near Port'Alfred in 
September 1994. A voucher specimen (No. PA94-002) resides at Rhodes University. 
The animals were identified by Dr G. Williams of the California Academy of Sciences. 
EXTRACTION AND ISOLATION - A portion of the EtOAc extract of the freeze-dried 
soft coral was fractionated according to SCHEME 6.1 (section 6.2). The fractionation 
yielded the new sesquiterpene hydroquinone rietone [141] (424.1 mg) in high yield, 
together with the minor compounds 8'-acetoxyrietone [142] (16.9 mg) and 8'-
desoxyrietone [143] (3.9 mg). 
Rietone [141] - orange oil; [a]g' +95 0 (c 0.8, CHCI3); IR (CHCI3) 3340, 3030, 2920, 
1730, 1680, 1620, 1510, 1432, 1230, 1020 cm-1; UV (MeOH) "max 209.0 (89600),235.0 
(8 7 400), 297.0 (8 2 400); 1H NMR (CDCI3) and 13C NMR (CDCI3) see TA,BLE 6.1 
(section 6.3); ElMS (70 eV) m/z (int. %) 416 (M+, 2),333 (17),195 (34),163 (26),149 
(11), 83 (100), 55 (28); HREIMS m/z 416.2188 (calcd for C24H320S' 416.2199). 
8'-Acetoxyrietone [142] - orange oil; [am +1330 (c 0.9, CHCI3); IR (CHCI3) ~~50, 
3030,2930,1730, 1620, 1440, 1230, 1020 cm-1; 1H NMR (CDCI3) and 13C NMR (CDCI3) 
see TABLE 6.2 (section 6.3); ElMS (70 eV) m/z (int. %) 457 (M+, 2), 233 (9), 189 (11), 
149 (19),135 (8),85 (14),83 (100),55 (18),43 (18); HREIMS m/z 458.2294 (calcd for 
C2sH3407,458.2303). 
8'-Desoxyrietone [143] - orange oil; IR (CHCI3) 3340, 3030, 2920, 1730, 1680, 1620, 
1440, 1350, 1200, 1000 cm-1; 1H NMR (CDCI3) and 13C NMR (CDCI3) see TABLE 6.2 
(section 6.3); ElMS (70 eV) m/z (int. %) 400 (M+, 5),212 (3),151 (4), 123 (5),84 (6), 
83 (100), 55 (17); HREIMS m/z 400.2265 (calcd for C24H320S' 400.2250). 
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Oxidation of reitone [141] - A920 (500 mg) and M92S04 (500 mg) were added to a 
stirred solution of reitone (167 mg) in ether (20 mL). The solution was refluxed for 30 
min, filtered through celite, and concentrated in vacuo to yield a dark red oil. TLC 
indiCated the presence of starting material which was removed by normal phase HPLC 
(35% EtOAc/hexane) to give the sesquiterpene quinone [163] (21.3 mg) in low yield. 
Sesquiterpene quinone [163] - red oil; [a]~ +231 0 (c 0.9, CHCI3); )H NMR (CDCI3) 
~ 6.68 (1H, 5, AH-6), 6.54 (1H, 5, AH-3), 6.12 (1H, 5, H-10'), 5.59 (1H, t, J = 5.8 Hz, H-
6'),5.18 (1H, t, J = 7.2 Hz, H-2'), 4.42 (1H, d, J = 4.3 Hz, BH-8'), 4.13 (1H, d, J = 4.4 Hz, 
BOH-8'), 3.70 (3H, 5, OMe), 3.43 (2H, d, J = 1.1 Hz, H-1"), 3.13 (2H, d, J = 7.2 Hz, H-1'), 
2.23 (2H, m, H-5'), 2.20 (3H, 5, H-12'), 2.14 (2H, m, H-4'), 1.91 (3H, 5, H-15'), 1.64 (3H, 
5, H-13'), 1.42 (3H, 5, H-14'); 13C NMR (CDCI3) ~ 199.1 (5), 187.3 (5),186.8 (5),169.7 
(5),159.8 (5),148.6 (5),141.5 (5),139.6 (5),135.1 (d), 133.4 (d), 132.2 (d), 131.8 (d), 
118.8 (d), 118.2 (d), 83.3 (d), 52.4 (q), 39.0 (t), 34.4 (t), 28.0 (q), 27.2 (t), 26.5 (t), 21.3 
(q), 16.1 (q), 10.9 (q) - (protons with identical superscripts may be interchanged). ~ 
Acetylation of rietone [141] - A~O (1 mL) was added to a solution of rietone (27.8 
mg) in pyridine (1 mL) and the reaction was left overnight. EtOH (1.5 mL) was added 
to quench the excess A~O and the solution was concentrated in vacuo to yield 2,5,8'-
triacetoxyrietone [164] (30.8 mg). 
Acetylation of 8'-acetoxyrietone [142]- the acetylation of [142] (4.8 mg) was 
conducted under the same conditions as were used for rietone and the resulting 2,5,8'-
triacetoxyrietone product (5.8 mg) was identical to [164] with respect to [aW, IR and 
NMR data. 
2,5,8'-Triacetoxyrietone [164] - orange oil; [a]~ +1420 (c 1.5, CHCI~; IR(CHCI ~ 
3030,1740,1620,1440,1370,1230,1170,1020,920 cm-1; 1H NMR (CDCI3) ~ 7.00 
(1 H, 5, H-3), 6.93 (1 H, 5, H-6), 6.08 (1 H, 5, H-10'), 5.67 (1 H, t, J = 6.5 Hz, H-6'), 5.36 
(1H, 5, H-8'), 5.22 (1H, t, J = 7.2 Hz, H-2'), 3.65 (3H, 5, OMe), 3.49 (2H, 5, H-1"), 3.20 
(2H, d, J = 7.2 Hz, H-1'), 2.27 (6H, 5, OAc-2 and OAc -5),2.18 (2H, m, H-5'), 2.14 (3H, 
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5, H-12'), 2.13 (3H, 5, OAe-8'), 2.10 (2H, m, H-4'), 1.86 (3H, 5, H-15'), 1.66 (3H, 5, H-
13'),1.58 (3H, 5, H-14'); 13C NMR (CDCI3) 0193.7 (5, C-9'), 170.7 (5, C-2"), 170.1 (5, 
OAe-8'), 169 (5, OAe-2 and OAe -5),158.7 (5, C-11'), 146.6 (5, C-5), 146.3 (5, C-2), 
136.l3 (5, C-3'), 133.5-(d, C-6'), 133.7 (5, C-1);<129.2 (5, C-7'), 125.1 (5, C-4), 124.7 (d, 
C-3), 123.6 (d, C-6), 121.3 (d, C-2'), 119.6 (d, C-10'), 84.7 (d, C-8'), 52.1 (q, OMe), 38.7 
(t, C-4'), 35.9 (t, C-1"), 28.3 (q, C-12'), 27.9 (t, C-1'), 26.5 (t, C-5'), 20.8 (q, C-15'), 20.8 
(q, OAe-8', OAe-5 and OAe-2), 16.2 (q, C-13'), 12.2 (q, C-14'); ElMS f70-eV) m/z (int. 
%) !;i42 (M+, 1),417 (14),275 (4),196 (8),195 (7),149 (9),84 (9),83 (100),55 (14), 
43 (63); HREIMS m/z 542.2517 (ealed for C30H3809' 542.2513). 
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